City University of New York (CUNY)

CUNY Academic Works
Dissertations and Theses
6-2-2020

An Evaluation of Respiratory Exacerbation in New York City Given
Current Trends in Climate Variability and Predictive
Sociodemographic Factors
Sarah L.R. Kuril
CUNY School of Public Health, sarah.kuril04@sphmail.cuny.edu

How does access to this work benefit you? Let us know!
More information about this work at: https://academicworks.cuny.edu/sph_etds/57
Discover additional works at: https://academicworks.cuny.edu
This work is made publicly available by the City University of New York (CUNY).
Contact: AcademicWorks@cuny.edu

AN EVALUATION OF RESPIRATORY EXACERBATION
IN NEW YORK CITY GIVEN
CURRENT TRENDS IN CLIMATE VARIABILITY AND
PREDICTIVE SOCIODEMOGRAPHIC FACTORS

A DISSERTATION
by
SARAH L. R. KURIL
Concentration: Environmental and Planetary Health Sciences

Presented to the Faculty at the Graduate School of Public Health and Health Policy in partial
fulfillment of the requirements for the degree of Doctor of Philosophy

Graduate School of Public Health and Health Policy
City University of New York
New York, New York
May 2020

Dissertation Committee:
Glen Johnson, PhD
Brian Pavilonis, PhD
Ashish Joshi, MBBS, PhD, MPH

i

Copyrighted By
SARAH L. R. KURIL
2020
All rights reserved

ii

Dissertation Abstract
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Author: Sarah L. R. Kuril
Advisor: Glen Johnson, PhD

Background: Within the last century, the massive increase in emissions due to economic growth
has made climate variability a major problem for many of the industrialized countries and an
emerging problem for the rest of the world. With an increasing number of extreme weather
events, such as heat waves, cold fronts, floods, heavy rain, and storms, individuals with Chronic
Obstructive Pulmonary Disease (COPD) and asthma remain a vulnerable population, placing
them at highest risk of respiratory exacerbation. This dissertation aims to contribute to our
understanding of how climate variability, which can influence patterns of rainfall, temperature
and other variables on a wide range of timescales, and sociodemographic factors impact
respiratory disease exacerbation among New York City (NYC) residents.
Methods: Outcome variables of asthma and COPD exacerbation occurring in the inpatient and
outpatient medical settings are from the New York State Department of Health Statewide
Planning and Research Cooperative System (SPARCS). Secondary outcome variables of hospital
length of stay (LOS) and total charges for the third study are also from SPARCS. Additional
datasets include products for climate (temperature, precipitation, wind, relative humidity, PM
2.5) and socio-demographic potential predictor covariates (sex, age, race, income, poverty,
educational attainment, and type of house heating fuel). The first study uses a space-time
permutation model to determine spatial and temporal clusters of increased risk of respiratory
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exacerbation episodes across NYC neighborhoods. The second study uses Poisson regression
using a series of three models (general linear model (GLM), general linear mixed model
(GLMM) and a Bayesian spatio-temporal model) to further quantify the complexity of factors
such as overall climate and socioeconomic status (SES). The third study applies Bayesian spatiotemporal modelling to predict the expected cases into the year 2039, total hospital charges and
length of stay (inpatient setting only) based on Intergovernmental Panel on Climate Change
(IPCC) predictive climatic factors and other predictive socio-demographic and SES factors.
Results: The first study determined temporal and spatial variation of respiratory exacerbation
episodes across NYC neighborhoods throughout the study period, with disproportionate
increases in ZCTAs demonstrating geographic and hypothesized socioeconomic disparity.
Results from the second study indicate the associations between respiratory exacerbation and
predictive climate and sociodemographic factors vary according to location and are both positive
and negative (increase and decrease risk). The third study found respiratory exacerbation,
hospital length of stay and total hospital charges had a combination of positive (increase risk,
increase LOS and increase total hospital costs), negative (decrease risk, LOS, cost) and zero
associations into the year 2039 with increased temperature and precipitation projections by the
IPCC well as predictive sociodemographic and SES factors.
Conclusion: The studies in this dissertation provide additional evidence for the relationships
between climate variability, sociodemographic factors and respiratory exacerbation in New York
City. Spatio-temporal methods identify both time periods and spatial locations of increased risk
and the role of predictive factors in certain neighborhoods. For example, the first and second
studies determined neighborhoods in the south Bronx, upper Manhattan, eastern Brooklyn (as
well as parts of north-western Brooklyn), north-central Queens (near LGA airport) and southern
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Queens (near JFK airport) all presented with elevated risk. These neighborhoods are in proximity
to major highways and/or airports and are known to have the highest rates of populations that are
either in poverty or black regardless of ethnicity. Race and poverty were consistent risk factors
throughout the second and third studies, whereas increased temperatures were protective
suggesting cooler temperatures may potentially increase risk instead. The third study determined
long-term implications of IPCC projected climatic trends and predictive factors: factors
determining SES (black, poverty status) would be predictive of respiratory exacerbation into
2039, and so would age for COPD outcomes; hospital LOS and total charges would be impacted
by SES, age and IPCC projected precipitation increase, but for COPD outcomes only.
The findings from this research support on-going respiratory management goals, which
aim to improve disease management through underlying clinical components including proper
medication reconciliation, follow-up on medication adherence, education on diagnosis/prognosis
and access to resources to better track environmental conditions (e.g., weather, pollutant levels).
The results also support adaptation measures, which are aimed at factors that are difficult to
change in themselves, such as living in disadvantaged neighborhoods that are more vulnerable to
the impacts of climate variability. The findings can further translate into pragmatic and practical
measures to alleviate the variation observed in risk factors of respiratory exacerbation, including
the promotion of increased annual primary care physician visits, increased access to specialty
care within the outpatient setting, population health informatics tools to easily connect patients to
medical resources, and coalitions with local environmental justice groups to help carry out these
measures. Limitations, including spatial, temporal, and methodological issues with the data
sources are discussed, as are suggestions for future research.

v

DEDICATION
In dedication to all persons who have suffered and lost lives from Asthma, Chronic Obstructive
Pulmonary Disease (COPD) and other respiratory ailments, many simply from preventable
inequalities that are too often experienced within our communities.

vi

Table of Contents
Dissertation Abstract .................................................................................................................. iii
List of Figures ............................................................................................................................ ix
List of Tables ............................................................................................................................. xi
Acknowledgements .................................................................................................................. xiv
Disclosure ................................................................................................................................ xvi
Chapter 1. Introduction ............................................................................................................... 1
1.1 Respiratory (COPD and Asthma) Exacerbations .................................................................. 2
1.2 Climate Variability and Respiratory Exacerbation ............................................................... 6
1.3 The Effect of Socio-demographic Factors .......................................................................... 13
1.4 Overall Goal of the Dissertation ......................................................................................... 15
1.5 Specific Aims and Hypotheses .......................................................................................... 18
1.6 References ........................................................................................................................... 20
Chapter 2. The spatio-temporal distribution of Chronic Obstructive Pulmonary Disease
and Asthmatic exacerbation across New York City from 2016 to 2018: A cluster analysis
using space-time permutation modelling .................................................................................. 25
2.1 Introduction ......................................................................................................................... 25
2.2 Methods............................................................................................................................... 27
2.3 Results ................................................................................................................................. 36
2.4 Discussion ........................................................................................................................... 11
2.5 Conclusion .......................................................................................................................... 16
2.6 References ........................................................................................................................... 19
2.7 Appendix ............................................................................................................................. 23
Chapter 3. Associations between Respiratory (Chronic Obstructive Pulmonary Disease and
Asthma) Exacerbations, Socio-demographic and Climatic Predictive Factors in New York
City: A Poisson Regression Approach ...................................................................................... 35
3.1 Introduction ......................................................................................................................... 35
3.2 Methods............................................................................................................................... 42
3.3 Results ................................................................................................................................. 56
3.4 Discussion ........................................................................................................................... 94
3.5 Conclusion ........................................................................................................................ 105
3.7 References ......................................................................................................................... 110
Chapter 4. Bayesian Spatio-temporal Modelling to Assess the Future Burden of Socioeconomic and Climate Predictive Factors in New York City, New York ............................ 118
4.1 Introduction ....................................................................................................................... 118
4.2 Methods............................................................................................................................. 122
vii

4.3 Results ............................................................................................................................... 129
4.4 Discussion ......................................................................................................................... 147
4.5 Conclusions ....................................................................................................................... 152
4.7 References ......................................................................................................................... 157
Chapter 5. Summary of results, conclusions and future research directions...................... 162
5.1 Major findings from Chapter 2 ......................................................................................... 162
5.2 Major findings from Chapter 3 ......................................................................................... 163
5.3 Major findings from Chapter 4 ......................................................................................... 168
5.4 Significance of findings and Key strengths ...................................................................... 170
5.5 Public Health Relevance ................................................................................................... 172
5.6 Limitations ........................................................................................................................ 174
5.7 Future Research Directions ............................................................................................... 177
5.8 References ......................................................................................................................... 178

viii

List of Figures
Figure 1.1: Map of New York City Zip Code Tabulation Areas (ZCTAs) that make up the study
area. Source: The Baruch College Geospatial Data Library, OpenStreetMap ............................... 2
Figure 1.2: Ten Warmest Years (1880–2018) The above table lists the global combined land and
ocean annually-averaged temperature rank and anomaly for each of the 10 warmest years on
record. Source: NOAA.................................................................................................................... 7
Figure 1.3: Precipitation (in) to Date for New York (LaGuardia), N.Y. The 3 wettest periods
since 1940 (showcased in green) are 2011, 1983 and 1975. Source: NOAA. .............................. 10
Figure 1.4: Annual comparison of PM 2.5 levels, shown with a ZCTA overlay, 2016-2018.
Source: New York City Community Air Survey (NYCCAS), 2020 ............................................ 13
Figure 1.5: The conceptual framework informing this research proposal integrates theories of the
Social Ecological Model (SEM), and the Climate-Related Illness Vulnerability framework
(CRIV). ......................................................................................................................................... 15
Figure 2.1: Map of New York City Zip Code Tabulation Areas (ZCTAs) that make up the study
area ................................................................................................................................................ 26
Figure 2.2: Location of statistically significant (p ≤ 0.05) asthma exacerbation inpatient clusters
by order of statistical significance, New York City, 2016–2018, for space-time permutation
cluster search. .................................................................................................................................. 2
Figure 2.3: Location of statistically significant (p ≤ 0.05) asthma exacerbation outpatient clusters
by order of statistical significance, New York City, 2016–2018, for space-time permutation
cluster search. .................................................................................................................................. 3
Figure 2.4: Location of statistically significant (p ≤ 0.05) COPD exacerbation inpatient clusters
by order of statistical significance, New York City, 2016–2018, for space-time permutation
cluster search. .................................................................................................................................. 4
Figure 2.5: Location of statistically significant (p ≤ 0.05) COPD exacerbation outpatient clusters
by order of statistical significance, New York City, 2016–2018, for space-time permutation
cluster search. .................................................................................................................................. 6
Figure 2.6: Statistically significant asthma exacerbation neighborhood clusters, New York, 20162018, by spatial-temporal analysis. ................................................................................................. 9
Figure 2.7: Statistically significant COPD exacerbation neighborhood clusters, New York, 20162018, by spatial-temporal analysis. ................................................................................................. 9
Figure 2.8: Observed and expected case counts for statistically significant (p ≤ 0.05) asthma
exacerbation inpatient clusters, New York City, 2016-2018 ........................................................ 27
Figure 2.9: Observed and expected case counts for statistically significant (p ≤ 0.05) asthma
exacerbation outpatient clusters, New York City, 2016-2018 ...................................................... 28
Figure 2.10: Observed and expected case counts for statistically significant (p ≤ 0.05) COPD
exacerbation inpatient clusters, New York City, 2016-2018 ........................................................ 29
Figure 2.11: Observed and expected case counts for statistically significant (p ≤ 0.05) COPD
exacerbation outpatient clusters, New York City, 2016-2018 ...................................................... 31
ix

Figure 3.1: Map of New York City ZIP Code Tabulation Areas (ZCTAs) that make up the study
area. Source: Geospatial Data Library at CUNY Baruch College. ............................................... 41
Figure 3.2: PM 2.5 Air pollution monitoring stations across NYC, 2008-2020. Source:
NYCCAS. ..................................................................................................................................... 46
Figure 3.3: Map portraying location of unpopulated ZCTAs across NYC................................... 48
Figure 3.4: Potential predictor variables highly correlated. .......................................................... 57
Figure 3.5: Monthly New York City Asthma Exacerbation Inpatient Population-Based Rates per
100,000 residents, 2016 to 2018. Source: NYS Department of Health SPARCS. ....................... 58
Figure 3.6: Monthly New York City Asthma Exacerbation Inpatient Case Counts, 2016 to 2018.
Source: NYS Department of Health SPARCS.............................................................................. 58
Figure 3.7: Spatio-temporal dynamic of asthma exacerbation inpatient case counts of fitted
values (based on seasonal averages of posterior medians) per ZIP Code Tabulated Area (ZCTA)
per for years 2016 – 2018. ............................................................................................................ 63
Figure 3.8: Monthly New York City Asthma Exacerbation Outpatient Population-Based Rates
per 100,000 residents, 2016 to 2018. Source: NYS Department of Health SPARCS. ................. 67
Figure 3.9: Monthly New York City Asthma Exacerbation Outpatient Case Counts, 2016 to
2018. Source: NYS Department of Health SPARCS. .................................................................. 67
Figure 3.10: Spatio-temporal dynamic of asthma exacerbation outpatient case counts of fitted
values (based on seasonal averages of posterior medians) per ZIP Code Tabulated Area (ZCTA)
per for years 2016 – 2018. ............................................................................................................ 72
Figure 3.11: Monthly New York City COPD Exacerbation Inpatient Population-Based Rates per
100,000 residents, 2016 to 2018. Source: NYS Department of Health SPARCS. ....................... 76
Figure 3.12: Monthly New York City COPD Exacerbation Inpatient Case Counts, 2016 to 2018.
Source: NYS Department of Health SPARCS.............................................................................. 76
Figure 3.13: Spatio-temporal dynamic of COPD exacerbation inpatient case counts of fitted
values (based on seasonal averages of posterior medians) per ZIP Code Tabulated Area (ZCTA)
per for years 2016 – 2018. ............................................................................................................ 81
Figure 3.14: Monthly New York City COPD Exacerbation Outpatient Population-Based Rates
per 100,000 residents, 2016 to 2018. Source: NYS Department of Health SPARCS. ................. 85
Figure 3.15: Monthly New York City COPD Exacerbation Outpatient Case Counts, 2016 to
2018. Source: NYS Department of Health SPARCS. .................................................................. 85
Figure 3.16: Spatio-temporal dynamic of COPD exacerbation outpatient case counts of fitted
values (based on seasonal averages of posterior medians) per ZIP Code Tabulated Area (ZCTA)
per for years 2016 – 2018. ............................................................................................................ 90

x

List of Tables
Table 2.1: Description of the study population with case counts and corresponding percent
respiratory (Asthma and COPD) exacerbation episodes by: diagnosis, medical facility setting and
diagnosis-medical facility setting. ................................................................................................ 37
Table 2.5: Statistically significant ZCTA’s with corresponding neighborhoods appearing within
both inpatient and outpatient settings for space-time permutation COPD exacerbation cluster
search, New York City, 2016-2018. ............................................................................................. 10
Table 2.2: Case counts and population-based rates of respiratory (Asthma and COPD)
exacerbation episodes by ‘diagnosis-medical facility setting’ in 43 neighborhoods within the
study area, New York City, 2016-2018. Source: New York State SPARCS, U.S. Census .......... 24
Table 2.3: Location of statistically significant (p ≤ 0.05) COPD and asthma clusters, New York
City, 2016-2018, for space-time permutation cluster search. ....................................................... 26
Table 2.4: Statistically significant ZCTA’s with corresponding neighborhoods appearing within
both inpatient and outpatient settings for space-time permutation asthma exacerbation cluster
search, New York City, 2016-2018. ............................................................................................. 33
Table 2.6: Statistically significant ZCTA’s with corresponding neighborhoods appearing across
outpatient settings for space-time permutation respiratory (asthma and COPD) exacerbation
cluster search, New York City, 2016-2018. .................................................................................. 34
Table 3.1: Table listing unpopulated ZCTAs across NYC. Source: U.S. Census 2010. .............. 47
Table 3.2: Table presenting all four response variables and potential predictor variables by type
(Socio-demographic, Meteorological). ......................................................................................... 50
Table 3.3: Relative risks (RR) of potential predictor covariates for asthma exacerbation in the
inpatient setting, across two models: general linear model (GLM) and general linear mixed
model (GLMM). ........................................................................................................................... 61
Table 3.4: Table showing statistics in the form of a Z-score for Geweke diagnostic function
determining convergence of all covariates across Asthma Inpatient outcomes. .......................... 62
Table 3.5: Asthma exacerbation inpatient discharges reported by month and ZCTA, New York
City, 2016 – 2018, as presented across three models ................................................................... 65
Table 3.6: A summary of the Asthma Inpatient parameter estimates from the spatio-temporal
model............................................................................................................................................. 66
Table 3.7: Relative risks (RR) of potential predictor covariates for asthma exacerbation in the
outpatient setting, across two models: general linear model (GLM) and general linear mixed
model (GLMM). ........................................................................................................................... 70
Table 3.8: Table showing statistics in the form of a Z-score for Geweke diagnostic function
assessing convergence of all covariates across Asthma Outpatient outcomes. ............................ 71
Table 3.9: Asthma exacerbation outpatient discharges reported by month and ZCTA, New York
City, 2016 – 2018, as presented across three models ................................................................... 74

xi

Table 3.10: A summary of the Asthma Outpatient parameter estimates from the spatio-temporal
model............................................................................................................................................. 75
Table 3.11: Relative risks (RR) of potential predictor covariates COPD exacerbation in the
inpatient setting, across two models: general linear model (GLM) and general linear mixed
model (GLMM). ........................................................................................................................... 79
Table 3.12: Table showing statistics in the form of a Z-score for Geweke diagnostic function
determining convergence of all covariates across COPD Inpatient outcomes. ............................ 80
Table 3.13: COPD exacerbation inpatient discharges reported by month and ZCTA, New York
City, 2016 – 2018, as presented across three models ................................................................... 82
Table 3.14: A summary of the COPD Inpatient parameter estimates from the spatio-temporal
model............................................................................................................................................. 84
Table 3.15: Relative risks (RR) of potential predictor covariates COPD exacerbation in the
outpatient setting, across two models: general linear model (GLM) and general linear mixed
model (GLMM). ........................................................................................................................... 88
Table 3.16: Table showing statistics in the form of a Z-score for Geweke diagnostic function
determining convergence of all covariates across COPD Outpatient outcomes........................... 89
Table 3.17: COPD exacerbation outpatient discharges reported by month and ZCTA, New York
City, 2016 – 2018, as presented across three models ................................................................... 91
Table 3.18: A summary of the COPD outpatient parameter estimates from the spatio-temporal
model............................................................................................................................................. 93
Table 3.19: Moran’s I statistic and associated p-values for Bayesian spatio-temporal modelling.
..................................................................................................................................................... 102
Table 4.1: Table presenting all four primary outcomes, six secondary outcomes, and potential
predictor variables by type (Socio-demographic, socio-economic and Meteorological). .......... 126
Table 4.2: Table showing statistics in the form of a Z-score for Geweke diagnostic function
determining convergence of all covariates across Asthma Inpatient outcomes. ........................ 130
Table 4.3: Predicted asthma exacerbation inpatient discharges across New York City, modelled
through 2039. A summary of the parameter estimates from the Bayesian spatio-temporal model
with Poisson regression............................................................................................................... 131
Table 4.4: Predicted asthma exacerbation outpatient length of hospital stay and total charges per
hospital stay across New York City, modelled through 2039. A summary of the parameter
estimates from the Bayesian spatio-temporal model with Gaussian regression. ........................ 132
Table 4.5: Table showing statistics in the form of a Z-score for Geweke diagnostic function
determining convergence of all covariates across Asthma Outpatient outcomes. ...................... 134
Table 4.6: Predicted asthma exacerbation outpatient discharges across New York City, modelled
through 2039. A summary of the parameter estimates from the Bayesian spatio-temporal model
with Poisson regression............................................................................................................... 135
Table 4.7: Predicted asthma exacerbation outpatient total charges per hospital stay across New
York City, modelled through 2039. A summary of the parameter estimates from the Bayesian
spatio-temporal model with Gaussian regression. ...................................................................... 136
xii

Table 4.8: Table showing statistics in the form of a Z-score for Geweke diagnostic function
determining convergence of all covariates across COPD Inpatient outcomes. .......................... 138
Table 4.9: Predicted COPD exacerbation inpatient discharges across New York City, modelled
through 2039. A summary of the parameter estimates from the Bayesian spatio-temporal model
with Poisson regression............................................................................................................... 139
Table 4.10: Predicted COPD exacerbation inpatient length of hospital stay and total charges per
hospital stay across New York City, modelled through 2039. A summary of the parameter
estimates from the Bayesian spatio-temporal model with Gaussian regression. ........................ 140
Table 4.11: Table showing statistics in the form of a Z-score for Geweke diagnostic function
determining convergence of all covariates across COPD outpatient outcomes. ........................ 143
Table 4.12: Predicted COPD exacerbation outpatient discharges across New York City, modelled
through 2039. A summary of the parameter estimates from the Bayesian spatio-temporal model
with Poisson regression............................................................................................................... 144
Table 4.13: Predicted COPD exacerbation outpatient total charges per hospital stay across New
York City, modelled through 2039. A summary of the parameter estimates from the Bayesian
spatio-temporal model with Gaussian regression. ...................................................................... 145

xiii

Acknowledgements
I begin my acknowledgements with a heartfelt thank you to all my family and friends,
both near and far, who have encouraged and supported me over these past years.
Rinku, my husband and best friend, thank you for turning our story into the perfect
romance. You are my rock and my continued inspiration for being my best self. As I spent
endless hours working on the doctoral program, you too spent countless hours maintaining our
household and the overall well-being of our family. I cannot imagine a life without you, nor
could I envision any other being to share my achievements with. To my children - though you
are both very small, you are my motivation behind everything I do. From my son’s gaze into my
eyes to my daughter’s gentle kicks within my womb, I am constantly reminded of the value
behind my efforts.
To my parents, Carole and Olson, and my younger sister Natalie, thank you for shaping
me into the woman I have become today. Your love, support, and encouragement have set the
foundation for a bright and successful future. I am forever appreciative of all that you do and all
that you are to me. I would also like to express my deep appreciation for my mother- and
brother-in-law, Daksha and Abhishek, who have believed in me and supported me from the
moment Rinku introduced me to the family. In addition, I am extremely grateful for my closest
friends who have turned into family over the years – Victoria B., Melissa C., Sarah J., Melissa
R., and Shirmila T. Thank you ladies for inspiring me and keeping my spirits high throughout
our entire friendship, beginning with the moment we all met as teenagers.
I would also like to express my deep appreciation and gratitude to my committee
members – Dr. Glen Johnson (Chair), Dr. Brian Pavilonis (First Reader), and Dr. Ashish Joshi
(Outside Reader) – for their guidance, thought-provoking suggestions, and general collegiality

xiv

throughout the doctoral experience. I would also like to thank the faculty, staff, and my fellow
students at CUNY from whom I learned so much. The highlight of my experience within the
program are the companionship of my Environmental and Planetary Health Science “Planeteers”
- Catherine, Jonathan, Amelia, Bri, Daryle, Tony and David. Your intellect, enthusiasm and
overall liveliness have eased the rigor of the entire process.
Finally, to my patients, which is the reason for my involvement in the fields of Public
Health and Respiratory Care in the first place. I value the moments spent discussing your
personal experiences living with respiratory illness and working together to improve your quality
of life. I appreciate each & every one of you and I am extremely grateful for your contributions
that have shaped me into the Public Health and Respiratory care professional I have become
today. May your strength and light continue to inspire me into my future endeavors.

xv

Disclosure
This research was partially supported through funding from the Environmental, Occupational,
and Geospatial Health Sciences (EOGHS) Departmental Scholarship Award through the City
University of New York Graduate School of Public Health and Health Policy. I have no conflicts
of interest to disclose.

xvi

Chapter 1. Introduction
This dissertation is concerned with environmental health through the facet of climate variability,
and the impact it has on individuals with pre-existing respiratory disease. Although there are
numerous diseases of the lung, this dissertation will be limiting the discussion of respiratory
disease to two of the most prevalent: Asthma and Chronic Obstructive Pulmonary Disease
(COPD). There are a multitude of factors affecting the prevalence of asthma and COPD
exacerbation, yet the interplay of these components is not well understood. The population of
interest are individuals pre-diagnosed with asthma and COPD in New York City (Figure 1.1).
This region was chosen because it contains one of the largest and most diverse urban populations
in the world1 and experiences the four seasons (Fall, Winter, Spring, Summer). Climate
variability has been found associated with respiratory disease, but the extent of its current and
future impacts are still being extensively studied, especially among vulnerable individuals.

1

Figure 1.1: Map of New York City Zip Code Tabulation Areas (ZCTAs) that make up the study area. Source: The Baruch College
Geospatial Data Library, OpenStreetMap

1.1 Respiratory (COPD and Asthma) Exacerbations
Asthma accounts for 9.8 million doctor’s office visits, 188,968 discharges from hospital inpatient
care and 1.8 million emergency department visits each year.2 Children are especially vulnerable
as asthma is the leading chronic disease in children2 and is the third-ranking cause of
hospitalization among children younger than 15.3 Asthma is the top reason for missed school
days; in 2013 about 13.8 million missed school days were reported due to asthma.4
Moreover, COPD stands as the third leading cause of death and second leading cause of
disability in the United States (US).5,6 Almost 15.7 million Americans (6.4%) reported that they
have been diagnosed with COPD.7 More than 50% of adults with low pulmonary function were
not aware that they had COPD,8 so the actual number may be even higher.
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The guidelines of the World Health Organization (WHO) and US National Heart Lung and
Blood Institute Global Initiative for Chronic Obstructive Lung Disease (GOLD) define an
exacerbation as “an event in the natural course of the disease characterized by a change in the
patient's baseline dyspnea, cough, and/or sputum that is beyond normal day-to-day variations, is
acute in onset, and may warrant a change in regular medication in a patient with underlying
respiratory disease”.9 This is characterized by an acute worsening of respiratory symptoms (e.g.,
increased airway and systemic inflammation and physiological changes, such as airway edema,
bronchospasm, and increased sputum production), leading to worsening airflow limitation.10,11

Certain definitions for COPD exacerbation have also been suggested based on unscheduled
physician visits, use of antibiotics or oral steroids at exacerbation, and hospital admissions.12
However, many COPD and asthma exacerbations are not reported to health-care professionals
and are either self-treated or left untreated altogether.13 Researchers have found that health-care
use in COPD and asthma can vary depending on access, leading to substantial difficulty in the
standardization of such a definition.14 Nonetheless, health-care use can still be implemented in
defining the severity of an exacerbation (which GOLD considers an indicator of COPD disease
stage), with higher frequency of exacerbations indicating an augmentation in severity of disease:
mild if increases in regular inhaled medication are needed, moderate if courses of steroids or
antibiotics are needed, and severe if the patient requires hospital admission.14,15

Public health authorities are interested in reducing hospitalizations rates for several reasons:
there is a need for improvement of the population's well-being, reducing healthcare costs and
reducing consumption of resources.16 For instance, the New York State healthcare system spends
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US$1.3 Billion dollars per year for asthma alone (second highest state in the US) and current
asthma prevalence in adults living in New York City is 10.2%, higher than 9.3% of adults who
live in the rest of the State.17 COPD also presents with its own burdens on morbidity, mortality
and healthcare systems overall. Although there is limited research done on COPD in NYC,
national studies have modelled the financial burden associated with COPD prevalence showing
direct healthcare costs were found to range from US$1,681 for patients in stage I COPD (early
stage), US$5,037 for patients in stage II (moderate stage) and US$10,812 for those in stage III
(severe stage).18

Effect of Respiratory Exacerbation on Human Health
COPD and asthma exacerbations impose a substantial burden on health as they are a major cause
of morbidity, mortality, and reduced health status.13 In a study of the time-course of communitytreated exacerbations, a proportion of patients never returned to baseline level and 14% of the
patients still had not returned to baseline symptoms within 35 days (or 5 weeks) of onset.19
Additionally, high exacerbation frequency suggests a higher risk of future exacerbations.
According to the GOLD guidelines, patients with two or more exacerbations in the past 12
months are at a high risk of future exacerbations compared to low-risk patients with one or zero
exacerbations in the past 12 months.15 An audit of hospital admissions showed that around 30%
of patients presenting with an index (first) exacerbation will be seen again and possibly
readmitted with another (or recurrent) event within 8 weeks.20 In a cohort of patients with
moderate to severe COPD followed-up after exacerbation, 22% had a recurrent event within 50
days (or 7 weeks) of the first (index) exacerbation.21 Additionally, a retrospective cohort study
utilizing data from a large US national health plan conducted from 2007 to 2012 showed 44.3%

4

had at least one exacerbation; 26.3%, 9.5%, and 8.5% had one, two, and ≥ three exacerbations in
the 24-month follow-up period, respectively.22

Repeated episodes of COPD and asthma exacerbations may lead to an accelerated rate of decline
in pulmonary function, as measured by the forced expiratory volume (FEV1) test which measures
how much air a person can exhale during the first second of a forced breath.23 Studies have found
that patients with an FEV1 below 50% predicted (i.e., moderate-to-severe COPD) were reported
to experience 1 to 2 exacerbations on a yearly basis.24 For example, Donaldson et al27 reported a
mean of 2.92 exacerbations per year in COPD patients with moderate to very severe disease
where mean FEV1 was 38% predicted. Furthermore, studies25,26 have shown a prolonged return
to baseline pulmonary function levels with higher rates of exacerbation per year. Celli et al28
reported patients had a faster decline in FEV1 when they experienced a greater frequency of
exacerbations during their 3-year study period.

Patients with impaired lung tissue as a result of frequent exacerbations are more likely to
experience a poorer quality of life as compared to patients with a history of less frequent
exacerbations.11,29,30 A study by Connors Jr et al31 reported the quality of life outcomes in
patients hospitalized with acute exacerbations of COPD: at 6 months about 54% of patients
required assistance with at least one activity of daily living and 49% considered their health
status to be either fair or poor. COPD exacerbations can also lead to a significant reduction in
physical activity and overall exercise tolerance.32 Additional investigations have further found
inpatient mortality rates associated with COPD exacerbations to occur at a rate of anywhere
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between 2.5% and 10%, with increases up to 40% in 1 year.15 In patients older than 65 years of
age, the 1-year mortality rate was observed to be as high as 59%.33

1.2 Climate Variability and Respiratory Exacerbation
Climate variability is formally defined by the World Meteorological Organization as “variations
in the mean state and other statistics of the climate on all temporal and spatial scales, beyond
individual weather events.”34 The fluctuations comprising climate variability can influence
patterns of rainfall, temperature and other variables on timescales anywhere from a few weeks to
a few decades.35 Variability may be due to natural internal processes within the climate system
(internal variability), or to variations in natural or anthropogenic external factors (external
variability).34

Within the last century, massive increases in emissions associated with population and economic
growth has made climate variability a major challenge for countries throughout the world.36
Increased concentrations of greenhouse gases in the earth’s atmosphere have substantially
warmed the planet, affecting the biosphere and causing more severe and prolonged heat waves,
temperature variability, heavy rainfall, storms, air pollution, forest fires, droughts, and floods.3638

One of the best indicators of the impacts of climate variability on societies is human health and

well-being.39 The European Respiratory Society (ERS) provided a position statement
highlighting climate-related health impacts, which included a growing toll of deaths and
morbidity due to climate extremes.40,41 Unfavorable changes in climate can specifically impact
air quality and pose a quantifiable threat towards an increased frequency of respiratory disease
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requiring hospital care. Such episodes can permanently affect the overall function of the
respiratory system, causing COPD to progress faster or asthmatic disease to worsen.42

The Influence of Temperature and other Meteorological Factors
The earth’s atmosphere has been warming since 1880, which is the first year of temperature
record in NASA Goddard Institute for Space Studies (GISS). Currently, average annual global
temperatures have increased by about 0.8° Celsius (1.4° Fahrenheit).43 Two-thirds of the
warming has occurred since 1975 at a rate of roughly 0.15-0.20°C per decade,43 with 16 of the 17
warmest years on record having occurred since 2001.44 According to NASA GISS and National
Oceanic and Atmospheric Administration (NOAA), the warmest year on record to date is 2016
with temperature anomalies at 0.95°C and 1.71°F (Figure 1.2).45

Figure 1.2: Ten Warmest Years (1880–2018) The above table lists the global combined land and ocean annually-averaged
temperature rank and anomaly for each of the 10 warmest years on record. Source: NOAA
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Evidence of increased mortality and acute morbidity among respiratory patients as a result of
heat waves makes COPD and asthma patients extremely vulnerable to respiratory illness during
the summer season.46 During a period of extremely high temperatures, each degree Celsius (C)
above the threshold of the temperature-health effect curve (29°C–36°C) was associated with a
2.7% – 3.1% increase in same-day hospitalizations due to respiratory diseases.47 There was also
an increased risk of premature death up to six times higher among respiratory patients than in the
rest of the population.38 COPD patients have also been reported to experience more frequent
exacerbation of their disease and were found to have higher hospitalization and morbidity rates
during the winter season.48,49 The winter season is also associated with an increased prevalence
in respiratory viral infections.50,51

Although COPD and asthma exacerbations are more frequent in the winter and summer seasons,
it is currently unclear which combination of meteorological factors exert the greatest influence
on respiratory exacerbations, and whether or not time and/or space plays a role.52 The
temperatures experienced locally and in short periods can fluctuate significantly due to
predictable cyclical events (night and day, summer and winter) and hard-to-predict wind and
precipitation patterns, whereas the global temperature are long-term averages of daily weather
and mainly depends on how much energy the planet receives from the Sun and how much it
radiates back into space—quantities that are supposed to change very little.53 Therefore, critical
barriers to general understanding of the relationship between global climate change and
respiratory exacerbation include meteorological factors, such as regional temperature, rainfall,
humidity, wind speed, and particulate matter (PM 2.5), which tend to vary with different seasons
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and across different locations. This is especially true in regions experiencing all four seasons
such as in NYC.

Rainfall, Humidity and Wind on Respiratory Health
While asthma in children and young adults have been less common in areas with colder winters
and lower humidity than along the wetter coastal areas, more severe rainfall and storms could
increase this risk.54 Studies were done to determine the effects of fluctuations in climatic factors
(temperature, humidity, and barometric pressure) on pediatric asthma exacerbations, and found
emergency department visits for pediatric asthma occurred 1 to 2 days after fluctuations in
humidity and temperature.55 In another study56 looking at respiratory disease and climatic
seasonality in children under 15 years old in a town in the Brazilian Amazon, results showed
peaks in number of visits due to respiratory disease during the months of March and August
(being more accentuated during March and April, which is the wet season in the region). The
number of hospital visits declined thereafter until another peak in August that was accompanied
with a lower relative humidity of air.56 Out of the 3-year time period analyzed in this dissertation,
NYC experienced higher than normal precipitation in 2018 with nearly 57 inches.57 (Figure 1.3)

Recent epidemic thunderstorm asthma has been reported about a dozen times in the past 35
years; the threshold for reporting seems to be an increase of at least five to ten times in asthma
presentations to emergency departments over a short period of time.58 Nevertheless, many
individuals are affected by these events but do not seek acute medical care.59 This emerging
phenomenon is accompanied with periods of heavy rainfall and intense wind, which are believed
to increase extreme exposure to allergens, predominantly grass pollen, in susceptible allergic
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individuals.60 Wind speed, air turbulence, and mixing depth all affect how pollutants disperse
within a region or possibly spread out from an area.61

Figure 1.3: Precipitation (in) to Date for New York (LaGuardia), N.Y. The 3 wettest periods since 1940 (showcased in green) are
2011, 1983 and 1975. Source: NOAA. The three driest periods (showcased in brown) are 1965, 1970 and 1964. The normal
precipitation periods (underlaid in dark gray) reflect baseline normal for 1981-2010. The most recent precipitation period was in
2018, with nearly 57 inches.

Poor Air Quality, as a result of PM 2.5, on Respiratory Health
In modern society, people spend 80 to 90% of their time indoors where the quality of air is
driven by pollutant source and loss mechanisms.62 This includes indoor emission sources in
close proximity to occupants, and outdoor pollutants that are transported indoors via ventilation
and infiltration, pollutant deposition to indoor surfaces, and filtration, among others.62

Fuel oil/kerosene, coal/coke, wood and utility gas with improper ventilation systems are all
sources of indoor particulate matter (PM). Although NYC has mandated cleaner burning oil in
recent years through the NYC Clean Heat program created in 2010, the remaining residual oil
10

boilers in buildings that have yet to convert to cleaner oil can still emit PM, especially when
fuels are incompletely burned.63 Residual fuel oil #4, which won’t be banned until 2030,
continued to be burned by 3,253 residential buildings, despite the city’s efforts to educate and
incentivize owners to switch to cleaner fuels.64 Of these buildings, studies found 1,724 or 53
percent were clustered in Manhattan north of 110th Street and the Bronx— portraying the role of
space as these neighborhoods are disproportionately higher than the area’s population (only onefifth of city residents live in these neighborhoods).65

Aforementioned, Indoor Air Quality (IAQ) is also challenged by outdoor air pollution entering
indoors through ventilation and infiltration and by indoor emission sources.62 Studies found that
approximately 62% of the 2 million annual DALYs of indoor exposure was caused by the
transport of outdoor PM2.5 to the indoor environment via ventilation and 16% by indoor
sources.66 Nevertheless, air pollution can be reduced by periods of heavy rainfall which also has
the potential to “wash” PM pollutants out of the atmosphere.67 Wind speed can have a similar
effect on fine particulate matter as fine PM 2.5 concentrations have been found to decrease
gradually with the increase of wind speed, whereas coarse PM 10 concentrations can increase
due to dust resuspension under strong wind.68

PM 2.5 levels have declined from 2016 through 2018 (Figure 1.4), however, levels remained
relatively higher throughout much of Manhattan and in areas of higher traffic density, building
density and industrial areas in the outer boroughs.69 Additional driving factors of poor IAQ
include occupant density, pets, pests, smoking and cooking.70 Acute exposure to particulate air
pollution has been found to be associated with increases in the rates of daily asthma attacks, the
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rate of respiratory exacerbations due to respiratory infections, hospital admissions, and
mortality.46,71

Respiratory disorders may be also exacerbated by warming-induced increases in the frequency of
particulate air pollution matter by fostering conditions favorable to forest fires and, in some arid
parts of the world, promoting sand storms.72 The association of PM with wildfire smoke is
influenced by increased wind erosion, which can increase levels of particulate air pollution
extending over great distances.73 Such exposures to wildfires can lead to an increase in
respiratory and cardiovascular hospital admissions and emergency room visits.74,75

12

Figure 1.4: Annual comparison of PM 2.5 levels, shown with a ZCTA overlay, 2016-2018. Source: New York City Community Air
Survey (NYCCAS), 2020

1.3 The Effect of Socio-demographic Factors
Of further concern, studies have consistently shown the impact an individual’s social or
economic standing, measured by an individual's or family's social or economic position or rank
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in a social group,76 has on morbidity, mortality, and access to health care with regards to
respiratory health.77-79 Research addressing low SES among individuals diagnosed with COPD
and asthma is associated with disproportionate access to respiratory health care; SES has an
inverse relationship with COPD prevalence, mortality, health utilization costs and health-related
quality of life (HRQoL), and asthma has shown an increased severity and hospitalizations in
relationship to a lower SES.79 As COPD and asthmatic events are often triggered by
environmental irritants, and can be augmented by certain socioeconomic conditions, climate
variability can alter air quality and pose a quantifiable threat by permanently affecting the overall
function of an individual’s respiratory system, causing COPD to progress faster or asthmatic
disease to worsen.

Figure 1.5 is a conceptual framework showing the relationships between the individual, the
community and the environment, all placing an individual vulnerable (measured by exposure,
sensitivity and resilience) to adverse health outcomes. Global climate change serves as the
overarching contextual hazard that transgresses into exposure determined by regional weather
variability (e.g., extreme temperature (high, low), rainfall/humidity, wind patterns and PM 2.5).
The exposures transcending into a system’s sensitivity to climate variability as a result of climate
change is mitigated by factors such as resilient housing and infrastructure as well as emission
reduction. Mediating influences and negative moderators to how a system can withstand
variations in climate include neighborhood-level (e.g., proximity to highways, toxic waste sites)
and individual-level (socioeconomic, pediatric, elderly, pre-existing medical condition)
variables. Collectively, these influences determine which societies or communities are resilient
and adaptive to climate variability and change. Potential outcomes include adverse health effects
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in communities that are less resilient, whereas adaptive capacities such as air condition use can
support a system’s resiliency.

Figure 1.5: The conceptual framework informing this research proposal integrates theories of the Social Ecological Model
(SEM), and the Climate-Related Illness Vulnerability framework (CRIV).

The SEM is a theory-based framework for understanding the multifaceted and interactive effects of individual and
environmental factors. It was originally developed by Bronfenbrenner, who illustrated nesting circles that place the
individual in the center surrounded by various systems.80 The CRIV conceptual framework provides broad classes of
components and linkages that comprise a coupled system's vulnerability to hazards. It aims to determine
populations vulnerable to environmental variability (exposure), how the consequences of these changes are either
attenuated or amplified by different human and environmental conditions, and methods that can be implemented to
reduce vulnerability to change (i.e., responses such as coping, impacts, adjustments, adaptations).81

1.4 Overall Goal of the Dissertation
Though substantial progress has been made in defining the etiology of exacerbations in COPD
and asthma in the context of extreme high temperatures or extreme cold temperatures leading to
respiratory exacerbations and in some instances mortality,46,47,52 there are still many gaps in the
understanding of how time and space play a role combined with the effect of climate and
sociodemographic predictor variables. For example, there are inconclusive findings between
15

studies detecting evidence that increasing temperature modifies the effect of air pollution
exposure leading to respiratory disease and studies detecting interactive effects only.82-88 In
addition, studies77-79 addressing the effect of an individual’s social or economic standing on
respiratory exacerbation lack inclusion of climatic co-variables. Furthermore, very few studies
have provided a spatio-temporal analysis of the future burden COPD and asthma exacerbation
poses on morbidity and the healthcare system as a whole.

The goal of this dissertation is to address these gaps and contribute to our understanding of how
climate variability and sociodemographic factors impact respiratory disease among NYC
residents. Therefore, this dissertation will focus solely on respiratory disease as a function of
space and time, given an individual’s community-level contextual factors and climatic variation.
One aim examines spatial-temporal patterns of respiratory exacerbation hospital discharges
across NYC ZCTAs from 2016 to 2018. Using a space-time permutation model, this study uses
geo-spatial techniques to determine whether there is temporal and/or spatial variation of
respiratory exacerbation episodes across NYC ZCTAs throughout the study period and identify
statistically significant space-time clusters of elevated risk. Another aim examines the
associations between climatic variation, sociodemographic composition and respiratory disease
across the whole study area, which comprises of 214 ZCTAs across New York City from 2016 to
2018. This study uses Poisson regression using a series of 3 models (general linear model
(GLM), general linear mixed model (GLMM) and a Bayesian spatio-temporal model) to 1)
determine whether there is spatio-temporal variation in the associations between respiratory
disease, climatic and sociodemographic covariates, 2) determine regions of elevated risk after
controlling for climatic and sociodemographic covariates, and 3) determine whether the relative
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risk of COPD and asthma exacerbation rates will increase within both the inpatient and
outpatient settings. The third aim seeks to estimate the spatio-temporal association between
respiratory-related exacerbations across New York City as a whole given predictive temperature
and precipitation covariates provided by the Intergovernmental Panel on Climate Change (IPCC)
and certain predictive socio-demographic and socio-economic factors. The secondary outcomes
that were also analyzed included 1) total charges per stay and 2) length of stay (for the inpatient
medical settings only).

This dissertation draws upon the epidemiologic and medical understanding of COPD and asthma
exacerbation, along with components of climate variability such as variation in temperature,
rainfall, humidity, wind, and air pollution [as measured by PM 2.5]. Poisson regression models
have the potential to forecast patterns and simulate the interaction of the different climate
variables on the burden of COPD and Asthma, especially given the potential of model instability
caused by the relatively small number of reported cases. In addition, geographic information
sciences (GISc) coupled with space-time scan statistics provides an analysis of spatial and
temporal relationships between variables of interest. Using these methods collectively, the
findings from this dissertation may lend new perspectives to current understandings of
respiratory exacerbation across time and space within NYC and support decision-making with
the potential to reduce the future burden.
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1.5 Specific Aims and Hypotheses
Specific Aim 1: To analyze spatio-temporal patterns of COPD and asthma exacerbation hospital
discharges across NYC ZIP code tabulation areas (ZCTAs) by month during the period 20162018, including identification of statistically significant space-time clusters of elevated risk.

Hypotheses: It is hypothesized rates of COPD and asthma exacerbation will vary across NYC
ZCTAs and throughout the duration of the study period in a non-random manner.

Specific Aim 2: To estimate the association of COPD and asthma exacerbation hospital
discharges across NYC ZIP code tabulated areas (ZCTAs), after adjusting for sociodemographic
predictive factors (sex, age, race, income, poverty, educational attainment, and type of house
heating fuel) and climatic predictive factors (temperature, precipitation, wind, relative humidity,
and PM 2.5). This will be accomplished through a series of three Poisson regression models: the
first is a general linear model (GLM), the second is a general linear mixed model (GLMM) with
adjustment for temporal autocorrelation, and the third is a Bayesian spatio-temporal model with
adjustment for spatio-temporal random effects variances.

Hypotheses: It is hypothesized Poisson regression results will be best fitted after utilizing the
Bayesian spatio-temporal approach to adjust for spatio-temporal autocorrelation. We further
hypothesize results from our Bayesian spatio-temporal model will suggest sociodemographic
predictive factors (including sex, age, race, income, poverty, educational attainment, and type of
house heating fuel) and climatic predictive factors (including temperature, precipitation, wind,
relative humidity, and PM 2.5) will increase the relative risk of COPD and asthma exacerbation
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rates within both the inpatient and outpatient settings. We also hypothesize there will be spatiotemporal variation in the associations between respiratory disease, climatic and
sociodemographic covariates, and certain regions within NYC will have elevated risk relative to
other regions.

Specific Aim 3: To estimate the future burden of COPD and asthma-related hospital discharges
across the entire city of New York with IPCC predicted temperature and precipitation measures,
as well as predictive factors that are socio-demographic (age) and socio-economic (race and
poverty) in nature. The sub-aims entail looking at similar associations using the following
secondary outcomes: 1) Total charges and 2) Length of stay (LOS) (for inpatient settings only).
The aims will be carried out using Bayesian spatio-temporal modelling to adjust for spatiotemporal autocorrelation, which can lead to case observations from geographically close areal
units and temporally close time periods to have more similar values than units and time periods
that are further apart.89

Hypotheses: We hypothesize the number of cases of respiratory-related hospitalizations (primary
outcome), number of total charges (secondary outcome), and length of stay [for inpatient settings
only] (secondary outcome) will increase into the year 2039 across New York City as a whole,
given the IPCC predicted temperature and precipitation values, as well as the socio-economic
and socio-demographic predictive covariates.
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Chapter 2. The spatio-temporal distribution of Chronic Obstructive
Pulmonary Disease and Asthmatic exacerbation across New York
City from 2016 to 2018: A cluster analysis using space-time
permutation modelling
2.1 Introduction
Individuals diagnosed with pre-existing respiratory disease remain vulnerable in regions most
prone to a changing climate, and are susceptible to a respiratory exacerbation during periods of
climate variability.1 Specifically, asthma and chronic obstructive pulmonary disease (COPD) are
both known to decrease lung function into adulthood.2 As asthma and COPD are both
incurable,3,4 and COPD stands as the third leading cause of death and second leading cause of
disability in the United States,4,5 exacerbations of COPD and asthma determine a full range of
difficulties.6

The Role of Time and Space in Respiratory Exacerbation
Despite progress in understanding spatial variation in population-based rates of COPD and
asthma cases across NYC, there are few published studies assessing the manner with which these
rates change over both space and time. In fact, little to no studies have either detected or have
used statistical software that automatically adjusts for the location of both purely spatial and
purely temporal clusters of COPD and asthma exacerbations across NYC and have evaluated
their statistical significance.

The aim of this study is to analyze spatial-temporal patterns of COPD and asthma exacerbation
hospital discharges across NYC ZIP code tabulation areas (ZCTAs) (Figure 2.1) during the
period 2016-2018, including identification of statistically significant clusters of elevated risk.
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New York City was selected as the study area since this socioeconomically diverse city has a
high burden of respiratory disease.29-31 An estimated 5% of adults aged 18 years or older in New
York City (335,000 adults) report being told by a health care provider that they have COPD.32
Furthermore, the current asthma prevalence for NYC adults is 7.1%.33 New York City children
had an even higher prevalence of asthma (9.7%), compared to children residing in the rest of the
state (7.4%) and adults in general.33 Due to its latitude position on the globe, New York City also
has a varied climate with all four seasons. The availability of hospital discharge data within a
reasonable timeframe was also a consideration when selecting the study time period.

Figure 2.1: Map of New York City Zip Code Tabulation Areas (ZCTAs) that make up the study area

26

Hypotheses
It is hypothesized rates of COPD and asthma exacerbation will vary across NYC ZCTAs and
throughout the duration of the study period in a non-random manner.

2.2 Methods
Data
This study combines health and spatial data from a variety of sources. The outcome of interest –
hospital discharges related to COPD and asthma exacerbation episodes – are provided by the
New York State (NYS) Statewide Planning and Research Cooperative System (SPARCS), after a
limited dataset application, entailing a data use agreement, which does not contain any direct
identifiers under HIPAA34,35. SPARCS consists of two geocoded datasets – an inpatient dataset
of hospital discharges (including emergency department (ED) visits that subsequently result in a
hospital admission) and an outpatient dataset that includes “treat and release” visits to the ED
and visits to health care facilities certified under Article 28 of the New York State Public Health
Law (NYSPHL)35. Article 28 facilities are hospitals, diagnostic and treatment centers (also called
clinics), and nursing homes.35 In-hospital deaths from asthma or COPD are also included in this
study. Due to data availability issues for hospital discharge information prior to 2016, only
hospital discharge data from 2016-2018 are used as part of this study. NYC spatial designations
are derived from specialized products described below.

The NYS SPARCS hospital discharge data only provides patient-level address information as a
5-digit United States Postal Service (USPS) ZIP code. However, USPS ZIP codes do not have
specific geographic boundaries since they are simply assigned to ranges of addresses associated
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with street segments. A ZIP code tabulation area, otherwise known as a ZCTA, is an
approximate area representation of USPS five-digit ZIP Code service areas that the Census
Bureau creates using whole blocks to present statistical data from censuses and the American
Community Survey (ACS).36 Blocks that do not contain addresses but are completely surrounded
by a single ZCTA (enclaves) are assigned to the surrounding ZCTA; those surrounded by
multiple ZCTAs will be added to a single ZCTA based on limited buffering performed between
multiple ZCTAs.36 ZCTAs are also defined by a 5-digit numeric code as well. There are some
non-geographical ZIP Codes for which there are no corresponding ZCTAs. In NYC there are
several small ZCTAs that cover nonresidential office buildings or public facilities, primarily in
Midtown Manhattan.37 ZCTAs may also cross borough and/or county boundaries; in particular
ZCTAs 11001, 11003, and 11040 are partially located in Queens, but a large majority of the land
area and population are in Nassau County.37

In order to convert residence postal ZIP codes from the NYS SPARCS hospital discharge data to
ZCTAs, a crosswalk Microsoft Excel file was used, provided by the Geospatial Data Library at
the City University of New York (CUNY) Baruch College.38 This file crosswalks all USPS ZIP
Codes in the five boroughs of New York City to 2010 ZIP Code Tabulation Areas (ZCTAs)
created by the US Census Bureau. This enables users working with address-based data to
aggregate ZIP Codes to ZCTAs, in order to associate their data with census data published at the
ZCTA level, and to map their data using ZCTA boundaries.39 It is a subset of the ZIP to ZCTA
Crosswalk 2010 file provided by the Missouri Census Data Center40 and originally sourced from
the Uniform Data System (UDS) mapper41.
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The Baruch College Geospatial Data Library also provides a NYC Geodatabase37 with metadata
for the individual layers and tables in the NYC Geodatabase (‘nyc_gdb’), for mapping and
analyzing city-level features and data in GIS. The geodatabase is made available on a Spatialite
version 4.1.1 format built on SQLite version 3.8.8.2 that can be used in an open source software
like QGIS version 3.10.2. The individual geodatabase layer used for this study was ‘a_zctas’,
which is a multi-polygon layer representing ZCTAs. It is a subset of the U.S. Census TIGER
ZCTA file, re-projected to local state plane and modified by subtracting a subset of the U.S.
Census TIGER water layer (a_water_coastal) to create land-based boundaries.37

COPD and/or Asthma Exacerbation
The outcome of interest was obtained from NYS SPARCS, which was measured by
International Classification of Diseases 10th Revision Codes (ICD-10CM)42,43 pertaining to
either a COPD exacerbation:
J44.1 for “Chronic obstructive pulmonary disease with acute exacerbation, unspecified,”
Or an asthma exacerbation:
J45.21 for “Mild intermittent asthma with [acute] exacerbation,”
J45.31 for “Mild persistent asthma with [acute] exacerbation,”
J45.41 for “Moderate persistent asthma with [acute] exacerbation,”
J45.51 for “Severe persistent asthma with [acute] exacerbation,”
J45.901 for “Unspecified asthma with [acute] exacerbation.”
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Type of Diagnosis Code
Data on the type of diagnosis code was obtained from NYS SPARCS, which indicates whether a
diagnosis was “PR” Principal; “OT” Other; “EX” External Cause of Injury; “AD” Admitting;
“RV” Reason for Visit.35 For this study, only ‘Admitting Diagnosis (AD)’ was used for the
inpatient dataset as it more accurately represents reason for patient admission into the hospital
after assessment by a physician, as compared to ‘Principal Diagnosis’ which may simply reflect
suspected cause of presentation to the hospital. Only ‘Reason for Visit (RV)’ was used for the
outpatient dataset.

Discharge Date
Discharge data for each patient record was provided by the NYS SPARCS hospital discharge
dataset. Discharge data was provided for each patient record in month and year format, between
January 2016 through December 2018.

Population Data
Population data in NYC for the 3-year time period 2016 - 2018 was collected for computation of
COPD and asthma-related discharge rates per NYC neighborhood per year. This data was be
derived from U.S. Census Bureau population estimates from the 2010 U.S. Census.

NYC Spatial Designation
The NYC spatial designation was derived from the CUNY Baruch College NYC Geodatabase,
which contained an individual database layer for NYC ZCTAs. The spatial designation was used
to assign each patient hospital record to a specific ZCTA within NYC, after cross-walking NYC
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ZIP codes to ZCTAs. ZCTAs were also linked to their corresponding latitude and longitudinal
coordinates using data obtained from the US Census Gazetteer44 files.

Analyses
Data Preparation
NYS SPARCS Hospital discharge data information was prepared using SAS version 9.4, as per
NYS SPARCS data usage guideline recommendations35. Data was provided in a total of six (6)
datasets organized by year of discharge (2016, 2017 and 2018) and by inpatient/outpatient status:
2016 Inpatient (2016 IP)
2016 Outpatient (2016 OP)
2017 Inpatient (2017 IP)
2017 Outpatient (2017 OP)
2018 Inpatient (2018 IP)
2018 Outpatient (2018 OP)
The 6 SPARCS hospital discharge datasets were also provided using SAS format consisting of
14 relational tables. For the purposes of this study, only the following 3 relational tables were
kept:
Location
Diagnosis
Claim
For each dataset, patient records were linked across tables by the Claim Transaction ID variable
(clm_trans_ID). Within SAS, discharge data was filtered by “Diagnosis Code” using the ‘Query’
function to filter for COPD and asthma exacerbation ICD-10 diagnosis codes42,43: ‘J441’ for
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COPD with acute exacerbation, unspecified, ‘J4521’ for mild intermittent asthma with [acute]
exacerbation, ‘J4531’ for mild persistent asthma with [acute] exacerbation, ‘J4541’ for moderate
persistent asthma with [acute] exacerbation, ‘J4551’ for severe persistent asthma with [acute]
exacerbation, and ‘J45901’ for unspecified asthma with [acute] exacerbation. Discharge data was
then filtered by “Diagnosis Type Code” using the ‘Query’ function to filter for ‘Admitting
Diagnosis (AD)’ (inpatient dataset) and ‘Reason for Visit (RV)’ (outpatient dataset). Rows with
missing information on any of the 4 final variables were omitted from the final 6 datasets to be
used for analysis.

The final 6 datasets were imported into R Studio version 1.2.5033 using the R ‘Haven’ library
package. Using the R ‘Dplyr’ library package, the datasets were converted into R data frames for
easier data manipulation and only the following three (3) variables were retained:
Patient 5-digit ZIP code (pat_address_zip 5)
ICD-10 diagnosis code (dx_cd)
Discharge date (disch_dt)
ICD-10 diagnosis codes were extracted from each of the 6 data frames using the ‘subset’
function within R, where a new dataset was created for each diagnosis (COPD, asthma) and each
year (2016, 2017, 2018). The following data frames resulted: COPD 16 IP, COPD 16 OP, COPD
17 IP, COPD OP, COPD 18 IP, COPD 18 OP, Asthma 16 IP, Asthma 16 OP, Asthma 17 IP,
Asthma 17 OP, Asthma 18 IP, and Asthma 18 OP. These data frames were then condensed into
the final 4 data frames using the ‘rbind’ function in R, in order to distinguish between overall
‘disease-medical facility setting’:
COPD Exacerbation Inpatient (COPD IP)
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COPD Exacerbation Outpatient (COPD OP)
Asthma Exacerbation Inpatient (Asthma IP)
Asthma Exacerbation Outpatient (Asthma OP)

Cross-walking NYS SPARCS discharge data from ZIP codes to ZCTAs
The Microsoft Office Excel crosswalk file provided by the Baruch College geospatial library,
‘zip_to_zcta10_nyc_revised’, was imported into R Studio. In addition, the US Census provides
the US Gazetteer Files that makes available all geographic areas for selected geographic area
types including representative latitude and longitude coordinates.44 A comma separated value
(CSV) file that lists all NYC ZCTAs and their corresponding latitude and longitudinal
coordinates (‘2013_Gaz_zcta_national’) was obtained from the US Gazetteer files and imported
into R Studio.

Both imported files, ‘zip_to_zcta10_nyc_revised’ and ‘zipcode_coordinates’, were then merged
to create a final ZIP code to ZCTA crosswalk dataset with corresponding latitude and
longitudinal coordinates. This crosswalk dataset was then merged with each of the final 4 patient
record data frames by ZIP code, resulting in cross-walked ZCTAs for each ZIP code linked to a
patient record. Corresponding latitude and longitudinal coordinates were also kept. Unmatched
ZIP code data were removed because it revealed patient ZIP codes that did not fall within the
NYC region (e.g., if a patient record had a ZIP code of ‘00602’, it was not included into the
merged data frame because this represents an instance where a patient was seen at a NYC
medical facility but their place of legal residence lies outside of NYC). Each data frame was then
cleaned to remove the ZIP code variable.
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Counting Number of Discharges per ZCTA
Using the ‘arrange’ function within R ‘dplyr’ library package, each of the final 4 data frames
were sorted by ZCTA and then by discharge month. Next, using the ‘count’ function within the
same library package, the number of discharges were counted based on ZCTA primarily, and
then by discharge date secondarily. The results from the ‘arrange’ and ‘count’ functions were
saved into a new data frame and converted into a CSV file. This was done for each of the final 4
data frames.

Spatial and Temporal Adjusted Cluster Detection and Evaluation
Statistically significant spatio-temporal clusters of COPD and asthma exacerbation events were
detected in the study area through the space-time scan statistic, as encoded in SaTScan software
version 9.6.45 This method evaluates many possible clusters due to space-time interaction in the
form of cylindrical windows on the map, where the size of the circular base represents the
geographic area depending on the number of contiguous circles, and the height of the cylindrical
window reflects the time period of potential clusters. For the space-time permutation model, the
analysis automatically adjusts for both temporal trends and temporal clusters. If there is an
increasing temporal trend in the data, then the space-time scan statistics will pick up that trend by
assigning a cluster during the end of the study period. If there is a decreasing trend, it will instead
pick up a cluster at the beginning of the time period.45 This method automatically adjusts for
spatial clusters as well by adjusting the expected count separately for each location, removing all
purely spatial clusters, then stratifying by location ID to ensure that each location has the same
number of events in the real and random data sets.45
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A space-time permutation model is used to search for increases in COPD and asthma
exacerbation episodes across the study area during the three-year study period. This cluster
search was retrospective, with the space unit represented by ZCTAs and the time unit
represented by months. Using this model, a cylindrical window is moved in space and time so
that for each possible geographical location and size, each possible time period is also visited.45
The number of observed and expected observations inside the window at each location is noted
in order to evaluate the potential clusters in a geographical area during a specific time period,
and to compare whether or not these clusters have a higher proportion of its cases in that time
period relative to the remaining geographical areas. For each potential cluster with risk that is
elevated relative to everywhere in the study area outside of the cluster in that time period, the
null hypothesis is tested whereby the elevated cluster is assumed to have occurred from random
chance alone.46

Statistical significance of the clusters was established by comparing the observed likelihood ratio
of each cluster to the null distribution generated from 999 Monte Carlo replications 47 of the
maximum likelihood ratio, where cases are randomly distributed across space and time.48 A
statistically significant cluster was identified if there was no more than a 5% chance of
incorrectly rejecting the null hypothesis that a cluster with elevated risk was from random
variation (p ≤ 0.05).

Analyses were conducted separately for each diagnosis-medical facility setting within the study
time period: COPD exacerbation inpatient (COPD IP), COPD exacerbation outpatient (COPD
OP), asthma exacerbation inpatient (asthma IP) and asthma exacerbation outpatient (asthma OP).
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In running the four models, the maximum cluster size was designated as up to 50% of the
population at risk (the maximum), p-values were based on 999 iterations (results were the same
for 9,999 iterations), and there was no geographic overlap among clusters.45,46 All the clusters
with a p-value of ≤ 0.05 were mapped in qGIS version 3.10 by convex polygons, bounded by
latitude and longitudinal coordinates.

2.3 Results
Table 2.1 presents a description of the study population by diagnosis, medical facility setting and
diagnosis-medical facility setting. Of the 300 745 total respiratory (asthma and COPD)
exacerbation cases included in the study across the 214 NYC ZCTAs during the 2016 – 2018
period, 243 336 cases (80.91%) were asthma-related and 57 409 cases (19.09%) were COPDrelated. Respiratory exacerbation cases occurring in the inpatient medical facility setting made
up 21.18% (63 686 cases) of the total population, while cases occurring in the outpatient setting
made up 78.82% (237 059 cases). Of the asthma exacerbation episodes, 10.25% (30 828 cases)
occurred in the inpatient medical facility setting and 70.66% (212, 508 cases) were outpatient. Of
the COPD exacerbation episodes, 10.93% (32, 858 cases) occurred in the inpatient medical
facility setting and 8.16% (24, 551 cases) were outpatient.

The distribution of respiratory exacerbation cases by diagnosis and medical facility setting at the
level of NYC neighborhood is summarized in Table 2.2. Due to NYS DOH SPARCS small-cell
regulations, all cells less than 6 must be suppressed. Therefore, Table 2.2 summarizes case
counts and population-based rates (per 1000 individuals) for each NYC neighborhood (as
opposed to NYC ZCTAs) as per the DOH definitions of NYC neighborhoods by ZIP codes
cross-walked to ZCTAs.49 The highest population-based rates for ‘asthma-inpatient’ could be
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seen in the Hunts Point and Mott Haven neighborhoods of the Bronx (12.79 per 1000
individuals), and for ‘asthma-outpatient’ could be seen in the East Harlem neighborhood of
Manhattan (93.61 per 1000 individuals). The highest population-based rates for ‘COPDinpatient’ and ‘COPD-outpatient’ could both be seen in the Battery Park neighborhood of
Manhattan with rates 293.33 and 175.41 per 1000 individuals, respectively.

Type of Respiratory
Exacerbation
Diagnosis

Medical Facility
Setting

Asthma
COPD

Asthma
Asthma
COPD
COPD
Total

Inpatient
Outpatient
Inpatient
Outpatient
Inpatient
Outpatient

Case Counts

Percent

243,336
57,409
63,686
237,059
30,828
212,508
32,858
24,551
300,745

80.91
19.09
21.18
78.82
10.25
70.66
10.93
8.16

Number of
ZCTAs
214
214
214
214
214
214
214
214
214

Table 2.1: Description of the study population with case counts and corresponding percent respiratory (Asthma and COPD)
exacerbation episodes by: diagnosis, medical facility setting and diagnosis-medical facility setting.

Space-time permutation cluster analysis
The asthma exacerbation cluster search with the space-time permutation approach detected ten
statistically significant clusters during the study period for ‘Asthma-Inpatient’ and four
statistically significant clusters during the study period for ‘Asthma-Outpatient’ (Table 2.3). The
COPD exacerbation cluster search with the space-time permutation approach detected three
statistically significant clusters during the study period for ‘COPD-Inpatient’ and nine
statistically significant clusters during the study period for ‘COPD -Outpatient’ (Table 2.3).
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A temporal description, as measured in seasons, of the timeframe for each statistically significant
cluster is also presented in Table 2.3. For asthma exacerbation episodes across both medical
facility settings, Summer 2018 appeared in the most statistically significant clusters for a total of
8 clusters. Spring 2018 and Autumn 2018 followed, each appearing in a total of 6 statistically
significant clusters. Winter 2017 was also among the top seasons, appearing in 4 statistically
significant clusters. For COPD exacerbation episodes across both medical facility settings,
Summer 2016 appeared in the most statistically significant clusters for a total of 5 clusters. Other
seasons appearing in exactly four of the statistically significant COPD exacerbation clusters
included Winter 2016, Spring 2016, Autumn 2017, Winter 2017, Spring 2018 and Summer 2018.
Across total respiratory (asthma and COPD) exacerbation, Summer 2018 notably appeared in 12
statistically significant clusters across total respiratory exacerbations and Spring 2018 appeared
in 10 statistically significant clusters.

The distribution of ‘Asthma-Inpatient’ exacerbation episodes at the ZCTA level is presented in
Figures 2.2 - 2.5. Most of the significant asthma exacerbation inpatient clusters occurred in the
second half of the study period, indicating increased inpatient hospitalizations for asthma
exacerbation diagnoses throughout the five boroughs of NYC beginning with Lower Manhattan
(Wall Street, Tribeca), as well as other neighborhoods in Manhattan including Chelsea, Clinton,
Gramercy Park, Murray Hill, Meatpacking District, Garment District, East Village, City Hall and
Lower East Side (Figure 2.2). The borough of Queens also saw increased inpatient
hospitalizations for asthma exacerbation diagnoses with patients residing in Bayside, Central
Queens, North Queens, Rego Park, West Queens, Maspeth, Ridgewood, West Central Queens
and Woodhaven. Within Brooklyn, increased asthma exacerbation inpatient hospitalizations
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occurred in East New York, Bay Ridge, Southwest Brooklyn, Bedford Stuyvesant, Bushwick and
Williamsburg, Crown Heights, Northwest Brooklyn, Prospect Heights and Prospect Leffert.
Staten Island saw increased hospitalizations in Stapleton and St. George, and Bronx within the
neighborhoods of Bronx Park, Fordham, Central Bronx, Northeast Bronx, Riverdale and
Southeast Bronx. One cluster was identified in Queens within the first half of the study period
(March through August 2017). The neighborhoods part of this cluster were Central Queens,
Douglaston, Jamaica, Oakland, Southeast Queens, and Utopia. This area was the only one with
increased asthma exacerbation inpatient hospitalizations in the first half of the study period.

Figure 2.2: Location of statistically significant (p ≤ 0.05) asthma exacerbation inpatient clusters by order of statistical
significance, New York City, 2016–2018, for space-time permutation cluster search.

Most of the significant asthma exacerbation outpatient clusters occurred in the second half of the
study period, indicating increased outpatient visits for asthma exacerbation diagnoses throughout
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the five boroughs of NYC beginning with Northwest Staten Island (Figure 2.3). The boroughs of
Bronx and Manhattan also saw increased outpatient hospitalizations for asthma exacerbation
diagnoses with patients residing throughout majority of Bronx and within the Manhattan
neighborhoods of Inwood, Washington Heights, Lower Manhattan and Midtown. Within
Queens, increased asthma exacerbation outpatient hospitalizations occurred in Hunter’s Point.
One cluster was identified spanning across Brooklyn and Queens within the first half of the study
period (March through August 2016). The neighborhoods part of this cluster were Eastern
Brooklyn, Central Queens, and Southwest Queens. This area was the only one with increased
asthma exacerbation outpatient hospitalizations in the first half of the study period.

Figure 2.3: Location of statistically significant (p ≤ 0.05) asthma exacerbation outpatient clusters by order of statistical
significance, New York City, 2016–2018, for space-time permutation cluster search.
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Most of the significant COPD exacerbation inpatient clusters occurred in the first half of the
study period, indicating increased inpatient hospitalizations for COPD exacerbation diagnoses in
Clinton and Midtown West (Manhattan) as well as Silver Lake and West Brighton (Staten
Island) (Figure 2.4). One cluster spanning across neighborhoods within Bronx and Manhattan
was identified in the second half of the study period (September 2017 through May 2018). The
neighborhoods part of this cluster included Melrose and Highbridge (Bronx), as well as
Washington Heights (Manhattan). This area was the only one with increased COPD exacerbation
inpatient hospitalizations in the second half of the study period.

Figure 2.4: Location of statistically significant (p ≤ 0.05) COPD exacerbation inpatient clusters by order of statistical
significance, New York City, 2016–2018, for space-time permutation cluster search.
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The significant COPD exacerbation outpatient clusters occurred throughout the entire study
period (Figure 2.5). The significant clusters in the first half of the study period were in
Bensonhurst, Brooklyn (February 2017 through April 2017), NoHo and SoHo, Manhattan
(November 2016 through January 2017), West Central Queens (January 2016 through July
2016), Northeast Brooklyn (January 2016 through July 2016), Bathgate Bronx (June 2016
through November 2016), and other neighborhoods of the Bronx including Mott Haven, Melrose
and Longwood (February 2016 through April 2017). The significant clusters of COPD
exacerbation outpatient visits in the second half of the study period included the entire borough
of Staten Island, as well as Southwest Brooklyn and Richmond Hill in Queens (December 2017
through November 2018). Another significant cluster in the second half of the study period
(August 2017 through March 2018) included Inwood and Washington Heights neighborhoods of
Manhattan, as well as Mid-West Bronx. An additional significant cluster during the second half
of the study period (April 2018 through August 2018) spanned Long Island City and Steinway
within Queens, and Upper West Side within Manhattan. The neighborhoods of Rockaway Park
and Belle Harbor within Queens saw a significant cluster in the second half of the study period
(April 2018 through July 2018) as well.

The average number of cases included in the asthma exacerbation inpatient clusters was 154.3
cases. The cluster including the largest number of asthma exacerbation inpatient hospitalization
was located within border neighborhoods of Brooklyn (Bedford Stuyvesant, Bushwick and
Williamsburg, Crown Heights, Northwest Brooklyn, Prospect Heights, and Prospect Leffert) and
Manhattan (City Hall and Lower East Side), with 395 cases. This cluster spanned from October
through December 2018. The average duration of the asthma exacerbation inpatient clusters was
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2.8 months. The clusters with the longest duration were in Manhattan (Chelsea and Clinton,
Meatpacking District, Garment District, and East Village) and Queens (Central Queens,
Douglaston, Jamaica, Oakland, Southeast Queens, and Utopia), each with 6 months (Table 2.3).

Figure 2.5: Location of statistically significant (p ≤ 0.05) COPD exacerbation outpatient clusters by order of statistical
significance, New York City, 2016–2018, for space-time permutation cluster search.

The average number of cases included in the asthma exacerbation outpatient clusters was 4,896
cases. The cluster including the largest number of asthma exacerbation outpatient hospitalization
was located within border neighborhoods of Bronx (Northeast Bronx, Southeast Bronx, Central
Bronx, Hunts Point and Mott Haven, Bronx Park and Fordham, Kingsbridge and Riverdale) and
Manhattan (Inwood and Washington Heights), with 8,555 cases. This cluster spanned from
September through December 2018. The average duration of the asthma exacerbation outpatient
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clusters was 7.5 months. The cluster with the longest duration was in Northwest Staten Island
(Port Richmond, Silver Lake, Bull's Head, and Grymes Hill) with 12 months (Table 2.3).

The average number of cases included in the COPD exacerbation inpatient clusters was 212
cases. The cluster including the largest number of COPD exacerbation inpatient hospitalization
was located within border neighborhoods of Bronx (Melrose and Highbridge) and Manhattan
(Washington Heights), with 481 cases. This cluster spanned from September 2017 through May
2018. The average duration of the COPD exacerbation inpatient clusters was 5.7 months. The
cluster with the longest duration was located within neighborhoods of Bronx (Melrose and
Highbridge) and Manhattan (Washington Heights) with 9 months (Table 2.3).

The average number of cases included in the COPD exacerbation outpatient clusters was 345.4
cases. The cluster including the largest number of COPD exacerbation outpatient hospitalization
was located within border neighborhoods of Queens (Elmhurst, Maspeth, Ozone Park, West
Central Queens, Woodhaven, and Woodside) and Brooklyn (Bushwick and Williamsburg,
Brownsville, Crown Heights, East New York, Ocean Hill, City Line), with 964 cases. This
cluster spanned from January through July 2016. The average duration of the COPD
exacerbation outpatient clusters was 7.2 months. The cluster with the longest duration was in
South Bronx (Mott Haven, Melrose, and Longwood) with 15 months (Table 2.3).

The statistically significant clusters for respiratory exacerbation medical visits by ‘diagnosissetting’ are summarized with their respective timeline in Figures 2.6 and 2.7, followed by a
temporal summary of observed and expected counts over time in Figures 2.8, 2.9, 2.10 and 2.11.
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There were a few neighborhoods in each borough that appeared in both statistically significant
asthma exacerbation clusters for clusters with the longest duration within both the inpatient and
outpatient settings. In Manhattan, they include: Chelsea & Clinton (appearing in 2 asthma IP
clusters for 6 months & 1 month respectively, and 7 months for OP), and City Hall & Lower East
Side (3 months IP, 7 months OP for each); then in Queens: West Central Queens (predominantly
Maspeth) (1 month IP, 6 months OP), and Jamaica (6 months IP, 6 months OP); In Brooklyn:
Bushwick, Williamsburg & Prospect Leffert (3 months IP, 6 months OP); in Staten Island: Silver
Lake, Stapleton & St. George/Silver Lake (4 months IP, 12 months OP); and finally in the
Bronx: Bronx Park & Fordham, Kingsbridge & Riverdale, Northeast & Southeast Bronx, and
Central Bronx (all 1 month IP, 4 months OP).

The Melrose neighborhood within the Bronx appeared in both statistically significant COPD
exacerbation clusters for clusters with the longest duration within both inpatient and outpatient
settings (Figure 2.7). The persistence of the Melrose, Bronx cluster can also be seen in the
timeline summary of observed and expected counts over time (Figures 2.10 and 2.11). No other
areas had persistent and significant clusters in the same location for an average of 12 months (9
months for inpatient and 15 months for outpatient) of the study period (Figures 2.6, 2.7, 2.8, 2.9,
2.10 and 2.11).

The Silver Lake (part of Stapleton and St. George), Staten Island ZCTA neighborhood appeared
across all statistically significant respiratory (asthma and COPD) exacerbation clusters within
both the inpatient and outpatient settings. No other ZCTA was persistent and significant across
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all four ‘diagnosis-settings’ (asthma inpatient, asthma outpatient, COPD inpatient and COPD
outpatient) for all three years of the study period (Tables 2.4 and 2.5).

Figure 2.6: Statistically significant asthma exacerbation neighborhood clusters, New York, 2016-2018, by spatial-temporal
analysis.

Figure 2.7: Statistically significant COPD exacerbation neighborhood clusters, New York, 2016-2018, by spatial-temporal
analysis.
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Borough

Matching COPD
ZCTAs

Neighborhood

Manhattan

10032

Washington Heights

Manhattan

10033

Washington Heights

Staten Island

10301

Silver Lake (Stapleton and St. George)

Staten Island

10302

West Brighton

Staten Island

10310

West Brighton

Bronx

10452

Highbridge

Bronx

10456

Melrose

Table 2.2: Statistically significant ZCTA’s with corresponding neighborhoods appearing within both inpatient and outpatient
settings for space-time permutation COPD exacerbation cluster search, New York City, 2016-2018.

There were a couple of ZCTA neighborhoods appearing in statistically significant asthma
exacerbation clusters across both the inpatient and outpatient settings (Table 2.4). Within
Manhattan, the ZCTA neighborhoods of Chelsea, City Hall, East Village, Lower East Side,
Meatpacking District, Midtown West, Theatre District, Tribeca, Turtle Bay, and Upper West
Side all appeared. Within Staten Island, there were the ZCTA neighborhoods of Silver Lake and
Grymes Hill. Within Bronx, the ZCTA neighborhoods of Bathgate, Belmont, Bronx Park South,
Coop City, Eastchester Bay, Jerome Park, Morris Heights, North Baychester, Pelham Gardens,
Riverdale, Soundview Bruckner, Southeast Bronx, Van Cortlandt Park, Van Nest, Wakefield,
and Westchester Square all appeared. Within the borough of Brooklyn, the neighborhoods of
Bushwick, Prospect Heights, Prospect Leffert, and Ridgewood were included. Within the
borough of Queens, the neighborhoods of Elmhurst, Glendale, Jamaica Hills, Kew Garden Hills,
Maspeth, Middle Village, Rego Park, St. Albans, and Woodhaven all appeared across both
inpatient and outpatient asthma exacerbation settings.

A few ZCTA neighborhoods appeared in statistically significant COPD exacerbation clusters
across both the inpatient and outpatient settings (Table 2.5). They included Melrose and
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Highbridge ZCTAs within Bronx, Brighton and Silver Lake within Staten Island, and
Washington Heights within Manhattan.

The Highbridge ZCTA neighborhood within the Bronx appeared in statistically significant
asthma outpatient, COPD inpatient and COPD outpatient exacerbation clusters. However, it did
not appear in statistically significant asthma inpatient clusters.

There were no persistent ZCTAs that appeared across all statistically significant inpatient
respiratory (asthma and COPD) exacerbation cluster searches. However, there were several
ZCTA neighborhoods that appeared across all statistically significant outpatient respiratory
(asthma and COPD) exacerbation cluster searches (Table 2.6). They included neighborhoods
within all five NYC boroughs: Manhattan (NoHo/SoHo, Inwood, Upper West Side and
Washington Heights), Staten Island (Grymes Hill, Mariners Park, Silver Lake – part of Stapleton
and St. George, and West Brighton), Bronx (Bathpage, Highbridge, Jerome Park, Longwood,
Melrose, Morris Heights, and Mott Haven), Brooklyn (Brownsville, Bushwick, City Line, Crown
Heights, East New York, Ocean Hill and Williamsburg), and Queens (Elmhurst, Forest Hills,
Glendale, Maspeth, Middle Village, Ozone Park, Richmond Hill, Ridgewood, Rego Park, and
Woodhaven).

2.4 Discussion
In the present study, the analyses identified statistically significant clusters of asthma and COPD
exacerbation medical visits in specific ZCTAs of New York City from 2016 to 2018. Those
clusters were persistent in the Silver Lake ZCTA, part of the Staten Island neighborhood of
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Stapleton and St. George, across all four ‘diagnosis-setting’ space-time permutation analyses.
This finding is similar to a recent study which found higher positive relation between obesity and
asthma hospitalizations in all New York City, with high significance value in northern Staten
Island.51

The Melrose ZCTA part of the South Bronx borough was persistent for the longest duration of
the study period in both COPD inpatient and outpatient exacerbation space-time permutation
analyses. The Melrose neighborhood of the South Bronx, as well as the Inwood and Washington
Heights neighborhoods of Northern Manhattan, were also statistically significant across three of
the space-time permutation analyses (Asthma inpatient, COPD inpatient, and COPD outpatient).
Although there is limited COPD research within this region, the research findings within this
study are consistent with the available research on spatio-temporal asthma hospitalizations
within NYC. There is a high percentage of urban populations residing near major roadways and
the high prevalence of urban asthma.52 The literature shows an average of 45% of children
residing in Manhattan and the Bronx live within 400-480 m of a state or county highway and
zones of elevated concentrations of traffic-related pollutants.53 These children presented with
wheeze, asthma and high levels of immunoglobulin (Ig) E.53,54

Another study assessing asthma hospitalizations within New York City found the Bronx, East
Harlem and some neighborhoods in North/Central Brooklyn close to some of the biggest
highways of the city (e.g., Brooklyn-Queens Expressway, Long Island Expressway) and having
the highest hospitalization rates of the whole city, together with the highest pollution level of all
the neighborhoods excluding the wealthiest areas of Manhattan.51 They further found those areas
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with the highest hospitalization rates also had the highest poverty rate as well as the lowest
percentage of insured people in the city.51

This study also identified statistically significant outpatient respiratory (asthma and COPD)
exacerbation clusters across all five NYC boroughs: Manhattan (NoHo/SoHo, Inwood, Upper
West Side and Washington Heights), Staten Island (Grymes Hill, Mariners Park, Silver Lake –
part of Stapleton and St. George, and West Brighton), Bronx (Bathpage, Highbridge, Jerome
Park, Longwood, Melrose, Morris Heights, and Mott Haven), Brooklyn (Brownsville, Bushwick,
City Line, Crown Heights, East New York, Ocean Hill and Williamsburg), and Queens
(Elmhurst, Forest Hills, Glendale, Maspeth, Middle Village, Ozone Park, Richmond Hill,
Ridgewood, Rego Park, and Woodhaven). These findings align with the current research which
shows race seemed to play a role on asthma exacerbation hospitalizations, where the highest
percentage of the NYC population identifying as black reside in the Bronx, in Harlem and East
Harlem, Southeast Queens and East Brooklyn, especially Crown Heights, Flatbush and
Brownsville.51

Each statistically significant cluster was presented temporally by season in Table 2.3. There was
a consistent amount of Spring 2018 and Autumn 2018 timeframes appearing in statistically
significant clusters across total respiratory exacerbations. The population strata may help explain
temporal clusters, where the sociodemographic makeup may explain some of the variation of
clusters across time. For example, the population is aging over time leading to age, period and
cohort (APC) as different sources of health-related change. First, individuals can age, meaning
that they change as they progress through their life course. Second, change can occur over time
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due to differences between cohort groups, whereby as new cohorts replace old cohorts, the social
composition (and thus the health) of society as a whole can change. Third, and finally, change
can occur as a result of period effects, whereby passage through time results in a change in
health, regardless of the age of the individual.55

Meteorological conditions may have also played a role on the seasonal rates of respiratory
exacerbation, where the National Oceanic and Atmospheric Administration (NOAA) stated New
York set/tied their all-time warmest minimum temperature records for October 2018, falling
under the Autumn 2018 timeframe.56 Low temperatures ranged from 70 degrees F (21 degrees C)
to 72 degrees F (22 degrees C) throughout New York on October 9, 2018.56 It was also the
coldest Thanksgiving Day on record for New York, with temperature lows in NYC ranging from
38.1 degrees F (3.4 degrees C) to 40.5 degrees F (4.7 degrees F).56 In addition, a nor’easter
moved through NYC on March 21, 2018, contributing to Kennedy Airport, New York City
having their snowiest spring on record.56 This storm brought along the greatest snowfall totals
reported in New York to date, causing schools to close throughout NYC and more than 5,000
flights to be cancelled. A late Autumn storm also moved through New York from November 15
to 16, 2018 and dropped mixed precipitation and up to 18 inches (46 cm) of snow on the
region.56 Kennedy Airport in New York City had their greatest 1-day snowfall for November,
with 6.4 inches (16 cm) and 4.8 inches (12 cm), respectively.56 The storm also made it Kennedy
Airport's snowiest November on record.56 For Central Park in New York City, it was the earliest
6+ inch (15 cm) snowstorm on record.56
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A strength of this study is the analysis of space-time permutation for respiratory exacerbation
across New York City at the level of the ZCTA. USPS ZIP Codes lack a pre-defined geographic
area so the USPS assigns ZIPs to ranges of addresses associated with street segments. However,
the ZCTA is composed of aggregated census blocks where most addresses have the same ZIP
Code. In addition, the research shows there is substantially more spatial variability at the
neighborhood than at the county level for asthma-related emergency department (ED) visits
within New York City.57 One study found neighborhood variability was especially notable for
asthma-related ED visits where county-level rates vary four-fold, with highest rates in the
Bronx.57 They further found hospitalizations for respiratory causes varied by eight-fold across
United Hospital Fund (UHF) neighborhood, with highest rates in the Bronx and Northern
Manhattan while rates only vary by 1.8-fold at the county level.57

Clustering in the outpatient analyses were more sporadic. Outpatient medical visits tend to be
less severe, where patients are usually admitted into a hospital to treat more serious forms of the
condition. Furthermore, SPARCS data is unable to capture visits at the local level such as within
medical provider clinics, unless the case is serious enough to require immediate referral to a
hospital. These findings emphasize the importance of inpatient hospitalizations as a clearer
indicator of population-level health impacts. Additionally, the space-time cluster analysis
demonstrated increased asthma exacerbation episodes in the second half of the study, whereas
there were increased COPD exacerbation episodes in the first half of the study. Further studies
may be carried out to analyze climatic events (e.g., heat waves, hurricanes, blizzards) within
these time periods which may have contributed to the temporal associations with respiratory
exacerbation determined in this study. This can also include analyses to include climatic
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variables such as temperature and precipitation maximums, as well as wind and relative humidity
averages.

2.5 Conclusion
In summary, this study addresses important problems in the fields of public health,
environmental health, climate science, health care, and sociology. In particular, it addresses the
need for focused studies in major cities such as New York City, where there are diverse
sociodemographic classes residing in different geographic regions who experience adverse health
effects from climate patterns in varying ways.

The results from this study largely agree with the original hypothesis. Rates of COPD and
asthma exacerbation varied across NYC ZCTAs and throughout the study period. Aligning with
current research,54,58 our study found the difference in COPD and asthma exacerbation rates were
highest in areas appearing close in proximity to major highways and facilities with pollutant
emissions. The literature also cites those areas with the highest hospitalization rates also have the
highest positive association between obesity and asthma16, the highest poverty rate as well as the
lowest percentage of insured people in New York City 51

‘Summer 2018’ and ‘Spring 2018’ appeared in the most amount of statistically significant
clusters across total respiratory exacerbation episodes, indicating that seasonal allergies may
have played a role. Furthermore, the summer and winter seasons were among the most persistent.
For example, ‘Summer 2018’ appeared in the most statistically significant asthma exacerbation
episodes across both medical facility settings for a total of 8 clusters. ‘Winter 2017’ was also
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among the top seasons, appearing in 4 statistically significant clusters. For COPD exacerbation
episodes across both medical facility settings, ‘Summer 2016’ appeared in the most statistically
significant clusters for a total of 5 clusters.

This study has several limitations, including the 3-year time period. Traditionally, scientists have
defined a ‘Climate Normal’ as an average over a recent 30-year period simply because it is the
accepted convention.59 In addition, this may have affected the inconsistency of statistically
significant clusters of high respiratory exacerbation rates witnessed over time and season.
However, the results of this study can be used to inform future research with the capability of
accessing respiratory exacerbation for a longer period of time.

Misclassification of case location could have also occurred, because addresses and geocoded
coordinates can be subject to errors.60 In addition, cases may spend a majority of their time
outside of their place of residence such as work and/or school, so the ZCTAs recorded for the
cases may not represent the locations where they may have highest exposure to risk factors for a
respiratory exacerbation. However, respiratory exacerbation is usually an emergency so patients
are sent to the hospital or article 28 medical facility nearest their current location, which may
very likely be work or home. Further, these limitations are hypothetical in nature and there is no
available evidence that these potential location errors are systematic. Therefore, they should be
minimized by the use of ZCTAs as the unit of analysis, as done in this study, rather than the
specific geocoded address points.48
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Another limitation is the lack of primary care or pediatrician visits captured by SPARCS.35 Many
patients go to their Primary Care Physician (PCP) once they experience a symptom of
COPD/Asthma, prior to heading to their nearest hospital or medical facilities certified under
Article 28 of the Public Health Law35 where they fear experiencing long waiting periods.
Nevertheless, the findings from this study can guide future studies for analyses at the level of the
PCP.

Although our results determined respiratory exacerbation rates were highest in clusters appearing
closest in proximity to major highways and facilities with high emissions of toxic pollutants, our
study was methodologically limited in providing a systematic analysis to confirm this
association. Future research may measure the distance to major highways and toxic release
inventory sites (TRIs) within spatio-temporal clusters presenting with high rates of respiratory
exacerbation, and then compare to clusters with low rates. Studies can further assess climatic and
sociodemographic factors that may drive the spatio-temporal differences found between clusters,
such as obesity, seasonal allergies, and SES status, factors that have been associated with
increased respiratory hospitalizations.61,62

The findings from this study can be generalizable to other individuals living within NYC that are
pre-diagnosed with asthma and COPD but were not included in this research, as well as to
individuals in other urban areas diagnosed with a chronic health condition (e.g., cardiac), that
may be also experience health inequities. The New York State SPARCS hospital discharge data
includes outcomes from a representative sample of an urban area (New York City) within the
NYS population and includes individuals who were discharged from a NYS hospital or article 28
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medical facility, regardless of age, sex, race/ethnicity and socioeconomic status. Therefore, this
study could also be transportable to other diverse urban populations within the U.S. with a
similar population structure, where there is a disproportionate burden of chronic health disease
(e.g., respiratory, cardiac) among disadvantaged populations. Given our findings in NYC,
research can focus on similar racial and socioeconomic disparities that are expected in other
large cities with a similar population makeup across the United States.
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2.7 Appendix
Table 2.2: Case counts and population-based rates of respiratory (Asthma and COPD)
exacerbation episodes by ‘diagnosis-medical facility setting’ in 43 neighborhoods within New
York City, 2016-2018
Borough

Bronx
Bronx
Bronx

Bronx
Bronx
Bronx
Bronx
Brooklyn
Brooklyn
Brooklyn
Brooklyn
Brooklyn
Brooklyn
Brooklyn
Brooklyn
Brooklyn
Brooklyn
Brooklyn
Manhattan
Manhattan
Manhattan
Manhattan

Manhattan

Manhattan

Manhattan
Manhattan
Manhattan
Manhattan

Neighborhood

Bronx Park and
Fordham
Central Bronx
High Bridge
and Morrisania
Hunts Point
and Mott
Haven
Kingsbridge
and Riverdale
Northeast
Bronx
Southeast
Bronx
Borough Park
Bushwick and
Williamsburg
Canarsie and
Flatlands
Central
Brooklyn
East New York
and New Lots
Flatbush
Greenpoint
Northwest
Brooklyn
Southern
Brooklyn
Southwest
Brooklyn
Sunset Park
Battery Park
Central Harlem
Chelsea and
Clinton
East Harlem
Gramercy Park
and Murray
Hill
Greenwich
Village and
Soho
Inwood and
Washington
Heights
Lower East
Side
Lower
Manhattan
Upper East
Side

Asthma

Inpatient

Asthma

Outpatient

COPD

Inpatient

COPD

Outpatient

Count

PopulationBased Rate
(per 1000
people)

Count

PopulationBased Rate
(per 1000
people)

Count

PopulationBased Rate
(per 1000
people)

Count

PopulationBased Rate
(per 1000
people)

1576
1584

6.24
7.68

12847
13740

50.85
66.66

1527
824

6.04
4.00

954
448

3.78
2.17

2272

10.94

16119

77.63

576

2.77

343

1.65

1747

12.79

11428

83.67

370

2.71

270

1.98

314

3.45

2055

22.61

352

3.87

527

5.80

916

4.80

6700

35.14

551

2.89

694

3.64

1547
323

5.19
0.97

9652
2373

32.40
7.15

212
1320

0.71
3.98

48
1069

0.16
3.22

910

4.32

9121

43.34

1046

4.97

733

3.48

455

2.33

4544

23.30

527

2.70

181

0.93

1451

4.55

14497

45.46

1600

5.02

970

3.04

1129
759
287

6.01
2.56
2.26

8893
8615
1261

47.34
29.05
9.93

1146
864
739

6.10
2.91
5.82

980
770
524

5.22
2.60
4.12

1113

4.96

4201

18.74

314

1.40

261

1.16

606

2.12

3905

13.68

993

3.48

746

2.61

258
222
0
1099

1.29
1.74
0.00
6.76

1329
1949
31
11877

6.67
15.24
6.48
73.02

950
1207
1403
723

4.77
9.44
293.33
4.45

264
482
839
529

1.32
3.77
175.41
3.25

866
741

5.98
6.74

1562
10294

10.78
93.61

906
1640

6.25
14.91

681
1614

4.70
14.68

560

4.16

944

7.02

216

1.61

160

1.19

57

0.68

345

4.12

1376

16.43

867

10.35

844

3.40

8589

34.56

26

0.10

7

0.03

494

2.49

3215

16.17

676

3.40

1087

5.47

428

8.85

819

16.93

210

4.34

308

6.37

184

0.84

1223

5.58

390

1.78

156

0.71

23

Manhattan
Queens
Queens
Queens
Queens
Queens
Queens
Queens
Queens
Queens
Queens
Staten
Island
Staten
Island
Staten
Island
Staten
Island
Total

Upper West
Side
Central Queens
Jamaica
North Queens
Northeast
Queens
Northwest
Queens
Rockaways
Southeast
Queens
Southwest
Queens
West Central
Queens
West Queens

360
204
1393
518

1.68
2.11
4.82
1.99

3339
1000
6332
1677

15.54
10.33
21.90
6.46

423
957
824
1069

1.97
9.88
2.85
4.12

317
1029
1583
830

1.48
10.63
5.48
3.20

97

1.81

299

5.58

98

1.83

99

1.85

435
490

2.16
4.26

3272
3428

16.26
29.81

469
1147

2.33
9.98

607
586

3.02
5.10

666

3.52

3200

16.92

749

3.96

798

4.22

624

2.34

3835

14.40

843

3.17

467

1.75

724
1068

2.95
2.22

2126
6699

8.65
13.94

1012
736

4.12
1.53

414
488

1.68
1.02

Mid-Island

332

3.88

528

6.17

114

1.33

170

1.99

Port Richmond

430

6.11

1673

23.77

261

3.71

98

1.39

South Shore
Stapleton and
St. George

268

1.42

839

4.43

742

3.92

293

1.55

477
30828

3.86
3.79

2133
212508

17.25
26.16

730
32858

5.90
4.04

260
24551

2.10
3.02

Table 2.3: Case counts and population-based rates of respiratory (Asthma and COPD) exacerbation episodes by ‘diagnosismedical facility setting’ in 43 neighborhoods within the study area, New York City, 2016-2018. Source: New York State SPARCS,
U.S. Census

Table 2.3: Location of statistically significant COPD and asthma clusters, New York City, 20162018.
Disease
Exacerbation
Type-Setting

Cluster Location (NYC
Neighborhood)

Time Frame

Cases
Observed

Maximum
Likelihood
Ratio Test
Statistic

p-value

Asthma Inpatient

Wall Street, Lower Manhattan

09/2018
(Summer/Autumn 2018)

22

44.74

<0.0001

Chelsea and Clinton, Gramercy Park
and Murray Hill; Manhattan; NY

06/2018
(Spring/Summer 2018)

34

27.09

<0.0001

16

25.8

<0.0001

155

21.62

<0.0001

Tribeca, Lower Manhattan
Chelsea and Clinton, Meatpacking
District, Garment District, East Village

12/2017 - 01/2018
(Autumn 2017/Winter
2018)
03/2018 - 08/2018
(Winter 2017/Spring
2018/Summer 2018)

Bayside, Central Queens, North Queens,
Rego Park, West Queens

04/2018 - 07/2018
(Spring/Summer 2018)

235

17.4

0.0001

East New York, Brooklyn; Maspeth,
Ridgewood, West Central Queens &
Woodhaven, Queens

03/2018
(Winter 2017/Spring
2018)

74

12.2

0.013

Bay Ridge and Southwest Brooklyn,
Brooklyn; Stapleton and St. George,
Staten Island

08/2018 - 11/2018
(Summer/Autumn 2018)

107

12.03

0.016
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Asthma Outpatient

COPD Inpatient

Bronx Park and Fordham, Central
Bronx, Northeast Bronx, Riverdale,
Southeast Bronx; Bronx

11/2018
(Autumn 2018)

216

11.96

0.017

Central Queens, Douglaston, Jamaica,
Oakland, Southeast Queens, Utopia

03/2017 - 08/2017
(Winter/Spring/
Summer 2017)

289

11.71

0.023

Bedford Stuyvesant, Bushwick and
Williamsburg, Crown Heights,
Northwest Brooklyn, Prospect Heights,
Prospect Leffert, Brooklyn; City Hall &
Lower East Side, Manhattan

10/2018 - 12/2018
(Autumn 2018)

395

10.87

0.05

Port Richmond, Silver Lake, Bull's
Head, Grymes Hill; Staten Island; NY

01/2018 - 12/2018
(Winter/Spring/Summer
/Autumn 2018)

1564

105.07

<0.0001

Northeast Bronx, Southeast Bronx,
Central Bronx, Hunts Point and Mott
Haven; Bronx Park and Fordham,
Kingsbridge and Riverdale; Bronx; NY /
Inwood and Washington Heights;
Manhattan; NY

09/2018 - 12/2018
(Summer/Autumn 2018)

8555

50.3

<0.0001

Chelsea and Clinton, Midtown West,
Upper West Side, Upper East Side,
Gramercy Park and Murray Hill,
Theatre District, Greenwich Village and
SoHo, Lower East Side, City Hall,
Battery Park City, Tribeca; Manhattan;
NY / Hunters Point; Queens; NY

03/2018 - 09/2018
(Winter/Spring/Summer
2018)

1347

36.55

<0.0001

East New York and New Lots, Canarsie
and Flatlands, Central Brooklyn,
Bushwick and Williamsburg, Flatbush,
Prospect Leffert; Brooklyn; NY /
Southwest Queens, West Central
Queens, Forest Hills, Jamaica, Maspeth,
Kew Garden Hills, Elmhurst; Queens;
NY

03/2016 - 08-2016
(Spring/Summer 2016)

8118

28.14

<0.0001

28

18.46

<0.0001

127

13.18

0.0057

481

12.25

0.013

805

40.12

<0.0001

42

25.4

<0.0001

26

22.96

<0.0001

Clinton - Midtown West; Manhattan;
NY
Silver Lake, West Brighton; Staten
Island; NY
Melrose, Highbridge; Bronx /
Washington Heights; Manhattan; NY

COPD Outpatient

Sunset Park, Southwest Brooklyn;
Brooklyn; NY /Richmond Hill; Queens;
NY / Bloomfield, South Bloomfield,
Mid-Island, Port Richmond, South
Shore, Silver Lake, Rosebank; Staten
Island; NY
Bensonhurst; Brooklyn; NY
NoHo, SoHo; Manhattan; NY

09/2016 - 11/2016
(Summer/Autumn 2016)
01/2016 - 05/2016
(Winter/Spring/Summer
2016)
09/2017 - 05/2018
(Summer 2017/Autumn
2017/Winter
2017/Spring 2018)
12/2017 - 11/2018
(Autumn 2017/Winter
2017/Spring
2018/Summer
2018/Autumn 2018)
02/2017 - 04/2017
(Winter/Spring 2017)
11/2016 - 01/2017
(Autumn 2016/Winter
2017)
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Elmhurst, Maspeth, Ozone Park, West
Central Queens, Woodhaven, Woodside;
Queens; NY / Bushwick and
Williamsburg, Brownsville, Crown
Heights, East New York, Ocean Hill,
City Line; Brooklyn; NY

01/2016 - 07/2016
(Winter/Spring/Summer
2016)

964

22.22

<0.0001

Inwood and Washington Heights;
Manhattan; NY / Morris Heights,
Highbridge, Jerome Park; Bronx; NY

08/2017 - 03/2018
(Autumn 2017/Winter
2017/Spring 2018)

345

17.18

<0.0001

115

16.95

0.0001

153

14.79

0.001

32

12.56

0.01

627

11.77

0.025

Bathgate; Bronx; NY
Long Island City, Steinway; Queens;
NY/ Upper West Side; Manhattan; NY
Rockaway Park, Belle Harbor; Queens;
NY

Mott Haven, Melrose, Longwood;
Bronx; NY

06/2016 - 11/2016
(Spring/Summer/Autumn
2016)
02/2018 - 08/2018
(Winter/Spring/Summer
2018)
04/2018 - 07/2018
(Spring/Summer 2018)
02/2016 - 04/2017
(Winter 2016/Spring
2016/Summer
2016/Autumn
2016/Winter
2016/Spring 2017

Table 2.4: Location of statistically significant (p ≤ 0.05) COPD and asthma clusters, New York City, 2016-2018, for space-time
permutation cluster search.

Figure 2.8: Observed and expected case counts for statistically significant asthma exacerbation
inpatient clusters, New York City, 2016-2018.
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Figure 2.8: Observed and expected case counts for statistically significant (p ≤ 0.05) asthma exacerbation inpatient clusters,
New York City, 2016-2018 (blue bars represent statistically significant clusters, and orange bars represent observed case counts
within those clusters over a period of time): (a) Wall Street, Lower Manhattan, (b) Chelsea, Clinton, Gramercy Park & Murray
Hill, Manhattan, (c) Tribeca, Lower Manhattan, (d) Chelsea, Clinton, Meatpacking District, Garment District & East Village,
Manhattan, (e) Bayside, Central Queens, North Queens, Rego Park & West Central Queens, (f) East New York, Brooklyn;
Maspeth, Ridgwood, West Central Queens & Woodhaven, Queens, (g) Bay Ridge & Southwest Brooklyn; Stapleton & St. George,
Staten Island, (h) Bronx Park & Fordham, Central Bronx, Northeast Bronx, Riverdale, Southeast Bronx, (i) Central Queens,
Douglaston, Jamaica, Oakland, Southeast Queens, Utopia, Queens, (j) Bedford Stuyvesant, Bushwick & Williamsburg,
Northwest Brooklyn; City Hall & Lower East Side, Manhattan.
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Figure 2.9: Observed and expected case counts for statistically significant asthma exacerbation
outpatient clusters, New York City, 2016-2018.

Figure 2.9: Observed and expected case counts for statistically significant (p ≤ 0.05) asthma exacerbation outpatient clusters,
New York City, 2016-2018(blue bars represent statistically significant clusters, and orange bars represent observed case counts
within those clusters over a period of time): (a) Northwest Staten Island, (b) West Bronx; Inwood & Washington Heights, (c)
Lower & Midtown Manhattan; Hunter’s Point, and (d) Eastern Brooklyn; Southwest & Central Queens.

Figure 2.10: Observed and expected case counts for statistically significant COPD exacerbation
inpatient clusters, New York City, 2016-2018.
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Figure 2.10: Observed and expected case counts for statistically significant (p ≤ 0.05) COPD exacerbation inpatient clusters,
New York City, 2016-2018 (blue bars represent statistically significant clusters, and orange bars represent observed case counts
within those clusters over a period of time): (a) Clinton & Midtown West, (b) Silver Lake & West Brighton, Staten Island, and (c)
Melrose & Highbridge, Bronx; Washington Heights, Manhattan.

Figure 2.11: Observed and expected case counts for statistically significant COPD exacerbation
outpatient clusters, New York City, 2016-2018.
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Figure 2.11: Observed and expected case counts for statistically significant (p ≤ 0.05) COPD exacerbation outpatient clusters,
New York City, 2016-2018 (blue bars represent statistically significant clusters, and orange bars represent observed case counts
within those clusters over a period of time): (a) Staten Island; Southwest Brooklyn; Richmond Hill, Queens, (b) Bensonhurst,
Brooklyn, (c) NoHo & SoHo, Manhattan, (d) West Central Queens; Northeast Brooklyn, (e) Inwood & Washington Heights,
Manhattan; Mid-West Bronx, (f) Bathgate, Bronx, (g) Long Island City & Steinway, Queens; Upper West Side, Manhattan, (h)
Rockaway Park & Belle Harbor, and (i) Mott Haven, Melrose & Longwood, Bronx.

Table 2.4: Statistically significant ZCTA’s with corresponding neighborhoods appearing within
both inpatient and outpatient settings for space-time permutation asthma exacerbation cluster
search, New York City, 2016-2018.

Borough

Matching Asthma
ZCTAs

Neighborhood

Manhattan

10001

Chelsea

Manhattan

10002

Lowest East Side

Manhattan

10003

East Village

Manhattan

10007

Tribeca

Manhattan

10011

Chelsea

Manhattan

10014

Meatpacking District

Manhattan

10019

Upper West Side

Manhattan

10020

Theatre District

Manhattan

10022

Turtle Bay

Manhattan

10038

City Hall

Manhattan

10103

Midtown West

Manhattan

10110

Midtown West

Manhattan

10111

Midtown West

Manhattan

10112

Theatre District

Manhattan

10119

Midtown West

Manhattan

10152

Midtown West

Manhattan

10153

Midtown West

Manhattan

10154

Midtown West

Manhattan

10165

Upper West Side

Manhattan

10167

Midtown West

Manhattan

10169

Upper West Side
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Manhattan

10170

Upper West Side

Manhattan

10171

Midtown West

Manhattan

10172

Upper West Side

Manhattan

10173

Upper West Side

Manhattan

10177

Upper West Side

Manhattan

10199

Chelsea

Staten Island

10301

Silver Lake (Stapleton & St. George)

Staten Island

10304

Grymes Hill

Bronx

10453

Morris Heights

Bronx

10457

Bathgate

Bronx

10458

Belmont

Bronx

10460

Bronx Park South

Bronx

10461

Westchester Square

Bronx

10462

Van Nest

Bronx

10463

Riverdale

Bronx

10464

Southeast Bronx

Bronx

10465

Eastchester Bay

Bronx

10466

Bronx

10467

North Baychester
Van Cortlandt Park

Bronx

10468

Jerome Park

Bronx

10469

Pelham Gardens

Bronx

10470

Bronx

10472

Wakefield
Soundview Bruckner

Bronx

10473

Soundview

Bronx

10475

Coop City

Brooklyn

11206

Williamsburg

Brooklyn

11207

East New York

Brooklyn

11211

Williamsburg

Brooklyn

11213

Brooklyn

11216

Crown Heights
Bedford Stuyvesant

Brooklyn

11221

Bushwick

Brooklyn

11225

Prospect Leffert

Brooklyn

11237

Ridgewood

Brooklyn

11238

Prospect Heights

Queens

11367

Kew Garden Hills

Queens

11373

Elmhurst

Queens

11374

Rego Park

Queens

11378

Maspeth

Queens

11379

Middle Village

Queens

11385

Glendale

Queens

11421

Woodhaven

Queens

11432

Jamaica Hills
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Queens

11433

St. Albans

Table 2.5: Statistically significant ZCTA’s with corresponding neighborhoods appearing within both inpatient and outpatient
settings for space-time permutation asthma exacerbation cluster search, New York City, 2016-2018.

Table 2.6: Statistically significant ZCTA’s with corresponding neighborhoods appearing across
outpatient settings for space-time permutation respiratory (asthma and COPD) exacerbation
cluster search, New York City, 2016-2018.

Borough

Matching
Outpatient
ZCTAs

Neighborhood

Manhattan

10012

NoHo/SoHo

Manhattan

10032

Washington Heights

Manhattan

10033

Washington Heights

Manhattan

10034

Inwood

Manhattan

10040

Washington Heights

Manhattan
Staten
Island
Staten
Island
Staten
Island
Staten
Island
Staten
Island
Staten
Island

10162

Upper West Side

10301

Silver Lake (Stapleton and St. George)

10302

West Brighton

10303

Mariners Park

10304

Grymes Hill

10310

West Brighton

10314

Bull's Head

Bronx

10451

Melrose

Bronx

10452

Highbridge

Bronx

10453

Morris Heights

Bronx

10454

Mott Haven

Bronx

10455

Mott Haven

Bronx

10456

Melrose

Bronx

10457

Bathgate

Bronx

10459

Longwood

Bronx

10468

Jerome Park

Brooklyn

11206

Williamsburg

Brooklyn

11207

East New York

Brooklyn

11208

City Line

Brooklyn

11212

Brownsville

Brooklyn

11213

Crown Heights

Brooklyn

11221

Bushwick

Brooklyn

11233

Ocean Hill

Queens

11237

Ridgewood

33

Queens

11373

Elmhurst

Queens

11374

Rego Park

Queens

11375

Forest Hills

Queens

11378

Maspeth

Queens

11379

Middle Village

Queens

11385

Glendale

Queens

11416

Woodhaven

Queens

11417

Ozone Park

Queens

11418

Richmond Hill

Queens

11421

Woodhaven

Table 2.6: Statistically significant ZCTA’s with corresponding neighborhoods appearing across outpatient settings for spacetime permutation respiratory (asthma and COPD) exacerbation cluster search, New York City, 2016-2018.

34

Chapter 3. Associations between Respiratory (Chronic Obstructive
Pulmonary Disease and Asthma) Exacerbations, Socio-demographic
and Climatic Predictive Factors in New York City: A Poisson
Regression Approach
3.1 Introduction
Individuals with Chronic Obstructive Pulmonary Disease (COPD) and asthma remain a
vulnerable population during periods of adverse climatic events.1 As asthma has been identified
as a known risk factor for development of reduced lung function and chronic obstructive
pulmonary disease (COPD) in adults,2 and COPD and asthma are both incurable,3,4 impacts will
not only affect individuals with existing respiratory diseases but will likely increase the
incidence and prevalence of respiratory conditions overall. Exacerbations of COPD and asthma
determine a full range of difficulties including disease-associated morbidity, mortality, resource
burden and healthcare costs.5

Variations in Climate and Respiratory Illness
Climate variability is formally defined by the World Meteorological Organization as “variations
in the mean state and other statistics of the climate on all temporal and spatial scales, beyond
individual weather events.”6 The fluctuations comprising climate variability can influence
patterns of rainfall, temperature and other variables on timescales anywhere from a few weeks to
a few decades.7 Variability may be due to natural internal processes within the climate system
(internal variability), or to variations in natural or anthropogenic external factors (external
variability).6 The European Respiratory Society (ERS) provided a position statement
highlighting climate-related health impacts, which included deaths and morbidity.8 Increased
concentrations of greenhouse gases, and especially CO₂, in the earth's atmosphere have already
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warmed the planet substantially. This has caused more severe and prolonged heat waves,
temperature variability, air pollution, forest fires, heavy rain, storms, droughts, and floods, all of
which put respiratory health at risk.9

Although COPD and asthma exacerbations are more frequent during periods of extreme heat and
cold, it is currently unclear which combination of meteorological factors exert the greatest
influence on respiratory exacerbations, and whether or not time and/or space play a role.10 The
dynamic qualities of climate are regulated by meteorological factors, such as regional
temperature, humidity, wind speed, rainfall and particulate matter (PM 2.5), which tend to vary
with different seasons and across different locations.

This is especially true in regions experiencing all four seasons such as in NYC. For example,
LaGuardia Airport (LGA) located in northern Queens recorded the warmest year on record in
2016, as well as the warmest autumn to date.11,12 NYC also experienced its coldest Thanksgiving
Day on record in 2018 with temperature lows ranging from 38.1 degrees F (3.4 degrees C) to
40.5 degrees F (4.7 degrees F).13 In addition, John F. Kennedy Airport (JFK) located in southern
Queens record their snowiest spring when a nor’easter moved through the city in March of
2018.13

Climate variability leaves the most vulnerable individuals of a population, including COPD and
asthmatic patients, susceptible to augmented chronic health outcomes. Asthma is already
understood to be the leading chronic disease in children14 and is the third-ranking cause of
hospitalization among children younger than 15 years old.15 Moreover, it is known that COPD
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stands as the third leading cause of death and second leading cause of disability in the United
States.4,16 During the winter season, COPD patients have been reported to experience more
frequent exacerbation of their disease and were found to have higher hospitalization and
morbidity rates.17,18 The winter season is also associated with an increased prevalence in
respiratory viral infections.19,20 Evidence of increased mortality and acute morbidity among
respiratory patients as a result of heat waves makes COPD and asthma patients extremely
vulnerable to respiratory illness during the summer season as well.21 During a period of
extremely high temperatures, each degree Celsius (C) above the threshold of the temperaturehealth effect curve (29°C–36°C) was associated with a 2.7%–3.1% increase in same-day
hospitalizations due to respiratory diseases.22 There is also an increased risk of premature death
up to six times higher among respiratory patients than in the rest of the population.23

Not only does temperature affect respiratory health outcomes, but studies have also shown
increases in relative humidity are related to decreased lung function.24 Studies were done to
determine the effects of fluctuations in climatic factors (temperature, humidity, and barometric
pressure) on pediatric asthma exacerbations, and found emergency department visits for pediatric
asthma occurred 1 to 2 days after fluctuations in humidity and temperature.25 Humidity can be
further affected by heavy rainfall events, which could alter the humidity in the environment and
contribute to changes in airflow within the pulmonary system that could further exacerbate
respiratory disease. 25-27

With the overall increase of global temperatures, many climate models have predicted a general
increase in atmospheric water vapor accompanied by an increase in the intensity of heavy rainfall
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events.28-30 Changes in temperature, air pressure, and most importantly precipitation patterns
affect the probability of storms and floods. Heavy rain and flooding may cause water damage on
buildings, leading to an increase in mold exposure. Although mold allergy is rare, there is a clear
relationship between damp houses and respiratory diseases such as asthma.31 Other studies
carried out in the Brazilian Amazon have even found peaks in the number of hospital visits due
to respiratory disease during the wet seasons (between the months of March and April), which
may of had an association with relative humidity in the air.32

Recent epidemic thunderstorm asthma has been reported about a dozen times in the past 35
years; the threshold for reporting seems to be an increase of at least five to ten times in asthma
presentations to emergency departments over a short time.33 Nevertheless, many individuals are
affected by these events but do not seek acute medical care.34 This emerging phenomenon is
accompanied with periods of heavy rainfall and intense wind, which are believed to increase
extreme exposure to allergens, predominantly grass pollen, in susceptible allergic individuals .35
However, wind can also have the reverse effect and move allergens outside of the region.

Acute exposure to particulate air pollution has also been found associated with increases in the
rates of daily asthma attacks, the rate of respiratory exacerbations due to respiratory infections,
respiratory-related hospital admissions and mortality.21,36 Fuel oil/kerosene, coal/coke, wood and
utility gas with improper ventilation systems are all sources of particulate matter (PM), which
can be directly emitted from remaining residual oil boilers in buildings or released when fuels
are incompletely burned.37 Although NYC has mandated cleaner burning oil in recent years
through the NYC Clean Heat program created in 2010, the remaining residual oil boilers in
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buildings that have yet to convert to cleaner oil can still emit PM, especially when fuels are
incompletely burned.37 Residual fuel oil #4, which won’t be banned until 2030, continued to be
burned by 3,253 residential buildings, despite the city’s efforts to educate and incentivize owners
to switch to cleaner fuels.38 Space appears to play a role as studies found 1,724 or 53 percent of
remaining residual oil boilers post-NYC Clean Heat program were clustered in Manhattan north
of 110th Street and the Bronx—disproportionately higher than the area’s population (only onefifth of city residents live in these neighborhoods).39

Outdoor air pollutants can also be transported indoors via ventilation and infiltration, pollutant
deposition to indoor surfaces, and filtration, among others.40 Studies have shown approximately
62% of the 2 million annual DALYs of indoor exposure was caused by the transport of outdoor
PM2.5 to the indoor environment via ventilation and 16% by indoor sources.41

Nevertheless, air pollution can be reduced by the climatic variables aforementioned. For
example, periods of heavy rainfall can decrease air pollution levels by “washing” PM pollutants
out of the atmosphere.42 Wind speed can also have a similar effect on fine particulate matter as
fine PM 2.5 concentrations have been found to decrease gradually with the increase of wind
speed, whereas coarse PM 10 concentrations can increase due to dust resuspension under strong
wind.43 Overall, there is limited research on the effects of air pollution exposure on respiratory
disease management. Most studies that were carried out on respiratory disease-air pollution were
mostly carried out among the asthmatic population and children.44
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The Role of Socioeconomic Conditions on the Relationship Between Climate Variability and
Respiratory Exacerbation
Research has consistently shown the impact an individual’s social or economic standing,
measured by an individual's or family's social or economic position or rank in a social group,45
has on morbidity, mortality, and access to health care with regards to respiratory health.46-48
Studies addressing low SES among individuals diagnosed with COPD and asthma have found an
association with disproportionate access to respiratory health care. For instance, there is an
inverse relationship between SES and COPD prevalence associated with mortality, health
utilization costs and health-related quality of life (HRQoL).48 There is also a relationship
between lower SES and increased severity of asthma leading to subsequent hospitalization.48
These findings are relevant to our study as there is over 8 million people currently residing in
NYC49 and the five boroughs that make up this city house a diverse sociodemographic
population with individuals in different socioeconomic classes experiencing adverse health
effects from climate change in varying ways.

Specific Aims
The aim of this ecological study is to estimate the association of COPD and asthma exacerbation
hospital discharges across NYC ZIP code tabulated areas (ZCTAs) (Figure 3.1), after adjusting
for sociodemographic predictive factors (sex, age, race, income, poverty, educational attainment,
and type of house heating fuel) and climatic predictive factors (temperature, precipitation, wind,
relative humidity, and PM 2.5). The aims will be carried out through a series of three Poisson
regression models: the first is a general linear model (GLM), the second is a general linear mixed
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model (GLMM) with adjustment for temporal autocorrelation, and the third is a Bayesian spatiotemporal model with adjustment for spatio-temporal random effects variances.

Figure 3.1: Map of New York City ZIP Code Tabulation Areas (ZCTAs) that make up the study area. Source: Geospatial Data
Library at CUNY Baruch College.

Hypotheses
We believe Poisson regression results will be best fitted after utilizing the Bayesian spatiotemporal modelling approach to adjust for spatio-temporal autocorrelation. Our outcomes and
potential predictive covariates vary significantly across time (36 time periods to include monthly
discharge data from 2016 to 2018) and space (214 ZCTAs across NYC). We further hypothesize
results from our Bayesian spatio-temporal model will suggest sociodemographic predictive
factors (including sex, age, race, income, poverty, educational attainment, and type of house
heating fuel) and climatic predictive factors (including temperature, precipitation, wind, relative
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humidity, and PM 2.5) will increase the relative risk of COPD and asthma exacerbation rates
within both the inpatient and outpatient settings. We also hypothesize there will be spatiotemporal variation in the associations between respiratory disease, climatic and
sociodemographic covariates, and certain regions within NYC will have elevated risk relative to
other regions.

3.2 Methods
Data
This study combines health and spatial data from a variety of sources. The outcome of interest –
hospital discharges related to COPD and asthma exacerbation episodes – are provided by the
New York State (NYS) Statewide Planning and Research Cooperative System (SPARCS), as
summarized in chapter 2.

COPD and/or Asthma Exacerbation
The outcome of interest was obtained from NYS SPARCS, which was measured by an
International Classification of Diseases 10th Revision Codes (ICD-10CM)50,51 pertaining to
either a COPD exacerbation:
J44.1 for “Chronic obstructive pulmonary disease with acute exacerbation, unspecified,”
Or an asthma exacerbation:
J45.21 for “Mild intermittent asthma with [acute] exacerbation,”
J45.31 for “Mild persistent asthma with [acute] exacerbation,”
J45.41 for “Moderate persistent asthma with [acute] exacerbation,”
J45.51 for “Severe persistent asthma with [acute] exacerbation,”
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J45.901 for “Unspecified asthma with [acute] exacerbation.”

Type of Diagnosis Code
Data on the type of diagnosis code was obtained from NYS SPARCS, which indicates whether
diagnosis was “PR” Principal; “OT” Other; “EX” External Cause of Injury; “AD” Admitting;
“RV” Reason for Visit.52 For this study, only ‘Admitting Diagnosis (AD)’ was used for the
inpatient dataset and ‘Reason for Visit (RV)’ was used for the outpatient dataset.

Discharge Date
Discharge data for each patient record was provided by the NYS SPARCS hospital discharge
dataset. Discharge data was provided for each patient record in month and year format, between
January 2016 through December 2018.

NYC Spatial Designation
The NYC spatial designation was derived from the CUNY Baruch College NYC Geodatabase53,
which contained an individual database layer for NYC ZCTAs. The spatial designation was used
to assign each patient hospital record to a specific ZCTA within NYC, after cross-walking NYC
ZIP codes to ZCTAs. ZCTAs were also linked to their corresponding latitude and longitudinal
coordinates using data obtained from the US Census Gazetteer54 files.

Sociodemographic Variables
American Community Survey (ACS) is a cross-sectional sample which provides single-year
poverty estimates for geographies with populations of 65,000 or greater and estimates for five-
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year periods at all geographies.55 For this study, the Census Bureau’s ‘American Community
Survey’ (ACS) 5-year estimates for 2014 through 2018 was used to obtain ZCTA-level estimates
on the following community-level co-variates:
Sex, measured as percentage of the population being female
Age, measured as percentage of the population ‘under 20 years old’ for the asthma
diagnoses as asthma is more prevalent in the young56, or percentage of the
population ‘over 64 years old’ for the COPD diagnoses as COPD is more
prevalent among the elderly.57
Race, measured as percentage of the population being black (non-Hispanic Latino or
Hispanic Latino)
Income, measured continuously as an average of the median income within annual
inflation-adjusted dollars
Poverty, measured as percentage of the population below poverty level (out of population
for whom poverty status is determined)
Educational attainment, measured as percentage of the population having completed a 4year college degree or higher.
Type of house heating fuel, measured as percentage of the population using fuel
oil/kerosene/etc. as their main source of house heating fuel

Climatic Variables
Monthly data on air temperature, precipitation, wind and relative humidity was obtained from
NOAA, which acquires recordings through their weather monitoring stations around NYC.
These data include quality controlled daily and monthly measurements of58:
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Temperature: maximum temperature in degrees Fahrenheit
Precipitation: total precipitation in inches
Wind: average wind speed in miles per hour
Relative humidity: average percent (measurement of water vapor, but relative to the
temperature of the air).
The search tool allows for users to access past weather and climate data by zip code, city, county,
state, or country. Given availability, climate data will be obtained from the three main weather
monitoring stations across NYC: Central Park in Manhattan, LaGuardia Airport and John F.
Kennedy Airport, both located in Queens.

PM 2.5
Data on PM 2.5 levels is provided by the New York City Community Air Survey (NYCCAS).
NYCCAS air quality monitoring began in December 2008. Field teams sampled the air at 150
NYC locations per year during the first two years and at 60 to 100 locations per year in
subsequent years.(Figure 3.2) Samples are collected bi-weekly in all seasons for all pollutants,
including PM 2.5, producing two-week averages.59 Furthermore, data on particulate matter is
only collected periodically within the 14-day period. Nevertheless, the data is averaged within
community districts, which is the smallest geographic unit available from NYCCAS. Data on
PM 2.5 from 2016 and 2017 was only available at the geographic level of city boroughs, whereas
2018 data was available at the level of community districts (CDs). The 2018 data was used for
the purposes of this study given its availability in a finer geographic unit. The data collected was
annual average PM 2.5 in the 90th percentile in mcg per cubic meter (mcg/m3) in order to capture
exposure extremes.
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Figure 3.2: PM 2.5 Air pollution monitoring stations across NYC, 2008-2020. Source: NYCCAS.

Analyses
Data Preparation
NYS SPARCS Hospital discharge data information was prepared using SAS version 9.4, as per
NYS SPARCS data usage guideline recommendations52. The data was then transferred to R
version 3.6.2, where it was organized into 4 final outcomes, as described prior in chapter 2:
COPD Inpatient (COPD IP)
COPD Outpatient (COPD OP)
Asthma Inpatient (Asthma IP)
Asthma Outpatient (Asthma OP)
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These final data frames were aggregated by discharge month-year and by ZCTA and included
respiratory exacerbation cases. However, 29 of the 214 ZCTAs had population counts of ‘0’ as
per the ACS. These ZCTAs were removed from the final datasets as they were unpopulated.
Table 3.1 shows a list of the unpopulated ZCTAs across NYC and Figure 3.3 displays them
spatially. They appear to align with the location of office buildings, college campuses, PO
Boxes, parks, and airports across NYC.60

Unpopulated NYC ZCTAs
10020
10103
10110
10111
10112
10115
10119
10152
10153
10154
10165
10167
10168
10169
10170
10171
10172
10173
10174
10177
10271
10278
10311
11351
11359
11371
11424
11425
11451
Table 3.1: Table listing unpopulated ZCTAs across NYC. Source: U.S. Census 2010.
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Figure 3.3: Map portraying location of unpopulated ZCTAs across NYC. Source: The shapefile was obtained from the
Geospatial Data Library at the City University of New York (CUNY) Baruch College. Population data was obtained from the
U.S. Census 2010.

Linking co-variates by ZCTA
The sociodemographic co-variates obtained from the ACS (sex, age, race, income, poverty,
educational attainment, and type of house heating fuel) were available by ZCTA across the study
period. They were then matched to the hospital discharge data by ZCTA for each ‘diseasemedical facility setting’ dataset. The climate co-variates (temperature, precipitation, wind levels
and relative humidity) obtained from the NOAA were only available across 3 weather
monitoring stations in NYC. These data were averaged across the 3 weather stations to create a
uniform value applicable across all ZCTAs. Additionally, the climate data were made available
by month-year enabling us to match it to the hospital discharge data by month-year of discharge
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across all ZCTAs. PM 2.5 was only available at the level of the community district and was
linked to corresponding ZCTAs.

A Series of Poisson Regression Modelling
Interest may focus on the use of exposure predictions from spatially misaligned exposure data
with random effects in generalized linear models for discrete outcomes (e.g. a binary or a count
variable).61 Therefore, our model was fitted with a Poisson distribution to model count events of
respiratory exacerbation. The Poisson model has many strengths in modeling count data,
analyzing rate data (where the rate is the count of events occurring per some unit of observation)
and time series of disease counts, as well as comparing rates between circumstances (e.g.
historical time) or between specific subgroup characteristics.62-64 A Poisson regression analysis
also assumes that counts of independent rare events follow a Poisson distribution, and models the
logarithm of outcome variables as a linear function of the predictor variables.65

A table presenting all four outcomes and potential predictor variables by type (Sociodemographic and Meteorological) is described in Table 3.2.

Response variables

Asthma exacerbation – inpatient cases*,
year 2016-2018 monthly case counts
Asthma exacerbation – outpatient cases*,
year 2016-2018 monthly case counts
COPD exacerbation – inpatient cases*,
year 2016-2018 monthly case counts
COPD exacerbation – outpatient cases*,
year 2016-2018 monthly case counts

Socio-demographic predictor
variables

2014 5-year ACS** community estimates
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offset

Total population

% female

Percent of the population who are female

% under 20 years old

Percent of the population age under 20 years (Asthma outcomes only)

% over 64 years old

Percent of the population age over 64 years (COPD outcomes only)

% black alone

Percent of total population that is Black or African American alone,
regardless of ethnicity

% college

Percent of the population who have a 4-year college degree or higher

% poverty

Percent of total population who live in poverty

Median income

Median income of total population in 2018-inflation adjusted dollars

% heat fuel

Percent of the population using fuel oil/kerosene/etc. as their main
source of house heating fuel

Climate predictor variables

2016 – 2018 NOAA estimates***

Average maximum temperature

Average monthly maximum temperature in degrees Fahrenheit

Total precipitation

Total monthly precipitation in inches

Average relative humidity

Average monthly relative humidity in percentage

Average wind speed

Average monthly wind speed in miles per hour

Average PM 2.5 90th percentile

Average annual PM 2.5 in the 90th percentile in micrograms per meters
cubed (mcg/m3)

Table 3.2: Table presenting all four response variables and potential predictor variables by type (Socio-demographic,
Meteorological).

*NYS DOH SPARCS, **American Community Survey, ***National Oceanic and Atmospheric Administration

Assessing the presence of Multicollinearity among the Covariates
Multicollinearity represents a high degree of linear intercorrelation between explanatory
variables in a multiple regression model and leads to incorrect results of regression analyses.66
We assessed for multicollinearity using the ‘ggscatter’ function within R to determine if any two
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potential predictor variables were highly correlated with one another, and if one of the two
should be removed from our final model.

Poisson Regression General Linear Model (GLM)
Initially, a Poisson generalized linear model (GLM) of the form:
Ykt ~ Poisson(μkt 𝑛𝑘𝑡 )

(1)

Log(μkt ) = β + β1−7 𝑠𝑜𝑐𝑖𝑜𝑑𝑒𝑚𝑜𝑔𝑟𝑎𝑝ℎ𝑖𝑐kt + β8−12 𝑐𝑙𝑖𝑚𝑎𝑡𝑖𝑐kt + log(𝑛𝑘𝑡 )
was fitted to each outcome data with just the potential socio-demographic and climatic
covariates. Here, μkt is the expectation risk of the observed respiratory case count in ZCTA k at
month t multiplied by the offset population at-risk nkt. This was done in R using the ‘fitglm’
function.

Poisson Regression General Linear Mixed Model (GLMM) with Adjustment for Temporal
Autocorrelation
After removing potential predictor variables that were not statistically significant from our GLM
model, we included the remaining potential predictors into our Poisson general linear mixed
model (GLMM) using Penalized Quasi-Likelihood67 (PQL), which accounted for time-dependent
influences that are not identified in the covariates through random effects that follow a
multivariate normal distribution. The GLMM adjusts for temporal autocorrelation which occurs
from the data largely relating to the same populations in consecutive time periods. This model68
is specified as:
Ykt ~ Poisson(μkt 𝑛𝑘𝑡 )

(2)

T
T
Log(μkt ) = β + βxkt
𝑠𝑜𝑐𝑖𝑜𝑑𝑒𝑚𝑜𝑔𝑟𝑎𝑝ℎ𝑖𝑐kt + βxkt
𝑐𝑙𝑖𝑚𝑎𝑡𝑖𝑐kt + μj + log(𝑛𝑘𝑡 )
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and was fitted to each outcome data with just the potential socio-demographic and climatic
covariates. Here, μkt is the expected risk of the observed respiratory case count of an individual
living in ZCTA k at month t multiplied by the offset population at-risk 𝑛𝑘𝑡 . The terms
T
T
βxkt
𝑠𝑜𝑐𝑖𝑜𝑑𝑒𝑚𝑜𝑔𝑟𝑎𝑝ℎ𝑖𝑐kt and βxkt
𝑐𝑙𝑖𝑚𝑎𝑡𝑖𝑐kt are the remaining sociodemographic and climatic

variables, and μj is the random effect representing time (by discharge month). This was done in
R using the ‘fitglmmPQL’ function.

We went on to remove those variables that were not statistically significant from our GLMM
analyses and used the remaining predictor variables into our final Bayesian spatio-temporal
model of case counts for each of our outcome. This was done in R using the ‘CARBayesST
package developed by Lee et al69.

Poisson Generalized Linear Mixed Model (GLMM) with Bayesian Spatio-Temporal Modelling
Traditional regression models are unable to model data that are spatio-temporal autocorrelated.
Spatial autocorrelation can arise due to unmeasured confounding, neighborhood effects and
grouping effects.70 Thereby, spatio-temporal autocorrelation can lead to case observations from
geographically close areal units and temporally close time periods to have more similar values
than units and time periods that are further apart.70

A few of the covariates within our final datasets were spatially and temporally misaligned with
the hospital discharge data: PM 2.5 levels were only made available at the geographic unit of
community district, of which there are 55. In addition, the sociodemographic covariates obtained
from the ACS and the PM 2.5 values obtained from the NYCCAS only vary across space
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(ZCTA) but are fixed for all 36 months. Furthermore, the climatic variables obtained from the
NOAA are fixed for all ZCTAs but vary across time (discharge months) and occur randomly in
nature, affecting the underlying (offset) population of interest differently71.

A Bayesian inferential approach is taken to model these data, where the spatio-temporal
autocorrelation is modelled via sets of autocorrelated random effects using the conditional
autoregressive (CAR) method proposed by Rushworth, Lee and Mitchell (2014).72 In this
method70, each set of random effects is mean-centered and can be written as:
Ykt ~ Poisson(μkt 𝑛𝑘𝑡 )
T
ln(μkt 𝑛𝑘𝑡 ) = βxkt
+ ψkt + ln(𝑛𝑘𝑡 )

(3)

where μkt , the expected risk of an individual living in ZCTA k and discharge month t, is
multiplied by 𝑛𝑘𝑡 , the offset population at-risk, of the observed respiratory case count Ykt. The
explanatory space–time covariates, Xkt, are associated with the mean process through the β
coefficients and ψkt is a set of spatio-temporally autocorrelated random effects for ZCTA k and
discharge month t.

The Bayesian paradigm naturally incorporates our prior belief about the unknown parameter φ,
and updates this belief based on observed data.73 This yields the posterior distribution of φ,
which represents our knowledge about the parameter φ after having observed the data X.73 The
proposed model represents the spatio-temporal structure with a multivariate first order
autoregressive process (which predicts future behavior from near-term past behavior) with a
spatially autocorrelated precision matrix.72 The model estimates the evolution of the spatial fitted
value surface over time:
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φ𝑡 |φ𝑡−1 ~ N (ρ𝑇 φ𝑡−1 , τ2 Q(W, ρ𝑆 )−1 )
φ1

𝑡 = 2, … , 𝑁,

~ N (0, τ2 Q(W, ρ𝑆 )−1 )

(4)

In this model70 φ𝑡 = (φ1t , … , φK𝑡 ) and is the vector of random effects for time period t, which
evolves over time via a multivariate first order autoregressive process with temporal
autoregressive parameter ρ𝑇 . Therefore, φK𝑡 is the overall spatial main effect with k representing
ZCTA and t representing discharge month. Temporal autocorrelation is thus induced via the
mean ρ𝑇 φ𝑡−1 , while spatial autocorrelation is induced by the variance τ2 Q(W, ρ𝑆 )−1.70 N
represents the non-overlapping areal units that make up the study region. In our study, the spatial
relationships between ZCTAs were binary neighborhood matrixes W, which is based on the
contiguity structure of the N areal units.72,74 In the second part of this model, the equation
estimates that at the first time period, t = 1, temporal autocorrelation induced via the mean is set
to 0.
τ²

∼ Inverse-Gamma(a, b)

ρS, ρT ∼ Uniform(0, 1)

(5)
(6)

In equation 5, τ² represents random effects for conjugate priors (when the computed posterior
distribution ends up being in the same distribution as the prior or preconceived75-78) wherein
equation 6, ρS and ρT are spatial and temporal dependence parameters, respectively, that govern
the strength of spatial and temporal autocorrelations.70,72

Bayesian spatio-temporal modeling of respiratory exacerbation cases was performed using the
CARBayesST package developed by Lee et al.70 Models goodness of fit were compared using
the deviance information criterion (DIC).77 All models were fitted in a hierarchical Bayesian
spatio-temporal setting using Markov chain Monte Carlo (MCMC) simulation.74 For inpatient
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outcomes (Asthma, COPD) that were more rare, the posterior distributions of model parameters
were run for three parallel Markov chain, each of which were run for 220,000 MCMC samples
with the first 20,000 samples removed as the burn-in period. The samples were then thinned by
100 to reduce the autocorrelation in the Markov chains, resulting in 6,000 samples for inference.
Whereas for each outpatient outcomes (Asthma, COPD), the posterior distributions of model
parameters were obtained on 2,000 MCMC samples generated from a single Markov chain,
which was executed for 220,000 iterations with a burn-in period of 20,000 and then thinned
by 100 to reduce Markov chain autocorrelation. Convergence was monitored across all
outcomes, both graphically through trace-plots of the parameters69 and by convergence
diagnostics proposed by Geweke79 using the geweke.diag() function in R.79

Assessing the presence of spatial autocorrelation in the case counts of Respiratory Exacerbation
The spatial autocorrelation of respiratory exacerbation cases across all four outcomes was
assessed by computing residuals from a preliminary non-spatial over-dispersed Poisson loglinear model that incorporates covariate effects at the ZCTA level. The covariates we used were
factors that may influence the likelihood of a respiratory exacerbation.19,21-25,36,46-48,80-83
To quantify the presence of spatial autocorrelation in residuals from our non-spatial GLM and
GLMM models, Moran’s I statistic was computed for each discharge month.84 Two spatial points
data frames were created in R using the coordinates for each ZCTA and the corresponding
residuals (averages per ZCTA) of our GLM and GLMM models, respectively. Using these
spatial points data frames, we constructed a weights matrix W for each model using the weights
assigned to the 10 nearest neighbors. To quantify the presence of spatial autocorrelation in
residuals from our Bayesian spatio-temporal model, Moran’s I statistic was computed for each
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discharge month.84 To compute Moran’s I statistic, a binary neighborhood matrix W based on the
border sharing of ZCTAs was created.85 Two ZCTAs were neighbors if they shared a common
boundary, so 𝑤𝑗𝑖 was assigned a value of 1 when 𝑆𝑗 and 𝑆𝑖 ZCTAs shared a common border, or
0 otherwise.69,74,84

After computing the Moran’s I statistic we conducted the permutation test using the moran.mc()
function from the ‘spdep’ package in R.69 The null hypothesis states there is no spatial
autocorrelation and the alternative hypothesis states positive spatial autocorrelation. Therefore, a
low p-value, such as p < 0.05, indicates spatial autocorrelation is present within the model.

3.3 Results
Multicollinearity
Multicollinearity represents a high degree of linear intercorrelation between explanatory
variables in a multiple regression model and leads to incorrect results of regression analyses.66 In
order to reduce the number of redundant variables in our model, we used the ‘ggscatter’ function
within R to determine if any two potential predictors were highly correlated. We found
‘college_pct’ and ‘income_median’ were highly correlated (R=0.84, p<2.2e-16) and so were
‘tempmax_avg’ and ‘wind_avg’ (R=-0.86, p<2.2e-16) (Figure 3.4).
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Figure 3.4: Potential predictor variables highly correlated.

(1) ‘college_pct’ and ‘income_median’ were highly correlated (R = 0 .84, p < 2.2e -16), (2) ‘tempmax_avg’ and
‘wind_avg’ (R = - 0.86, p < 2.2e-16)

Asthma Exacerbation Inpatient
Asthma exacerbation inpatient (AEi) cases across New York City, 2016 to 2018
At the city-wide level, the overall annual observed number of asthma exacerbation inpatient
discharges decreased between 2016 and 2018. The annual AEi crude case counts were estimated
at 4755, 4070 and 3871 per year for 2016, 2017, and 2018, respectively. The time-series
decompositions of the monthly AEi population-based rates over the study period peaked between
February and March of 2016. (Figure 3.5) We also observe that there is great variability for AEi
crude case counts as well as large outliers each month over the course of the study period,
especially for January through March 2016, October 2016 through March 2017, and October
2018. (Figure 3.6)
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Figure 3.5: Monthly New York City Asthma Exacerbation Inpatient Population-Based Rates per 100,000 residents, 2016 to 2018.
Source: NYS Department of Health SPARCS.

Figure 3.6: Monthly New York City Asthma Exacerbation Inpatient Case Counts, 2016 to 2018. Source: NYS Department of
Health SPARCS.

Poisson Regression General Linear Model (GLM)
Initially we used ‘fitglm’ function in R to fit our GLM model with Poisson regression for our
AEi outcome against our potential predictor variables, which did not consider spatial or temporal
autocorrelation. The covariate ‘female_pct’ (Pr[>|z|] 0.91) also determined to have marginal
significance in our output, possibly due to a near constant 50% female population across the
NYC ZCTAs. Our output also determined ‘income_median’ (Pr[>|z|] 0.28) and ‘wind_avg’
(Pr[>|z|] 0.09) had marginal significance in our model. Further results from our test of
multicollinearity indicated ‘income_median’ and ‘wind_avg’ were highly correlated with

58

‘college_pct’ and ‘tempmax_avg’, respectively. Therefore, we removed the following potential
predictor variables from our model moving forward: ‘female_pct’, ‘income_median’, and
‘wind_avg’.

A 10% increase in the population under 20 years old (RR = 0.85) and in the population with at
least a 4-year college degree (RR = 0.87) was protective of asthma exacerbation in the inpatient
setting. However, the community was at a greater risk of someone being hospitalized for asthma
exacerbation in the inpatient setting for each 10% increase of the total population being black
(RR = 1.86), 10% increase in the total population being in poverty (RR = 1.18), and 10%
increase in homes heated with fuel oil, kerosene and etc. (RR = 1.1). When looking at the
potential meteorological covariates, all were protective of AEi (RR < 1). (Table 3.3)

Next, we ran a Moran I test under randomization to determine if residual spatial autocorrelation
was present.69 Our output determined the p-value for the Moran I statistics is 0.0001, which is
< 0.05 and significant indicating this model is not properly specified, either due to the presence
of spatial autocorrelation or covariates (probably clustered in the landscape) that were not
included in the model.

Poisson Regression General Linear Mixed Model (GLMM) with Adjustment for Temporal
Autocorrelation
We used ‘fitglmmPQL’ function in R to fit our GLMM model with multivariate normal random
effects, using Penalized Quasi-Likelihood67 to account for the situation where our random effects
are correlated. In this model, we set time as measured in discharge month as our random effect.
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Our output determined the beta estimates for ‘precip_total’ (p = 0.13) and ‘rel_hum_avg’ (p =
0.42) were statistically insignificant, therefore we removed these potential predictors from our
model moving forward.

A 10% increase in the population under 20 years old (RR = 0.84) and in the population with at
least a 4-year college degree (RR = 0.85) was protective of asthma exacerbation in the inpatient
setting. However, the community was at a greater risk of someone being hospitalized for asthma
exacerbation in the inpatient setting for each 10% increase of the total population being black
(RR = 1.06), 10% increase in the total population being in poverty (RR = 1.2), and 10% increase
in homes heated with fuel oil, kerosene and etc. (RR = 1.09). When looking at the potential
meteorological covariates, all were protective of AEi (RR < 1). (Table 3.3)

Next, we ran a Moran I test under randomization to determine if spatial autocorrelation was still
present.69 Our output determined the p-value for the Moran I statistics was 3.96e-05, which is
significant, indicating this model is not properly specified due to the presence of spatial
autocorrelation.

Asthma Inpatient Covariates

GLM RR

GLMM RR

10% increase in 'Under 20'

0.850

0.844

10% increase in 'Black'

1.860

1.062

10% increase in 'Poverty'

1.180

1.197

10% increase in at least '4-year College
graduate'

0.866

0.852

10% increase in homes heated with
'Fuel oil, kerosene, etc.'

1.099

1.094

10-degree increase in average 'monthly
maximum temperature'

0.916

0.923

2-inch increase in total 'monthly
precipitation'

0.996

---
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10% increase in average relative
humidity

0.931

---

10 mile/hour increase in average wind
speed

0.795

---

Increase of annual average
PM2.5_90%-tile by 2 micrograms/m3

0.936

0.9268

Table 3.3: Relative risks (RR) of potential predictor covariates for asthma exacerbation in the inpatient setting, across two
models: general linear model (GLM) and general linear mixed model (GLMM).

Bayesian results for Spatio-Temporal Changes in Asthma Exacerbation Inpatient Case Counts
The Markov chains appeared to have converged indicating posterior distributions of parameters
are essentially identical. This is the distribution representing our belief about
the parameter values after we have performed our calculations and taking the observed data into
account.86 The trace-plots of the parameters suggest convergence as they are stationary and show
random fluctuations around a single mean level.69 In addition, CARBayesST presents the
convergence diagnostic proposed by Geweke79 for sample parameters, which uses the
geweke.diag() function. This statistic is in the form of a Z-score, and values between (-1.96,
1.96) are suggestive of convergence.79 All covariates had values between (-1.96, 1.96) and can
be seen in Table 3.4.

Asthma
Inpatient
Socio-demographic Variables
Percentage female

---

Percentage under 20 years old

1.7

Percentage over 64 years old

---

Percentage identifying as 'Black
(Hispanic and Non-Hispanic)'

0.6

Percentage in Poverty

-0.7

Percentage having a 4-year
college degree or higher

-0.6

Percentage using fuel
oil/kerosene/etc. as their main
source of house heating fuel

1.4
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Median income

---

Meteorological Variables
Average maximum temperature

0.5

Total precipitation

---

Average relative humidity

---

Average wind speed

---

Average PM 2.5 in the 90th
percentile (micrograms/m3)

1.1

Table 3.4: Table showing statistics in the form of a Z-score for Geweke diagnostic function determining convergence of all
covariates across Asthma Inpatient outcomes.
Values between (-1.96, 1.96) are suggestive of convergence.

The estimated Moran’s I statistics obtained from the residuals of this model was -0.027 and the
p-value was 0.666, which is greater than (>) 0.05 and suggested no evidence of unexplained
spatial autocorrelation after accounting for the covariate effects.

The spatial and temporal dependence parameters were ρS = 0.964 and ρT = 0.967. The seasonal
AEi posterior incidence case counts for the inpatient setting exhibited a spatial heterogenicity
across the city (Figure 3.7). The highest AEi posterior case counts mainly occurred in the ZCTAs
located throughout majority of the Bronx, Upper Manhattan, eastern Brooklyn and Central
Queens. Northern and central Staten Island ZCTAs were also affected. However, the lowest AEi
posterior case counts mainly occurred in the ZCTAs located in Mid- to Lower Manhattan, southwestern Brooklyn, southern Staten Island, and north-eastern Queens.
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Figure 3.7: Spatio-temporal dynamic of asthma exacerbation inpatient case counts of fitted values (based on seasonal averages
of posterior medians) per ZIP Code Tabulated Area (ZCTA) per for years 2016 – 2018

Source: The shapefile was obtained from the Geospatial Data Library at the City University of New York (CUNY)
Baruch College. The asthma exacerbation inpatient case counts were obtained from NYC Department of Health
SPARCS.

Effects of covariates on case counts of AEi
Table 3.5 summarizes the three models, general linear model (GLM), general linear mixed model
(GLMM) and Bayesian spatio-temporal model, evaluating the effects of covariates on case
counts of AEi. The latter model further evaluates the spatio-temporal random effects on the case
counts of AEi across NYC ZCTAs. In models 1 and 2, the Moran I statistic p-value was
significant indicating the models were not properly fitted due to spatial autocorrelation.
However, model 3 had an insignificant p-value for the Moran I statistic indicating this model was
properly fitted and was able to adjust for spatial autocorrelation. Covariates with insignificant pvalues in models 1 and 2 were also dropped in model 3 as they had no statistical significance on
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the outcome. Covariates that were also highly correlated with one another were dropped in
models 2 and 3, based on both their statistical significance in model 1 and prior understanding of
their relationship with the outcome.

Asthma Inpatient Indicator
Fixed Effects
Intercept
Socio-demographic
Variables
Percentage female
Percentage under 20 years
old
Percentage over 64 years
old
Percentage identifying as
'Black (Hispanic and NonHispanic)'
Percentage in Poverty
Percentage having a 4-year
college degree or higher
Percentage using fuel
oil/kerosene/etc. as their
main source of house
heating fuel
Median income
Meteorological Variables
Average maximum
temperature
Total precipitation
Average relative humidity
Average wind speed
Average PM 2.5 in the 90th
percentile (micrograms/m3)
Spatio-temporal random
effects variances
Spatial and Temporal
Dependence
Spatial dependence (ρS)
Temporal dependence (ρT)
Moran I test (p-value)
DIC
MCMC Chain 1
MCMC Chain 2

General GLM
Model
(Coeff, [Pr(>|z|)])

GLMM TemporalAdjusted Model
(Coeff, [p-value])

Bayesian Spatio-Temporal
Adjusted Model
(Coef, [95% CrI])

-8.327 (<2e-16)

-8.677 (0.000)

-8.817 (-9.49, -8.207)

5.605e-04 (0.909)
-1.621e-02 (5.01e09)

---

---

-0.017 (0.000)

-0.02 (-0.031, -0.008)

---

---

---

6.205e-02 (<2e-16)
1.657e-02 (5.75e16)

0.006 (0.000)

0.007 (0.005, 0.009)

0.018 (0.000)

0.023 (0.016, 0.03)

-1.443e-02 (<2e-16)

-0.016 (0.000)

-0.012 (-0.017, -0.008)

9.401e-03 (<2e-16)
-1.001e-06 (0.276)

0.009 (0.000)
---

0.0004 (-0.006, 0.005)
---

-0.008 (0.001)
-0.029 (0.131)
-0.005 (0.421)

-0.009 (-0.013, -0.006)
-----

---

---

-3.283e-02 (0.022)

-0.038 (0.017)

-0.072 (-0.134, -0.007)

---

---

0.039 (0.027, 0.055)

------0.0001

------3.96E-05

0.964 (0.924, 0.981)
0.967 (0.945, 0.988)
0.666

-----

-----

19312
19310

-8.797e-03 (8.59e15)
-2.005e-03 (0.003)
-7.141e-03 (0.002)
-2.292e-02
(0.08530)
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MCMC Chain 3

---

---

19310

Table 3.5: Asthma exacerbation inpatient discharges reported by month and ZCTA, New York City, 2016 – 2018, as presented
across three models

General linear model (GLM) regression coefficients and p-values, General linear mixed model (GLMM) regression
coefficients and p-values, and Median of posterior regression coefficients and 95% credible interval from
hierarchical Bayesian spatio-temporal modelling. Note: CrI: credible interval, DIC: deviation information criteria.

Regarding socio-demographic variables, the results (Table 3.6) showed that the posterior median
and 95% credible interval for the relative risk of a 10% increase in the percentage of the
population under 20 years old within a ZCTA was 0.819 (0.734, 0.923) and a 10% increase in
the percentage of the population within a ZCTA having at least a 4-year college degree was
0.886 (0.886, 0.926), indicating that an increase of this magnitude corresponds to a decrease in
the episodes of AEi by 18.1% and 11.4%, respectively. In addition, the posterior median and
95% credible interval for the relative risk of a 10% increase in the percentage of the population
that is Black (Hispanic and non-Hispanic) within a ZCTA was 1.068 (1.047, 1.091), a 10%
increase in the percentage of the population that is in poverty within a ZCTA was 1.257 (1.176,
1.346), and a 10% increase in the percentage of the population that have their homes heated with
fuel oil, kerosene and etc. was 1.004 (0.946, 1.054), indicating that an increase of this magnitude
corresponds to an increase in the episodes of AEi by 6.8%, 25.7% and 0.4%, respectively.

Regarding meteorological variables, the results (Table 3.6) showed that the posterior median and
95% credible interval for the relative risk of a 10-degree Fahrenheit increase in the average
monthly maximum temperature within a ZCTA was 0.913 (0.881, 0.944), indicating that an
increase of this magnitude corresponds to a decrease in the episodes of AEi by 8.7%. The results
also showed that the posterior median and 95% credible interval for the relative risk of a 2
micrograms/meters cubed (mcg/m3) increase in the annual average PM 2.5 90th percentile within
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a ZCTA was 0.872 (0.771, 1.012), indicating that an increase of this magnitude corresponds to a
decrease in the episodes of AEi by 12.8%.

Asthma Inpatient Covariates

RR

95% CrI

10% increase in 'Under 20'

0.819

(0.734, 0.923)

10% increase in 'Black'

1.068

(1.047, 1.091)

10% increase in 'Poverty'

1.257

(1.176, 1.346)

10% increase in at least '4-year College
graduate'

0.886

(0.886, 0.926)

10% increase in homes heated with 'Fuel
oil, kerosene, etc.'

1.004

(0.946, 1.054)

10-degree increase in average 'monthly
maximum temperature'

0.913

(0.881, 0.944)

Increase of annual average PM2.5_90%tile by 2 micrograms/m3

0.872

(0.771, 1.012)

Table 3.6: A summary of the Asthma Inpatient parameter estimates from the spatio-temporal model.

The estimated asthma inpatient covariate effects are relative risks (RR) associated with a multiplier of 10 in all
covariates except for PM 2.5 90th percentile which is associated with a multiplier of 2.

Asthma Exacerbation Outpatient
Asthma exacerbation outpatient (AEO) cases across New York City, 2016 to 2018
At the city-wide level, the overall annual observed number of asthma exacerbation outpatient
(AEo) discharges decreased between 2016 and 2018. The annual AEo crude case counts were
estimated at 77 863, 74 137 and 69 016 per year for 2016, 2017, and 2018, respectively. The
time-series decompositions of the monthly AEo population-based rates over the study period
peaked between March and May of 2017. (Figure 3.8) We also observe great variability for AEo
crude case counts as well as large outliers each month over the course of the study period,
especially for January through May 2016, October 2016 through February 2017, May 2017,
September 2017 through January 2018, and October through December 2018. (Figure 3.9)
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Figure 3.8: Monthly New York City Asthma Exacerbation Outpatient Population-Based Rates per 100,000 residents, 2016 to
2018. Source: NYS Department of Health SPARCS.

Figure 3.9: Monthly New York City Asthma Exacerbation Outpatient Case Counts, 2016 to 2018. Source: NYS Department of
Health SPARCS.

Poisson Regression General Linear Model (GLM)
We used ‘fitglm’ function in R to fit our GLM model with Poisson regression for our AEo
outcome against our potential predictor variables, which did not consider spatial or temporal
autocorrelation. Our output did not determine any potential predictor variables that were
insignificant. However, in order to prevent multicollinearity we removed ‘income_median’ as a
potential predictor variable because its beta estimate was negatively associated with our outcome
(- 5.22e-06, Pr[>|z|] 2e-16) (as compared to the beta estimate of ‘college_pct’ which was positively
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associated (5.22e-03 (Pr[>|z|] 2e-16)). We also removed ‘wind_avg’ as its beta estimate was 3.42e-2 (Pr[>|z|] 2e-16 was more negatively associated with our outcome as compared to the beta
estimate of ‘tempmax_avg’ being -1 .14e-02 (Pr[>|z|] 2e-16, and we are using average maximum
temperature as a primary measure of climate variability.

A 10% increase in the population under 20 years old (RR = 0.82) was protective of asthma
exacerbation in the outpatient setting. However, the community was at a greater risk of someone
being hospitalized for asthma exacerbation in the outpatient setting for each 10% increase of the
total population being female (RR = 1.06), 10% increase of the total population being black (RR
= 1.17), 10% increase in the total population being in poverty (RR = 1.61), 10% increase in the
total population having at least a 4-year college degree (RR = 1.05), and 10% increase in homes
heated with fuel oil, kerosene and etc. (RR = 1.11). When looking at the potential meteorological
covariates, a 10-degree increase in average monthly maximum temperature (RR = 0.89), a 2-inch
increase in total monthly precipitation (RR = 0.98) and a 10 mile/hour increase in average wind
speed (RR = 0.71) were protective against AEo. However, a 10% increase in average relative
humidity (RR = 1.02) and an increase of annual average PM 2.5 in the 90th percentile by 2
micrograms per cubed meter (RR = 1.02) placed the community at higher risk of someone being
hospitalized for AEo. (Table 3.7)

Next, we ran a Moran I test under randomization to determine if spatial autocorrelation is
present.69 Our output determined the p-value for the Moran I statistics is < 2.2e-16, which is
< 0.05 and significant indicating this model is not properly specified due to the presence of
spatial autocorrelation.
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Poisson Regression General Linear Mixed Model (GLMM) with Adjustment for Temporal
Autocorrelation
We used ‘fitglmmPQL’ function in R to fit our GLMM model with multivariate normal random
effects, using Penalized Quasi-Likelihood67 to account for the situation where our random effects
are correlated. In this model, we set time as measured in discharge month as our random effect.
Our output determined the beta estimates for ‘college_pct’ (-0.001, p = 0.13), ‘precip_total’ (0.027, p = 0.13) and ‘rel_hum_avg’ (0.005, p = 0.42) were statistically insignificant, therefore
we removed these potential predictors from our model moving forward.

A 10% increase in the population under 20 years old (RR = 0.78) was protective of asthma
exacerbation in the outpatient setting. However, the community was at a greater risk of
hospitalizations for asthma exacerbation in the outpatient setting for each 10% increase of the
total population being female (RR = 1.09), 10% increase of the total population being black (RR
= 1.16), 10% increase in the total population being in poverty (RR = 1.73), and 10% increase in
homes heated with fuel oil, kerosene and etc. (RR = 1.11). When looking at the potential
meteorological covariates, a 10-degree increase in average monthly maximum temperature (RR
= 0.91) and an increase of annual average PM 2.5 in the 90th percentile by 2 micrograms per
cubed meter (RR = 0.97) were protective against hospitalizations for AEo within a community.
(Table 3.7)

Next, we ran a Moran I test under randomization to determine if spatial autocorrelation was
present.69 Our output determined the p-value for the Moran I statistics was < 2.2e-16, which is
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less than (<) 0.05 and significant indicating this model is not properly specified, either due to the
presence of spatial autocorrelation or covariates (probably clustered in the landscape) that were
not included in the model.

Asthma Outpatient Covariates

GLM (RR)

GLMM (RR)

10% increase in ‘female’

1.064

1.094

10% increase in 'Under 20'

0.815

0.779

10% increase in 'Black'

1.167

1.162

10% increase in 'Poverty'

1.612

1.733

10% increase in at least '4-year College
graduate'

1.054

---

10% increase in homes heated with 'Fuel oil,
kerosene, etc.'

1.106

1.105

0.892

0.905

0.976

---

1.016

---

0.710

---

1.019

0.970

10-degree increase in average 'monthly
maximum temperature'
Increase in total 'monthly precipitation' by 2inches
Increase in average relative humidity by 10%
Increase in average wind speed by 10
miles/hour
Increase of annual average PM2.5_90%-tile by
2 micrograms/m3

Table 3.7: Relative risks (RR) of potential predictor covariates for asthma exacerbation in the outpatient setting, across two
models: general linear model (GLM) and general linear mixed model (GLMM).

Bayesian results for Spatio-Temporal Changes in Asthma Exacerbation Outpatient Case Counts
The Markov chains appeared to have converged indicating posterior distributions of parameters
are essentially identical. Despite the Geweke convergence diagnostic inadvertently suggesting
there is a lack of convergence for majority of the covariates, it does suggest convergence for
‘Percentage female’ with a value inside (-1.96, 1.96).(Table 3.8) We were further able to
determine the presence of convergence among all of the covariates through trace-plot
visualization of the parameters as they were stationary and showed random fluctuations around a
single mean level.69
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Asthma
Outpatient
Socio-demographic Variables
Percentage female

0.8

Percentage under 20 years old

-11.9

Percentage over 64 years old

---

Percentage identifying as 'Black
(Hispanic and Non-Hispanic)'

20

Percentage in Poverty

17.6

Percentage having a 4-year
college degree or higher

---

Percentage using fuel
oil/kerosene/etc. as their main
source of house heating fuel

14.9

Median income

---

Meteorological Variables
Average maximum temperature

-18.2

Total precipitation

---

Average relative humidity

---

Average wind speed

---

Average PM 2.5 in the 90th
percentile (micrograms/m3)

-6.9

Table 3.8: Table showing statistics in the form of a Z-score for Geweke diagnostic function assessing convergence of all
covariates across Asthma Outpatient outcomes.

Values between (-1.96, 1.96) are suggestive of convergence.

The estimated Moran’s I statistics obtained from the residuals of this model was -0.036 and the
p-value was 0.195, which is greater than 0.05 and suggested no evidence of unexplained spatial
autocorrelation after accounting for the covariate effects.

The spatial and temporal dependence parameters were ρS = 0.999 and ρT = 0.884. The seasonal
AEo posterior incidence case counts for the inpatient setting exhibited a spatial heterogenicity
across the city (Figure 3.10). The highest AEo posterior case counts mainly occurred in the
ZCTAs located throughout mid- and South Bronx, mid- and Upper Manhattan, eastern Brooklyn
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and Central and Southern Queens. Parts of northern and eastern Staten Island ZCTAs were also
affected.

Figure 3.10: Spatio-temporal dynamic of asthma exacerbation outpatient case counts of fitted values (based on seasonal
averages of posterior medians) per ZIP Code Tabulated Area (ZCTA) per for years 2016 – 2018.

Source: The shapefile was obtained from the Geospatial Data Library at the City University of New York (CUNY)
Baruch College. The asthma exacerbation inpatient case counts were obtained from NYC Department of Health
SPARCS.

Effects of covariates on case counts of AEo
Table 3.9 summarizes the three models, general linear model (GLM), general linear mixed model
(GLMM) and Bayesian spatio-temporal model, evaluating the effects of covariates on case
counts of AEo. The latter model further evaluates the spatio-temporal random effects on the case
counts of AEo across NYC ZCTAs. In models 1 and 2, the Moran I statistic p-value was
significant indicating the models were not properly fitted due to spatial autocorrelation.
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However, model 3 had an insignificant p-value for the Moran I statistic indicating this model was
properly fitted and was able to adjust for spatial autocorrelation. Covariates with insignificant pvalues in models 1 and 2 were also dropped in model 3 as they had no statistical significance on
the outcome. Covariates that were also highly correlated with one another were dropped in
models 2 and 3, based on both their statistical significance in model 1 and prior understanding of
their relationship with the outcome.

General GLM
model
(Coeff, [Pr(>|z|)])

GLMM TemporalAdjusted Model
(Coeff, [p-value])

Bayesian SpatioTemporal Adjusted
Model
(Coef, [95% CrI])

-7.773 (<2e-16)

-8.395 (0.000)

-7.913 (-8.064, -7.756)

Percentage female
Percentage under 20 years
old
Percentage over 64 years
old
Percentage identifying as
'Black (Hispanic and NonHispanic)'

6.237e-03 (2.07e-09)

0.009 (0.000)

-2.043e-02 (<2e-16)

-0.025 (0.000)

-0.0003 (-0.003,
0.002)
-0.0003 (-0.002,
0.001)

---

---

---

1.547e-02 (<2e-16)

0.015 (0.000)

Percentage in Poverty
Percentage having a 4-year
college degree or higher
Percentage using fuel
oil/kerosene/etc. as their
main source of house
heating fuel
Median income
Meteorological Variables
Average maximum
temperature
Total precipitation
Average relative humidity
Average wind speed
Average PM 2.5 in the 90th
percentile
(micrograms/m3)
Spatio-temporal random
effects variances

4.776e-02 (<2e-16)

0.055 (0.000)

0.0001 (-0.0002,
0.0005)
0.0007 (-0.0003,
0.0023)

5.244e-03 (<2e-16)

-0.001 (0.121)

---

1.005e-02 (<2e-16)
-5.224e-06 (<2e-16)

0.01 (0.000)
---

0.000 (-0.0004,
0.0003)
---

-1.141e-02 (<2e-16)
-1.2e-02 (3.2e-13)
1.544e-03 (0.005)
-3.422e-02 (<2e-16)

-0.010 (0.000)
-0.027 (0.185)
0.005 (0.469)
---

-0.0001 (-0.0004,
0.0002)
-------

9.477e-03 (0.007)

-0.015 (0.049)

-0.001 (-0.008, 0.006)

---

---

0.042 (0.028, 0.06)

Asthma Outpatient
Indicator
Fixed Effects
Intercept
Socio-demographic
Variables
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Spatio and Temporal
Dependence
Spatial dependence (ρS)
Temporal dependence (ρT)
Moran I test (p-value)
DIC

------2.20E-16
---

------2.20E-16
---

0.0003 (0.0003,
0.0004)
0.9999 (0.9999, 1)
0.884 (0.846, 0.918)
0.195
30068

Table 3.9: Asthma exacerbation outpatient discharges reported by month and ZCTA, New York City, 2016 – 2018, as presented
across three models

General linear model (GLM) regression coefficients and p-values, General linear mixed model (GLMM) regression
coefficients and p-values, and Median of posterior regression coefficients and 95% credible interval from
hierarchical Bayesian spatio-temporal modelling. Note: CrI: credible interval, DIC: deviation information criteria

Regarding socio-demographic variables, the results (Table 3.10) showed that the posterior
median and 95% credible interval for the relative risk of a 10% increase in the percentage of the
population within a ZCTA being female was 0.997 (0.972, 1.024) and a 10% increase in the
percentage of the population under 20 years old within a ZCTA was 0.997 (0.984, 1.009),
indicating that an increase of this magnitude corresponds to a decrease in the episodes of AEo by
0.3% and 0.3%, respectively. In addition, the posterior median and 95% credible interval for the
relative risk of a 10% increase in the percentage of the population that is Black (Hispanic and
non-Hispanic) within a ZCTA was 1.001 (0.998, 1.005), a 10% increase in the percentage of the
population that is in poverty within a ZCTA was 1.007 (0.997, 1.024), and a 10% increase in the
percentage of the population that have their homes heated with fuel oil, kerosene and etc. was
1.000 (0.996, 1.003) indicating that an increase of this magnitude corresponds to an increase in
the episodes of AEo by 0.1%, 0.7% and 0%, respectively.

Regarding meteorological variables, the results (Table 3.10) showed that the posterior median
and 95% credible interval for the relative risk of a 10-degree Fahrenheit increase in the average
monthly maximum temperature within a ZCTA was 0.999 (0.996, 1.002), indicating that an
increase of this magnitude corresponds to a decrease in the episodes of AEo by 0.1%. The results
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also showed that the posterior median and 95% credible interval for the relative risk of a 2
micrograms/meters cubed (mcg/m3) increase in the annual average PM 2.5 90th percentile within
a ZCTA was 0.998 (0.984, 1.012), indicating that an increase of this magnitude corresponds to a
decrease in the episodes of AEo by 0.2%.

Asthma Outpatient Covariate

RR

95% CrI

10% increase in 'Female'

0.997

(0.972, 1.024)

10% increase in 'Under 20'

0.997

(0.984, 1.009)

10% increase in 'Black'

1.001

(0.998, 1.005)

10% increase in 'Poverty'

1.007

(0.997, 1.024)

1

(0.996, 1.003)

0.999

(0.996, 1.002)

0.998

(0.984, 1.012)

10% increase in homes heated
with 'Fuel oil, kerosene, etc.'
10-degree increase in average
'monthly maximum
temperature'
Increase of annual average
PM2.5_90%-tile by 2
micrograms/m3

Table 3.10: A summary of the Asthma Outpatient parameter estimates from the spatio-temporal model.

The estimated asthma outpatient covariate effects are relative risks (RR) associated with a multiplier of 10 in all
covariates except for PM 2.5 90th percentile which is associated with a multiplier of 2.

COPD Inpatient
COPD exacerbation inpatient (CEi) cases across New York City, 2016 to 2018
At the city-wide level, the overall annual observed number of COPD exacerbation inpatient
(CEi) discharges decreased between 2016 and 2018. The annual CEi crude case counts were
estimated at 11 752, 10 861 and 10 241 per year for 2016, 2017, and 2018, respectively. The
time-series decompositions of the monthly CEi population-based rates over the study period
peaked between November 2016 and January 2017. (Figure 3.11) We also observe that there is
great variability for CEi crude case counts as well as large outliers each month over the course of
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the study period, especially for March 2016, February and May 2017, and January, October and
December 2018. (Figure 3.12)
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Figure 3.11: Monthly New York City COPD Exacerbation Inpatient Population-Based Rates per 100,000 residents, 2016 to
2018. Source: NYS Department of Health SPARCS.

Figure 3.12: Monthly New York City COPD Exacerbation Inpatient Case Counts, 2016 to 2018. Source: NYS Department of
Health SPARCS.

Poisson Regression General Linear Model (GLM)
We used ‘fitglm’ function in R to fit our GLM model with Poisson regression for our CEi
outcome against our potential predictor variables, which did not consider spatial or temporal
autocorrelation. Our output did not determine any potential predictor variables that were
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insignificant. However, in order to prevent multicollinearity we removed ‘income_median’ as a
potential predictor variable because the p-value for its beta estimate was Pr[>|z|] = 2.2e-08 (as
compared to the p-value for the beta estimate of ‘college_pct’ being Pr[>|z|] 1.01e-11). We also
removed ‘wind_avg’ as its p-value for its beta estimate was Pr[>|z|] = 8.42e-14 (as compared to
the p-value for the beta estimate of ‘tempmax_avg’ being Pr[>|z|] < 2e-16) and we are using
average maximum temperature as a primary measure of climate variability.

A 10% increase in the population with at least a 4-year college degree (RR = 0.88) was
protective of COPD exacerbation in the inpatient setting. However, the community was at a
greater risk of someone being hospitalized for CEi for each 10% increase of the total population
being over 64 years old (RR = 1.39), 10% increase of the total population being black (RR =
1.02), 10% increase in the total population being in poverty (RR = 1.33), and 10% increase in
homes heated with fuel oil, kerosene and etc. (RR = 1.01). When looking at the potential
meteorological covariates, all were protective of CEi (RR < 1). (Table 3.11)

Next, we ran a Moran I test under randomization to determine if spatial autocorrelation is
present.69 Our output determined the p-value for the Moran I statistics is 3.21e-05, which is < 0.05
and significant indicating this model is not properly specified, either due to the presence of
spatial autocorrelation or covariates (probably clustered in the landscape) that were not included
in the model.
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Poisson Regression General Linear Mixed Model (GLMM) with Adjustment for Temporal
Autocorrelation
We used ‘fitglmmPQL’ function in R to fit our GLMM model with multivariate normal random
effects, using Penalized Quasi-Likelihood67 to account for the situation where our random effects
are correlated. In this model, we set time as measured in discharge month as our random effect.
Our output determined the beta estimates for ‘rel_hum_avg’ (-0.01, p = 0.17) was statistically
insignificant, therefore we removed this potential predictor variable from our model moving
forward.

A 10% increase in the population with at least a 4-year college degree (RR = 0.91) was
protective of COPD exacerbation in the inpatient setting. However, the community was at a
greater risk for CEi hospitalizations for each 10% increase of the total population being over 64
years old (RR = 1.19), 10% increase of the total population being black (RR = 1.02), 10%
increase in the total population being in poverty (RR = 1.26), and 10% increase in homes heated
with fuel oil, kerosene and etc. (RR = 1.01). When looking at the potential meteorological
covariates, all were protective of CEi (RR < 1). (Table 3.11)

Next, we ran a Moran I test under randomization to determine if spatial autocorrelation was
present.69 Our output determined the p-value for the Moran I statistics was 8.57e-05, which is
less than 0.05 and significant indicating this model is not properly specified, either due to the
presence of spatial autocorrelation or covariates (probably clustered in the landscape) that were
not included in the model.
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COPD Inpatient Covariates
10% increase in ‘female’

GLM (RR)

GLMM (RR)

1.014

1.185

10% increase in 'Over 64'

1.389

1.336

10% increase in 'Black'

1.022

1.020

10% increase in 'Poverty'

1.328

1.259

10% increase in at least '4-year
College graduate'

0.879

0.914

10% increase in homes heated with
'Fuel oil, kerosene, etc.'

1.011

1.010

10-degree increase in average
'monthly maximum temperature'

0.926

0.970

Increase in total 'monthly
precipitation' by 2-inches

0.980

0.949

0.901

---

0.534

---

0.858

0.876

Increase in average relative
humidity by 10%
Increase in average wind speed by
10 miles/hour
Increase of annual average
PM2.5_90%-tile by 2
micrograms/m3

Table 3.11: Relative risks (RR) of potential predictor covariates COPD exacerbation in the inpatient setting, across two models:
general linear model (GLM) and general linear mixed model (GLMM).

Bayesian results for Spatio-Temporal Changes in COPD Exacerbation Inpatient Case Counts
The Markov chains appeared to have converged indicating posterior distributions of CEi
parameters are essentially identical. We were able to determine convergence from the trace-plots
of the parameters, as they were stationary and showed random fluctuations around a single mean
level.69 In addition, the convergence diagnostic proposed by Geweke79 for sample parameters
showed all covariates for CEi had values between (-1.96, 1.96), which is suggestive of
convergence.79 (Table 3.12)

COPD Inpatient
Socio-demographic Variables
Percentage female

1.5

Percentage under 20 years old
Percentage over 64 years old

---1.5

79

Percentage identifying as 'Black (Hispanic
and Non-Hispanic)'
Percentage in Poverty

-1.9
-1.5

Percentage having a 4-year college degree
or higher

-1.1

Percentage using fuel oil/kerosene/etc. as
their main source of house heating fuel
Median income

0.1
---

Meteorological Variables
Average maximum temperature
Total precipitation
Average relative humidity
Average wind speed

1.1
0
-----

Average PM 2.5 in the 90th percentile
(micrograms/m3)

1.7

Table 3.12: Table showing statistics in the form of a Z-score for Geweke diagnostic function determining convergence of all
covariates across COPD Inpatient outcomes.

Values between (-1.96, 1.96) are suggestive of convergence.

The estimated Moran’s I statistics obtained from the residuals of this model was -0.03 and the pvalue was 0.225, which is greater than 0.05 and suggested no evidence of unexplained spatial
autocorrelation after accounting for the covariate effects.

The spatial and temporal dependence parameters were ρS = 0.924 and ρT = 0.963. The seasonal
CEi posterior incidence case counts for the inpatient setting exhibited a spatial heterogenicity
across the city (Figure 3.13). The highest CEi posterior case counts mainly occurred in the
ZCTAs located throughout mid- and south-Western Bronx, Upper Manhattan, eastern Brooklyn
and central Staten Island. Northern Queens near LGA airport as well as parts of south/central
Queens near JFK airport were also affected. However, the lowest CEi posterior case counts
mainly occurred in the ZCTAs located in Mid- to Lower Manhattan, southern Staten Island, and
eastern Queens.

80

Figure 3.13: Spatio-temporal dynamic of COPD exacerbation inpatient case counts of fitted values (based on seasonal averages
of posterior medians) per ZIP Code Tabulated Area (ZCTA) per for years 2016 – 2018.

Source: The shapefile was obtained from the Geospatial Data Library at the City University of New York (CUNY)
Baruch College. The asthma exacerbation inpatient case counts were obtained from NYC Department of Health
SPARCS.

Effects of covariates on case counts of CEi
Table 3.13 summarizes the three models, general linear model (GLM), general linear mixed
model (GLMM) and Bayesian spatio-temporal model, evaluating the effects of covariates on
case counts of CEi. The latter model further evaluates the spatio-temporal random effects on the
case counts of CEi across NYC ZCTAs. In models 1 and 2, the Moran I statistic p-value was
significant indicating the models were not properly fitted due to spatial autocorrelation.
However, model 3 had an insignificant p-value for the Moran I statistic indicating this model was
properly fitted and was able to adjust for spatial autocorrelation. Covariates with insignificant pvalues in models 1 and 2 were also dropped in model 3 as they had no statistical significance on
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the outcome. Covariates that were also highly correlated with one another were dropped in
models 2 and 3, based on both their statistical significance in model 1 and prior understanding of
their relationship with the outcome.

COPD Inpatient Indicator
Fixed Effects
Intercept
Socio-demographic Variables
Percentage female
Percentage under 20 years old
Percentage over 64 years old
Percentage identifying as
'Black (Hispanic and NonHispanic)'
Percentage in Poverty
Percentage having a 4-year
college degree or higher
Percentage using fuel
oil/kerosene/etc. as their main
source of house heating fuel
Median income
Meteorological Variables
Average maximum
temperature
Total precipitation
Average relative humidity
Average wind speed
Average PM 2.5 in the 90th
percentile (micrograms/m3)
Spatio-temporal random
effects variances
Spatio and Temporal
Dependence
Spatial dependence (ρS)
Temporal dependence (ρT)
Moran I test (p-value)
DIC
MCMC Chain 1
MCMC Chain 2
MCMC Chain 3

General GLM
Model (Coeff,
[Pr(>|z|)])

GLMM
TemporalAdjusted Model
(Coeff, [p-value])

Bayesian SpatioTemporal Adjusted
Model
(Coef, [95% CrI])

-8.384 (<2e-16)

-9.48 (0.000)

-9.871 (-10.749, -9.121)

1.372e-03 (0.000)
--3.284e-02 (<2e-16)

0.017 (0.001)
--0.029 (0.000)

0.01 (-0.004, 0.025)
--0.033 (0.024, 0.043)

2.174e-03 (7.63e-11)
2.839e-02 (<2e-16)

0.002 (0.000)
0.023 (0.000)

0.003 (0.0004, 0.005)
0.025 (0.02, 0.031)

-1.285e-02 (<2e-16)

-0.009 (0.000)

-0.008 (-0.012, -0.004)

1.070e-03 (0.007)
3.588e-06 (<2e-16)

0.001 (0.013)
---

-0.005 (-0.0086, 0.0012)
---

-7.64e-03 (<2e-16)
-1.022e-02 (0.016)
-1.038e-02 (3.41e-13)
-6.265e-02 (8.42e-14)

-0.003 (0.019)
-0.026 (0.027)
-0.005 (0.166)
---

-0.005 (-0.006, -0.003)
-0.025 (-0.037, -0.014)
-----

-7.657e-02 (<2e-16)

-0.066 (0.000)

-0.008 (-0.049, 0.031)

---

---

0.042 (0.028, 0.06)

------1.59E-05

------0.0002

0.03 (0.024, 0.038)
0.924 (0.873, 0.955)
0.963 (0.946, 0.978)
0.233

-------

-------

26951
26954
26949

Table 3.13: COPD exacerbation inpatient discharges reported by month and ZCTA, New York City, 2016 – 2018, as presented
across three models
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General linear model (GLM) regression coefficients and p-values, General linear mixed model (GLMM) regression
coefficients and p-values, and Median of posterior regression coefficients and 95% credible interval from
hierarchical Bayesian spatio-temporal modelling. Note: CrI: credible interval, DIC: deviation information criteria.

Regarding socio-demographic variables, the results (Table 3.14) showed that the posterior
median and 95% credible interval for the relative risk of a 10% increase in the percentage of the
population that had at least a 4-year college degree within a ZCTA was 0.892 (0.892, 0.959), a
10% increase in the percentage of the population within a ZCTA being female was 0.957 (0.957,
1.279) and a 10% increase in the percentage of the population that have their homes heated with
fuel oil, kerosene and etc. was 0.917 (0.917, 0.988), indicating that an increase of this magnitude
corresponds to a decrease in the episodes of CEi by 10.8%, 4.3% and 8.3%, respectively.
Furthermore, the posterior median and 95% credible interval for the relative risk of a 10%
increase in the percentage of the population over 64 years old within a ZCTA was 1.396 (1.266,
1.536), and a 10% increase in the percentage of the population that is Black (Hispanic and nonHispanic) within a ZCTA was 1.004 (1.004, 1.049), and a 10% increase in the percentage of the
population that is in poverty within a ZCTA was 1.219 (1.219, 1.363), indicating that an increase
of this magnitude corresponds to an increase in the episodes of CEi by 39.6%, 0.4% and 21.9%,
respectively.

Regarding meteorological variables, the results (Table 3.14) showed that the posterior median
and 95% credible interval for the relative risk of a 10-degree Fahrenheit increase in the average
monthly maximum temperature within a ZCTA was 0.938 (0.938, 0.974), indicating that an
increase of this magnitude corresponds to a decrease in the episodes of CEi by 6.2%. The results
also showed that the posterior median and 95% credible interval for the relative risk of a 2-inch
increase in the total monthly precipitation within a ZCTA was 0.951 (0.928, 0.975), indicating

83

that an increase of this magnitude corresponds to a decrease in the episodes of CEi by 4.9%. In
addition, the results showed that the posterior median and 95% credible interval for the relative
risk of a 2 micrograms/meters cubed (mcg/m3) increase in the annual average PM 2.5 90th
percentile within a ZCTA was 0.989 (0.916, 1.0184), indicating that an increase of this
magnitude corresponds to a decrease in the episodes of CEi by 1.1%.

COPD Inpatient Covariate

RR

95% CrI

10% increase in 'Over 64'

1.396

(1.266, 1.536)

10% increase in 'Black'

1.004

(1.004, 1.049)

10% increase in 'Poverty'

1.219

(1.219, 1.363)

10% increase in at least '4-year College
graduate'

0.892

(0.892, 0.959)

10% increase in 'Female'

0.957

(0.957, 1.279)

10% increase in homes heated with 'Fuel
oil, kerosene, etc.'

0.917

(0.917, 0.988)

0.938

(0.938, 0.974)

0.951

(0.928, 0.975)

0.989

(0.916, 1.084)

10-degree increase in average 'monthly
maximum temperature'
2-inch increase in total 'monthly
precipitation'
Increase of annual average PM2.5_90%tile by 2 micrograms/m3

Table 3.14: A summary of the COPD Inpatient parameter estimates from the spatio-temporal model.

The estimated COPD inpatient covariate effects are relative risks (RR) associated with a multiplier of 10 in all
covariates except for PM 2.5 90th percentile and total precipitation which are associated with a multiplier of 2.

COPD Outpatient
COPD exacerbation outpatient (CEo) cases across New York City, 2016 to 2018
At the city-wide level, the overall annual observed number of COPD exacerbation outpatient
(CEo) discharges decreased between 2016 and 2018. The annual CEo crude case counts were
estimated at 8 118, 8 354 and 8 075 per year for 2016, 2017, and 2018, respectively. The timeseries decompositions of the monthly CEo population-based rates over the study period peaked

84

between November 2016 and January 2017, as well as between September and November 2018.
(Figure 3.14) We also observe that there is great variability for CEo crude case counts as well as
large outliers each month over the course of the study period, especially for January, March and
June 2016, January and February 2017, and then again for October 2018. (Figure 3.15)
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Figure 3.14: Monthly New York City COPD Exacerbation Outpatient Population-Based Rates per 100,000 residents, 2016 to
2018. Source: NYS Department of Health SPARCS.

Figure 3.15: Monthly New York City COPD Exacerbation Outpatient Case Counts, 2016 to 2018. Source: NYS Department of
Health SPARCS.

Poisson Regression General Linear Model (GLM)
We used ‘fitglm’ function in R to fit our GLM model with Poisson regression for our CEo
outcome against our potential predictor variables, which did not consider spatial or temporal
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autocorrelation. Our output determined ‘wind_avg’ was not statistically significant (Pr[>|z|]
0.44) with our outcome. Therefore, we removed this potential predictor variable as it was also
highly correlated with our primary measure of climate variability, average maximum
temperature. We also removed ‘income_median’ (Pr[>|z|] 1.56e-15) in order to prevent
multicollinearity as it was highly correlated with ‘college_pct’ (Pr[>|z|] < 2e-16) and had less
statistical significance within our output.

A 10% increase in the population that are female (RR = 0.89) as well as a 10% increase in homes
heated with fuel oil, kerosene and etc. (RR = 0.99) was protective of COPD exacerbation in the
outpatient setting. However, the community was at a greater risk of a CEo hospitalization for
each 10% increase of the total population being over 64 years old (RR = 1.16), 10% increase of
the total population being black (RR = 1.14), 10% increase in the total population being in
poverty (RR = 1.61), and 10% increase in the population with at least a 4-year college degree
(RR = 1.24). When looking at the potential meteorological covariates, all were protective of CEo
(RR < 1) except for an increase in the relative humidity by 10% (RR = 1.04) which was a risk
factor for CEo. (Table 3.15)

Next, we ran a Moran I test under randomization to determine if spatial autocorrelation is
present.69 Our output determined the p-value for the Moran I statistics was 0.59, which is greater
than (>) 0.05 and insignificant indicating this model may be properly specified. Regardless, we
will continue with adjusting for spatio-temporal autocorrelation as we understand our data are
spatially and temporally misaligned and climate may still have a random effect.

86

Poisson Regression General Linear Mixed Model (GLMM) with Adjustment for Temporal
Autocorrelation
We used ‘fitglmmPQL’ function in R to fit our GLMM model with multivariate normal random
effects, using Penalized Quasi-Likelihood67 to account for the situation where our random effects
are correlated. In this model, we set time as measured in discharge month as our random effect.
Our output determined the beta estimates for ‘precip_total’ (-0.01, p = 0.24) and ‘rel_hum_avg’
(0.05, p = 0.28) were statistically insignificant so we removed these potential predictor variables
from our model moving forward.

Sociodemographic covariates protective of COPD exacerbation in the outpatient setting included
a 10% increase in the population that are female (RR = 0.89) as well as a 10% increase in homes
heated with fuel oil, kerosene and etc. (RR = 0.98). However, the community was at a greater
risk of CEo hospitalizations for each 10% increase of the total population being over 64 years old
(RR = 1.21), 10% increase of the total population being black (RR = 1.14), 10% increase in the
total population being in poverty (RR = 1.72), and 10% increase in the population with at least a
4-year college degree (RR = 1.17). In regards to the potential meteorological covariates, all were
protective of CEo (RR < 1). (Table 3.15)

Next, we ran a Moran I test under randomization to determine if spatial autocorrelation was
present.69 Our output determined the p-value for the Moran I statistics was 0.51 which is greater
than (>) 0.05 and insignificant indicating this model may be properly specified. Regardless, we
will continue with adjusting for spatio-temporal autocorrelation as we understand our data are
spatially and temporally misaligned and climate may still have a random effect.
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COPD Outpatient Covariates
10% increase in ‘female’

GLM (RR)

GLMM (RR)

0.890

0.887

10% increase in 'Over 64'

1.160

1.209

10% increase in 'Black'

1.140

1.139

10% increase in 'Poverty'

1.613

1.716

10% increase in at least '4-year College
graduate'

1.241

1.174

10% increase in homes heated with 'Fuel oil,
kerosene, etc.'

0.989

0.980

0.959

0.961

0.977
1.039

-----

Increase in average wind speed by 10 miles/hour

0.929

---

Increase of annual average PM2.5_90%-tile by 2
micrograms/m3

0.961

0.931

10-degree increase in average 'monthly
maximum temperature'
Increase in total 'monthly precipitation' by 2inches
Increase in average relative humidity by 10%

Table 3.15: Relative risks (RR) of potential predictor covariates COPD exacerbation in the outpatient setting, across two
models: general linear model (GLM) and general linear mixed model (GLMM).

Bayesian results for Spatio-Temporal Changes in COPD Exacerbation Outpatient Case Counts
The Markov chains appeared to have converged indicating posterior distributions of CEo
parameters are essentially identical. We are able to determine convergence from the trace-plots
of the parameters, as they were stationary and showed random fluctuations around a single mean
level.69 In addition, the convergence diagnostic proposed by Geweke79 for sample parameters
shows all covariates for CEo had values between (-1.96, 1.96), which is suggestive of
convergence.79 (Table 3.16)

COPD
Outpatient
Socio-demographic Variables
Percentage female

-0.7

Percentage under 20 years old

---

Percentage over 64 years old

0.2

Percentage identifying as 'Black
(Hispanic and Non-Hispanic)'

1.9

Percentage in Poverty

-0.5
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Percentage having a 4-year
college degree or higher

0.9

Percentage using fuel
oil/kerosene/etc. as their main
source of house heating fuel

0.4

Median income

---

Meteorological Variables
Average maximum temperature

-0.8

Total precipitation

---

Average relative humidity

---

Average wind speed

---

Average PM 2.5 in the 90th
percentile (micrograms/m3)

-0.6

Table 3.16: Table showing statistics in the form of a Z-score for Geweke diagnostic function determining convergence of all
covariates across COPD Outpatient outcomes..

Values between (-1.96, 1.96) are suggestive of convergence.

The estimated Moran’s I statistics obtained from the residuals of this model was -0.057 and the
p-value was 0.864, which is greater than 0.05 and suggested no evidence of unexplained spatial
autocorrelation after accounting for the covariate effects.

The spatial and temporal dependence parameters were ρS = 0.81 and ρT = 0.948. The seasonal
CEo posterior incidence case counts for the outpatient setting exhibited a spatial heterogenicity
across the city (Figure 3.16). The highest CEo posterior case counts mainly occurred in the
ZCTAs located throughout mid- and southern Bronx, Upper Manhattan, eastern and southern
Brooklyn and north-Western Staten Island. The island off Queens housing Far Rockaway,
Breezy Point and Broad Channel was also affected. However, the lowest CEo posterior case
counts mainly occurred in the ZCTAs located in north Bronx, Mid- to Lower Manhattan,
northern and eastern Queens, and southern Staten Island.
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Figure 3.16: Spatio-temporal dynamic of COPD exacerbation outpatient case counts of fitted values (based on seasonal
averages of posterior medians) per ZIP Code Tabulated Area (ZCTA) per for years 2016 – 2018.

Source: The shapefile was obtained from the Geospatial Data Library at the City University of New York (CUNY)
Baruch College. The asthma exacerbation inpatient case counts were obtained from NYC Department of Health
SPARCS.

Effects of covariates on case counts of CEo
Table 3.17 summarizes the three models, general linear model (GLM), general linear mixed
model (GLMM) and Bayesian spatio-temporal model, evaluating the effects of covariates on
case counts of CEo. The latter model further evaluates the spatio-temporal random effects on the
case counts of CEo across NYC ZCTAs. In all three models, the Moran I statistic p-value was
insignificant indicating the models were properly fitted and lacked spatial autocorrelation.
Covariates with insignificant p-values in models 1 and 2 were also dropped in model 3 as they
had no statistical significance on the outcome. Covariates that were also highly correlated with
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one another were dropped in models 2 and 3, based on both their statistical significance in model
1 and prior understanding of their individual relationship with the outcome.

COPD Outpatient Indicator
Fixed Effects
Intercept
Socio-demographic
Variables
Percentage female
Percentage under 20 years
old
Percentage over 64 years
old
Percentage identifying as
'Black (Hispanic and NonHispanic)'
Percentage in Poverty
Percentage having a 4-year
college degree or higher
Percentage using fuel
oil/kerosene/etc. as their
main source of house
heating fuel
Median income
Meteorological Variables
Average maximum
temperature
Total precipitation
Average relative humidity
Average wind speed
Average PM 2.5 in the 90th
percentile (micrograms/m3)
Spatio-temporal random
effects variances
Spatio and Temporal
Dependence
Spatial dependence (ρS)
Temporal dependence (ρT)
Moran, I test (p-value)
DIC

General GLM Model
(Coeff, [Pr(>|z|)])

GLMM TemporalAdjusted Model
(Coeff, [p-value])

Bayesian SpatioTemporal Adjusted
Model
(Coef, [95% CrI])

-1.058e+01 (<2e-16)

-10.843 (0.000)

-10.967 (-11.865, 10.087)

-1.169e-02 (0.000)

-0.012 (0.007)

-0.004 (-0.017, 0.011)

---

---

---

1.485e-02 (2.37e-13)

0.019 (0.000)

0.018 (0.006, 0.03)

1.309e-02 (<2e-16)
4.779e-02 (<2e-16)

0.013 (0.000)
0.054 (0.000)

0.009 (0.006, 0.11)
0.041 (0.035, 0.048)

2.159e-02 (<2e-16)

0.016 (0.000)

-0.0001 (-0.005, 0.004)

-1.135e-03 (0.014)
-4.628e-06 (1.56e-15)

-0.002 (0.024)
---

-0.004 (-0.009, 0.001)
---

-4.154e-03 (3.9e-07)
-1.168e-02 (0.018)
3.839e-03 (0.02)
-7.405e-03 (0.44)

-0.004 (0.012)
-0.013 (0.244)
0.004 (0.278)
---

-0.004 (-0.006, -0.001)
-------

-1.992e-02 (0.029)

-0.036 (0.006)

0.069 (0.003, 0.134)

---

---

0.042 (0.028, 0.06)

------0.59
---

------0.513
---

0.08 (0.066, 0.096)
0.81 (0.711, 0.882)
0.948 (0.932, 0.964)
0.864
24112

Table 3.17: COPD exacerbation outpatient discharges reported by month and ZCTA, New York City, 2016 – 2018, as presented
across three models
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General linear model (GLM) regression coefficients and p-values, General linear mixed model (GLMM) regression
coefficients and p-values, and Median of posterior regression coefficients and 95% credible interval from
hierarchical Bayesian spatio-temporal modelling. Note: CrI: credible interval, DIC: deviation information criteria.

Regarding socio-demographic variables, the results (Table 3.18) showed that the posterior
median and 95% credible interval for the relative risk of a 10% increase in the percentage of the
population that had at least a 4-year college degree within a ZCTA was 0.999 (0.955, 1.041), a
10% increase in the percentage of the population within a ZCTA being female was 0.964 (0.84,
1.113) and a 10% increase in the percentage of the population that have their homes heated with
fuel oil, kerosene and etc. was 0.961 (0.912, 1.011), indicating that an increase of this magnitude
corresponds to a decrease in the episodes of CEo by 0.1%, 3.6% and 3.9%, respectively.
Furthermore, the posterior median and 95% credible interval for the relative risk of a 10%
increase in the percentage of the population over 64 years old within a ZCTA was 1.199 (1.063,
1.354), and a 10% increase in the percentage of the population that is Black (Hispanic and nonHispanic) within a ZCTA was 1.088 (1.062, 1.116), and a 10% increase in the percentage of the
population that is in poverty within a ZCTA was 1.505 (1.414, 1.621), indicating that an increase
of this magnitude corresponds to an increase in the episodes of CEo by 19.9%, 8.8% and 50.5%,
respectively.

Regarding meteorological variables, the results (Table 3.18) showed that the posterior median
and 95% credible interval for the relative risk of a 10-degree Fahrenheit increase in the average
monthly maximum temperature within a ZCTA was 0.966 (0.943, 0.986), indicating that an
increase of this magnitude corresponds to a decrease in the episodes of CEo by 3.4%. The results
also showed that the posterior median and 95% credible interval for the relative risk of a 2
micrograms/meters cubed (mcg/m3) increase in the annual average PM 2.5 90th percentile within
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a ZCTA was 1.146 (1.016, 1.291), indicating that an increase of this magnitude corresponds to
an increase in the episodes of CEo by 14.6%.

COPD Outpatient Covariate

RR

95% CrI

10% increase in 'Over 64'

1.199

(1.063, 1.354)

10% increase in 'Black'

1.088

(1.062, 1.116)

10% increase in 'Poverty'

1.505

(1.414, 1.621)

10% increase in at least '4-year
College graduate'

0.999

(0.955, 1.041)

10% increase in 'Female'

0.964

(0.84, 1.113)

0.961

(0.912, 1.011)

0.966

(0.943, 0.986)

1.146

(1.016, 1.291)

10% increase in homes heated
with 'Fuel oil, kerosene, etc.'
10-degree increase in average
'monthly maximum
temperature'
Increase of annual average
PM2.5_90%-tile by 2
micrograms/m3

Table 3.18: A summary of the COPD outpatient parameter estimates from the spatio-temporal model.

The estimated COPD outpatient covariate effects are relative risks (RR) associated with a multiplier of 10 in all
covariates except for PM 2.5 90th percentile and total precipitation which are associated with a multiplier of 2.

Outliers and model quality
Each outcome was assessed for the presence of outliers to confirm model quality. The ZCTA
‘11430’ appeared as an extreme outlier across all four outcomes. This ZCTA mostly lies in John
F. Kennedy Airport in Jamaica, Queens, NY and only has a total population 198. All three
models were run with this ZCTA removed for each outcome and results were not much different.
This implies the presence of outliers within our study did not greatly inflate the variance estimate
of our predictor covariates.
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3.4 Discussion
This study aimed to estimate morbidity of respiratory exacerbation in NYC residents between
2016 and 2018. While causality cannot be inferred from this cross-sectional study, our results
suggest spatial and temporal heterogeneity in the relationship between asthma and COPD
exacerbation and key socio-demographic and climatic characteristics in NYC. Each of the
models within our three series adjusted for potential predictive covariates. However, time was
also adjusted for within the second GLMM series. Within the third series using the Bayesian
spatio-temporal approach, the modelling adjusted for time as well as the random effect of space.

The crude inpatient case counts across Asthma and COPD exacerbation decreased gradually over
the course of the study period. However, the crude outpatient case counts across Asthma and
COPD exacerbation first increased from 2016 to 2017 and then decreased from 2017 to 2018.
This may indicate possible fluctuation in the cases of outpatient respiratory exacerbation cases
per year, despite an overall decline in the trend. However, a study assessing a longer time period
may be better suited to address these concerns. Furthermore, crude case counts were higher for
asthma exacerbation episodes occurring within the outpatient setting than the inpatient, as
compared to crude case counts being higher for COPD exacerbation episodes occurring within
the inpatient setting than the outpatient. This suggests patients experiencing a COPD
exacerbation episode may primarily seek care within the inpatient setting, as opposed to those
experiencing an asthma exacerbation episode.

This disparity may be a result of asthma management policies that were implemented across
New York State and New York City promoting proper self-care and guidance for asthmatic
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disease, namely the ‘Asthma Action Plan’.87 Part of the ‘Asthma Action Plan’ provides guidance
for those pre-diagnosed with asthma in learning how to assess signs and symptoms of an
impending exacerbation episode and knowing where to seek care within the outpatient setting
(e.g., primary care physician[PCP]). This information is distributed in the form of educational
posters, handouts and a formal action plan to be completed in conjunction with the patient and
their PCP. In addition, part of the ‘Asthma Action Plan’ provides clinical guidelines for the
diagnosis, evaluation and management of adults and children with asthma.88 COPD, however,
lacks similar resources across both NYS and NYC. Although there are a number of resources for
patients with pre-diagnosed COPD such as online and local support groups organized by
organizations such as Freedom From Smoking® and a New York State Smokers’ Quitline
organized by the NYS Tobacco Control Program and the Roswell Park Cancer Institute, there is
no available formal ‘action plan’ for COPD disease management and education within NYC at
this time.89

We found high respiratory exacerbation rates peaked between February through March 2016,
October 2016 through May 2017, Jan 2018 and October through December 2018. These findings
indicate seasonal allergies may have played a role. Meteorological conditions may have also
influenced the temporal distribution of respiratory exacerbation rates, especially for October
through December of 2018, as mentioned prior in chapter 2.13

Bayesian spatio-temporal modelling showed neighborhoods located mainly in south Bronx,
upper Manhattan, eastern Brooklyn (as well as parts of north-western Brooklyn), north-central
Queens (near LGA airport) and southern Queens (near JFK airport) exhibited the highest risk
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levels, whereas neighborhoods located in Mid- to Lower Manhattan, southern Staten Island, and
eastern Queens (for COPD outcomes only) exhibited the lowest risk levels overall. The
neighborhoods with the highest risk appeared closest to major highways and airports (JFK in
southern Queens and LGA in north-central Queens).90 The literature substantiates these findings
showing about half of children residing in Manhattan and the Bronx live within close proximity
of a state or county highway and zones of elevated concentrations of traffic-related pollutants.91
These children presented with wheeze, asthma and high levels of immunoglobulin (Ig) E.91A
study further assessing asthma hospitalizations within New York City found the Bronx, East
Harlem and some neighborhoods in North/Central Brooklyn close to some of the biggest
highways of the city (e.g., Brooklyn-Queens Expressway, Long Island Expressway) to have the
highest hospitalization rates of the whole city, together with the highest pollution level of all the
neighborhoods excluding the wealthiest areas of Manhattan.92 They further found those areas
with the highest hospitalization rates also had the highest poverty rates as well as the lowest
percentage of insured people in the city.92 Research has also found that these areas (Bronx, East
Harlem, Southeast Queens and East Brooklyn, especially Crown Heights, Flatbush and
Brownsville) with the highest asthma-related hospitalization rates within NYC also had the
highest percentage of NYC residents identifying as non-Hispanic black.92 These findings align
with the results from our study portraying neighborhoods with the highest respiratory
exacerbation risk also having the highest population of lower income and minority groups.

Bayesian Spatio-temporal modelling further showed the effects of predictive sociodemographic
and climatic covariates on the outcome of respiratory exacerbation. Beginning with
sociodemographic covariates, an increasing proportion of people under age 20 was protective of
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asthma inpatient exacerbation, which may be explained by occupational exposures, smoking, and
obesity, variables that are all likely to be lower in this age group.93,94 However, an increasing
proportion of people over age 64 was a risk factor for COPD exacerbation across both the
inpatient and outpatient settings within a community. This finding may be explained by the
nature of the disease where an individual will not exhibit prominent signs and symptoms of
COPD until years after first exposure (e.g., smoking), despite loss of lung function more
accelerated in the early stages of COPD than in the later stages.95

It seems likely there are gender disparities with regards to asthma and COPD, but our findings
were inconsistent across our outcomes. Regardless, the literature shows as children, boys have
increased prevalence of asthma compared to girls. However, as adults, women have increased
prevalence of asthma compared to men.96 In regards to COPD, it seems likely there are gender
disparities but it is unclear which gender is associated with a higher risk of COPD.97 Further
research in this area should attempt to better elucidate these interactions and their mechanisms.

An increasing proportion of blacks, regardless of ethnicity, was a consistent risk factor across
COPD and asthma within a community. African American youth have greater odds of an asthma
diagnosis even compared with other minority groups, and the odds increase with each decrease
in socioeconomic status.98 Differences in illness management may account for some of these
disparities.99 Similarly, an increasing proportion of people living below the federal poverty level
was also a consistent risk factor. Further findings from our study determined higher increases in
the episodes of AEi as compared to AEo, given an increase in the percentage of the population
that is in poverty within a ZCTA. This indicates that those who are of a lower socioeconomic
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status continue to seek emergency care for asthma exacerbation as compared to those of higher
SES. Lower SES has long been associated with greater emergency health service use, worse
asthma control and worse asthma self-efficacy.100 This may be due to the influence of SES on
accessibility, affordability, acceptability and actual utilization of various available health
facilities.101

An increasing proportion of the adult population with at least a 4-year college degree was
protective against exacerbation in the inpatient setting for both asthma and COPD within a
community. This observation agrees with the literature suggesting educational attainment
reduces the risk for health morbidity and mortality due to increased accessibility to resources
such as health insurance through the employer, lack of occupational exposure, and lower
smoking prevalence.93,94 Other downstream benefits of educational attainment include the
resources and knowledge to adopt healthier behaviors and the resources to live in healthier
neighborhoods, which can inadvertently decrease air pollution exposure both indoors and
outdoors.102

Our findings across homes heated with fuel oil, kerosene, etc. were inconsistent across the
outcomes. However, these heating methods are all sources of combustion products and
particulate matter, which can be directly emitted from the remaining residual oil boilers in
buildings or released when fuels are incompletely burned.37 As a result, PM 2.5 can contribute to
poor air quality and lead to adverse health effects by lodging in the lungs and irritating or
damaging lung tissue.37 However, we were unable to assess the ventilation systems of homes
being heated with utility gas, or account for the adequacy of central air handling systems,
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including furnaces, flues and chimneys (e.g., whether or not they inspected annually or if any
cracks or damaged parts were properly repaired). Additionally, due to monthly data
unavailability we were unable to adjust for seasonal exposure to heating fuel demonstrating
higher uses of heating fuel during the winter as compared to the summer.

The meteorological covariates were similar across all four outcomes. Average monthly
maximum temperature was consistently protective of respiratory exacerbation across all four
outcomes. However, the increase in respiratory exacerbation episodes was only marginal for
asthma patients within the outpatient setting. These findings suggest less cases of both asthma
and COPD exacerbation during the summer and more in the winter, aligning with our spatial risk
analyses in chapter 2 where the Fall and Winter seasons presented with higher case counts of
respiratory exacerbation. Because it is well-known that the spring and summer seasons present
with more allergens, those pre-diagnosed with respiratory disease may take more precautionary
measures by utilizing inhalers during these periods. A major trigger of respiratory exacerbation
during the fall and winter season is cold air, which may present with a greater difficulty with
prevention. Although reduction in lung function may be caused by increased airway
inflammation in winter, which can be treated with inhalers or bronchodilators, recent work has
shown that exacerbations of asthma are largely precipitated by viral infections, especially with
rhinovirus, and it is likely that viruses are also important in increasing airway inflammation in
COPD in the winter.103 Furthermore, inflammatory changes in COPD could contribute to a
persistent decline in lung function without the presence of a symptomatic exacerbation.104 This
may be due to the role of mucous hypersecretion as a potential mediator of the COPD response
to cold temperature.105
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Total monthly precipitation was only assessed for the COPD exacerbation inpatient outcome as it
was insignificant against the other three outcomes. In this scenario, precipitation also appeared
protective of COPD exacerbation episodes within the inpatient setting. This may have occurred
because the rainfall may not have been as heavy to induce hydration and fragmentation of pollen
grains, which could release allergenic biological aerosols into the atmosphere making it more
difficult for those patients pre-diagnosed with respiratory conditions to breathe.106 It may also be
due to atmospheric washout which is recognized as one of the main mechanisms of reduction in
atmospheric particulate pollution.42

Finally, annual average PM 2.5 in the 90th percentile was very marginally protective for asthma
exacerbation (regardless of setting) and COPD exacerbation in the inpatient setting; while it was
a risk factor for COPD exacerbation in the outpatient setting. Atmospheric “washout” from
heavy rainfall is recognized as one of the main mechanisms of reducing atmospheric particulate
pollution, which may explain the findings in the AEi, AEo and CEi outcomes.15 Nevertheless,
PM 2.5 was still a risk factor for COPD exacerbation in the outpatient setting and had
disproportionate levels that aligned with results from our spatial risk analysis in chapter 2.59 PM
2.5 in the 90th percentile was highest in Midtown, Manhattan (12.4 mcg/m3), where 11.1% of the
population was in poverty, showing exposure may not have necessarily influenced SES within
our findings. However, our findings may be explained by industrialization of the neighborhood.
Midtown Manhattan is one of the world's largest central business district, with 400 million
square feet (37.2 million m2) of office space in 2018.107 Furthermore, it has one of the smallest
densities or persons per square mile within NYC, including a low density of children.108 It is
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important to note however, that data for PM 2.5 was only made available in 2018 and does not
accurately reflect levels in 2016 or 2017, which may have presented with higher or lower values.

We were able to declare approximate convergence in the results from our Bayesian spatiotemporal modelling concluding that each individual sequence of a Markov chain appeared
stationary and that the observed sequences have mixed well with each other.78 This suggests that
for our current study, the stationarity of the Markov chain and the sample size obtained was
adequate for the estimation of mean values of the three iterations.109

When using the convergence diagnostic proposed by Geweke79, the covariates for the Asthma
Outpatient outcome had values outside of (-1.96, 1.96), except for ‘Percentage female’, which
may be suggestive of non-convergence. The lack of convergence for our Asthma Outpatient
outcome using the Geweke diagnostic may indicate that the number of samples to generate,
whether or not to thin the Markov chains, and as a result how many samples to discard as the
burn-in period and then how many more to generate on which to base inference may have needed
to be altered.69,78 However, there has been a long and continuing debate about whether the issue
of selecting a model as a basis for inferences is amenable to a strict mathematical analysis. The
literature shows that although it is useful to have measures of fit and complexity, and to combine
them into overall criteria that have some theoretical justification, an overformal approach to
model ‘selection’ may be inappropriate since so many other features of a model should be taken
into account before using it as a basis for reporting inferences, e.g. the robustness of its
conclusions and its inherent plausibility.77 Nevertheless, the trace-plots of the parameters for the
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Asthma Outpatient outcome suggest convergence as they are stationary and show random
fluctuations around a single mean level.

The Moran’s I statistic for each outcome using Bayesian spatio-temporal modelling had p-values
ranging from 0.195 to 0.864, which were all greater than 0.05. This suggests little to no evidence
of unexplained spatial autocorrelation after accounting for the covariate effects in the Bayesian
spatio-temporal models.(Table 3.19) Given the Moran’s I test results were insignificant after
Bayesian spatio-temporal modelling, we can confirm this model was most appropriate for
addressing spatial autocorrelation within our study as compared to GLM and GLMM modelling.
The Moran’s I statistic was also negative across all four outcomes suggesting the spatial
distribution of high case counts and low cases counts in the study were probably more spatially
dispersed than would be expected if underlying spatial processes were random.110 A dispersed
spatial pattern often reflects some type of competitive process—a feature with a high value
repels other features with high values; similarly, a feature with a low value repels other features
with low values.110,111 This process can be explained by the heterogeneity of NYC where social
and environmental conditions vary significantly within relatively small distances.92

Moran's I
Statistic

P-value

Asthma Inpatient

-0.027

0.666

Asthma Outpatient

-0.036

0.195

COPD Inpatient

-0.03

0.225

COPD Outpatient

-0.057

0.864

Table 3.19: Moran’s I statistic and associated p-values for Bayesian spatio-temporal modelling.

This table suggests models across all four outcomes were insignificant and lacked spatial autocorrelation.
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In our GLMM model with temporal adjustment, there is still residual spatial autocorrelation. The
spatial and temporal dependence parameters from the Bayesian models across all four outcomes
(ρS and ρT), presented in Tables 3.5, 3.9, 3.13 and 3.17, further showed spatial dependency and
temporal autocorrelation. Although we did not test for temporal autocorrelation, the values for ρT
are all quite high (maximum value is 1) indicating significant temporal autocorrelation. These
findings corroborate our rationale for using more complex models (Bayesian) that further adjust
for spatial residual autocorrelation.

Despite spatial dispersion noticed in the findings from the Moran I’s statistic, the spatial and
temporal dependence parameters still suggest that the intensity of the respiratory exacerbation
from neighborhood communities tends to be more similar than that in communities that are
further apart.112 This situation could have some implications for the management and
surveillance at a ZCTA-level and can be replicated in the population between 19 and 65 years
old or in the general population. Notably, spatial and temporal dependency must be considered as
information sources rather than something to be corrected.113 Local authorities of neighboring
communities, in tandem with local health managers, could make concerted efforts to improve
routine health information systems (systematic collection of data, analysis, and interpretation) to
improve and strengthen existing measures to support achievement of on-going respiratory
management goals. More specifically in New York City, improvements can be made to the
Department of Health and Mental Hygiene’s asthma management policies which aims to
minimize symptoms and exacerbations so people with asthma can lead full, active
lives.74,114 Efforts should be in place to further include COPD as part of the city’s respiratory
management goals as this disease has a similar pathophysiology to asthma with comparable risk
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factors. Finally, it may be beneficial for the city and/or state departments to integrate the
geographic information system into routine surveillance programs to regularly produce and
update maps of asthma and COPD risk in general, but particularly of respiratory disease burden
during cases of extreme climate variability. Although COPD and asthma exacerbation
population-based rates appear to have decreased over the course of the study period, this
decrease is relatively small, and rates still appear high within disadvantaged neighborhoods. The
crude outpatient case counts across Asthma and COPD exacerbation both increased from 2016 to
2017, and then decreased from 2017 to 2018, indicating annual fluctuations that were not
properly accounted for in this study due to the short study time period.

One of the strengths of our study is the type of analysis used to explore the spatio-temporal
variations in the burden of respiratory exacerbation through routinely collected observational
health data. As recommended by the first principle of the National Asthma Control Program
(NACP) developed by the CDC, tracking is essential for collecting and analyzing data to
understand when, where, and in whom asthma occurs so that interventions can be better targeted,
and stakeholder partnerships can be created to develop, implement and evaluate local health
programs.115 An additional strength of this study is that it analyzes respiratory exacerbation
across NYC at the level of the ZCTA. USPS ZIP Codes lack a pre-defined geographic area so the
USPS assigns ZIPs to ranges of addresses associated with street segments. However, the ZCTA
is composed of aggregated census blocks where majority of addresses have the same ZIP Code.
Lastly, the application of the hierarchical Bayesian CAR approach with data from several
sources can address unknown sources of bias.74 Likewise, the CAR model smooths the
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respiratory exacerbation case counts, considering the potential impact of model instability caused
by the small number of reported cases and the diversity of data sources.116,117

3.5 Conclusion
In summary, this study addresses important problems in the fields of public health,
environmental health, climate science, health care, and sociology. In particular, it addresses the
need for focused studies in major cities such as New York City, where there are diverse
sociodemographic and socioeconomic groups who experience adverse health effects from
seasonal climate patterns in varying ways.

Long latency times, the effects of cumulative exposures, and multiple exposures to different
pollutants which might act synergistically all create difficulties in unraveling associations
between environmental pollution and health.82 Current knowledge about weather effects on air
pollution is still unsatisfactory; there is still a need for better emission inventories and
observational datasets.21

The results from this study mostly agree with the original hypothesis. Our results were best fitted
after utilizing the Bayesian spatio-temporal approach to adjust for spatio-temporal
autocorrelation. Our outcomes and potential predictive covariates varied significantly, both over
the course of the study period and across the NYC ZCTAs. Results from our Bayesian spatiotemporal model suggest certain sociodemographic predictive factors increased the risk of
respiratory exacerbation within a community. However, the effect of climatic predictors was
slightly different than what was expected, except for PM 2.5 being a risk factor for COPD

105

exacerbation in the outpatient setting. We expected temperature to have a different effect than
what was observed, however, our findings indicate that lower temperatures may potentially serve
as a risk factor for respiratory exacerbation instead.

The findings from this research support on-going respiratory management goals, specifically
New York City Department of Health and Mental Hygiene’s asthma management, which aim to
minimize symptoms and exacerbations so people with asthma can lead full, active lives.114
The results also support adaptation measures for disadvantaged individuals residing in specific
geographical locations that may likely be unable to cope during adverse climatic events.
Improvements can begin at the level of the Primary Care Physician (PCP) providing acute
(outpatient) medical care.

Future research can study patients within specific socioeconomic classes or disadvantaged
neighborhoods frequenting primary care and/or pulmonology-focused medical practices for their
prevention of respiratory exacerbations. Studies can further evaluate the effect of proximity to
one’s PCP and/or a formal pulmonary rehabilitation program on reducing respiratory
exacerbation. Potential research assessing public health interventions on risk of respiratory
exacerbation can include proper medication education using a formalized education tracking
system within a medical dashboard, improved electronic medical record documentation to
include sociodemographic variables predictive of respiratory exacerbation, and environmental
monitoring tracking applications that can be easily downloaded unto patients’ cellphones.
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This study has several limitations, including the 3-year time period.118 However, the results of
this study can be used to inform future research with the capability of accessing respiratory
exacerbation for a longer period of time. Misclassification of case location could have occurred,
as was described in chapter 2.119 However, these limitations are hypothetical in nature and there
is no available evidence that these potential location errors are systematic. Therefore, they should
be minimized by the use of ZCTAs as the unit of analysis, as done in this study, rather than the
specific geocoded address points.120

Additional limitations with this study’s methods involve point estimates of the slope parameters
(beta coefficients) in a linear model. The beta coefficient themselves will not be biased, but their
associated standard errors will be if the residuals are not randomly distributed and independent of
each other. Regression with connected spatial units like this will typically yield residual spatial
autocorrelation, which we were able to adjust for using our Bayesian spatio-temporal
model. Omitting covariables that may act as confounders or effect modifiers for some potential
predictive covariable could also bias the coefficient associated with the predictive variable of
interest121; however, this will typically manifest itself in residual spatial autocorrelation, which
again we were able to adjust for.

In addition, the range of margin of error can be high with ACS data resulting in loss of precision.
However, it is beneficial to work with small geographic boundaries that the ACS data provides
such as ZCTAs, as opposed to larger geographic boundaries (e.g., Public Use Microdata Areas or
PUMAs, Community Districts or CDs) provided by other data sources such as the NYC
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Community Health Survey. The tradeoff between geographic resolution allows the study to
account for variation across finer geographic units.

Another limitation is the lack of primary care or pediatrician visits captured by SPARCS,52 as
was described in chapter 2. Further limitations involve the PM 2.5 dataset obtained from the
New York City Community Air Survey. Although this is a robust dataset with over one-hundred
monitors across NYC with data spanning a decade, it does have drawbacks. Notably, it is a twoweek average and particulate matter data is collected only periodically within the 14-day
period.59 Therefore, this research is unable to obtain peak PM 2.5 exposures, which may be the
driver for hospital admissions, depending on the respiratory illness.

An additional limitation of this study was the inability to analyze indoor air quality (IAQ) covariates, especially the main drivers of poor IAQ: Crowding, second-hand smoke, pests
(cockroaches, mice/rats) and pets.122,123 Crowding or the number of people in the household and
number of people per room can be an indicator as concentration could indicate greater generation
sources over a smaller volume. The relative importance of these different triggers varies based
on different environmental factors depending on geographic, climatic, socioeconomic, and
housing conditions.123 Although ‘crowding’ was calculated by the American Community Survey
(ACS) using the estimated number of housing units with more than 1 occupant per room,124 this
data was collected at the geographic level of CDs, of which there are only 59. Additionally,
‘crowding’ was only made available as an average from 2013 to 2017, which doesn’t cover any
part of the time period used within this study. Nevertheless, multiple social and behavioral
factors can influence environmental exposures and health conditions.125 We posited poverty,
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educational attainment and ethnicity may all be potential indicators of higher likelihood of
worsened IAQ. For example, studies have found individuals with a higher educational attainment
and those who lived out of poverty had lower odds of second-hand smoke exposure at
home.126 Research has also shown bedroom allergen levels were associated with ethnicity and
housing instability.127 Future research may investigate additional proxy variables for IAQ,
potentially tenure by occupants per room. We were further unable to assess for ‘second-hand
smoke within the home’, ‘cockroaches’, and ‘mice/rats, as these data were last collected by the
New York City Community Health Survey (CHS) in 2012, four years prior to the beginning of
this study period.128 They were also collected at the geographic level of United Hospital Fund
(UHF) neighborhoods, of which there are only 34. Further, the data for ‘pets (dog or cat in the
home)’ and solely ‘cats in the home’ was also collected by NYC CHS at the UHF level and prior
to the beginning of the study period, in 2008 and 2013, respectively.

Prediction about the effects of climate variability on health-related air pollution is further
hampered by limits including population growth, economic development, energy use and
production. Current knowledge about weather effects on air pollution is still unsatisfactory; there
is still a need for better emission inventories and observational datasets.21

Nevertheless, the findings from this study can be generalizable to other individuals living within
NYC that are pre-diagnosed with asthma and COPD but were not included in this research, as
well as to individuals in other urban areas diagnosed with a chronic health condition (e.g.,
cardiac), that may be also experience health inequities. The New York State SPARCS hospital
discharge data includes outcomes from a representative sample of an urban area (New York
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City) within the NYS population and includes individuals who were discharged from a NYS
hospital or article 28 medical facility, regardless of age, sex, race/ethnicity and socioeconomic
status. Therefore, this study could also be transportable to other diverse urban populations within
the U.S. with a similar population structure, where there is a disproportionate burden of chronic
health disease (e.g., respiratory, cardiac) among disadvantaged populations. Given our findings
in NYC, research can focus on similar racial and socioeconomic disparities that are expected in
other large cities with a similar population makeup across the United States.

As COPD and asthmatic events are often triggered by environmental irritants, and can be
augmented by certain socioeconomic conditions, climate variability can impact air quality and
pose a quantifiable threat by permanently affecting the overall function of an individual’s
respiratory system. Data generated from this study is essential in identifying the interplay
between certain sociodemographic and environmental triggers of COPD and asthma
exacerbation on a spatio-temporal scale. In so doing, public health research can be better targeted
to populations within specific socioeconomic classes or disadvantaged neighborhoods that are at
higher risk for respiratory exacerbation. Support can also be garnered on a policy level towards
reducing air emissions from sources such as traffic and neighboring highways, along with
factories, warehouses, and other toxic release inventories.
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Chapter 4. Bayesian Spatio-temporal Modelling to Assess the
Future Burden of Socio-economic and Climate Predictive Factors in
New York City, New York
4.1 Introduction
Climate variability leaves the most vulnerable individuals of a population, including COPD and
asthmatic patients, susceptible to augmented chronic health outcomes. Asthma is already
understood to be the leading chronic disease in children1 and is the third-ranking cause of
hospitalization among children younger than 15 years old.2 Moreover, it is known that COPD
stands as the third leading cause of death and second leading cause of disability in the United
States.3,4 The literature has shown climate variability is associated with an increase in same-day
respiratory hospitalizations5 and an increased risk of premature death up to six times higher
among respiratory patients than in the rest of the population.6

During the winter season, COPD patients have been reported to experience more frequent
exacerbation of their disease and were found to have higher hospitalization and morbidity
rates.7,8 This may be due to the increased prevalence in respiratory viral infections during the
winter season.9,10 Evidence also cites increased mortality and acute morbidity from respiratory
illness during the summer season, mainly from increased exposure to pollutants such as grass
pollen in the air, and high levels of the gaseous pollutant ozone which is associated with elevated
temperatures.11-13 Ozone, a respiratory irritant created by chemical reactions between oxides of
nitrogen (NOx), VOC, carbon monoxide (CO) and methane (CH4), can cause a reduction in lung
function and increase in respiratory symptoms.14 Over the last century, global temperatures have
risen and are projected to continue to rise and cause changes in weather and climate.11 With the
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overall increase of global temperatures, many climate models have predicted a general increase
in atmospheric water vapor accompanied by an increase in relative humidity and the intensity of
heavy rainfall events.15-17 Changes in temperature, air pressure, and most importantly
precipitation patterns affect the probability of storms and floods. Heavy rain and flooding may
cause water damage on buildings, leading to an increase in mold exposure. Although mold
allergy is rare, there is a clear relationship between damp houses and respiratory diseases such as
asthma.18 Other studies carried out in the Brazilian Amazon have even found peaks in the
number of hospital visits due to respiratory disease during the wet seasons (between the months
of March and April), which may of had an association with relative humidity in the air.19
Nevertheless, periods of heavy rainfall can also reduce the amount of ambient air pollution by
“washing” particulate matter pollutants out of the atmosphere.20

Recent epidemic thunderstorm asthma has been reported about a dozen times in the past 35
years; the threshold for reporting seems to be an increase of at least five to ten times in asthma
presentations to emergency departments over a short time.21 Nonetheless, many individuals are
affected by these events but do not seek acute medical care.22 This emerging phenomenon is
accompanied with periods of heavy rainfall and intense wind, which are believed to increase
extreme exposure to allergens, predominantly grass pollen, in susceptible allergic individuals.23
Heavy rainfall, wind speed, air turbulence, and mixing depth can affect how pollutants disperse
within a region, or even cause a reverse effect and spread pollutants away from a region.24

During periods of climate variability accompanied by temperature and/or precipitation extremes,
individuals who are socio-economically disadvantaged are most vulnerable. Research has
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consistently shown the impact of an individual’s social or economic standing on morbidity,
mortality, and access to health care with regards to respiratory health.25-27 Studies addressing low
SES among individuals diagnosed with COPD and asthma have found associations with
disproportionate access to respiratory health care. For instance, there is an inverse relationship
between SES and COPD prevalence associated with mortality, health utilization costs and
health-related quality of life (HRQoL).27 There is also a relationship between lower SES and
increased severity of asthma leading to subsequent hospitalization.27

Public health authorities are interested in reducing hospitalizations rate for several reasons. They
include improving the population's well-being and reducing healthcare costs and consumption of
resources; this is particularly true in New York City (NYC).28 For instance, the New York State
(NYS) healthcare system spends US$1.3 Billion dollars per year for asthma alone (second
highest state in the United States [US]) and the current asthma prevalence in adults living in
NYC is 10.2%, higher than 9.3% of adults who live in the rest of the State.29

COPD also presents with its own burdens on morbidity and mortality and subsequent challenge
on healthcare systems. Although there is limited research done on COPD in NYC, national
studies have modelled the financial burden associated with COPD prevalence showing direct
healthcare costs ranged from US$1,681 for patients in stage I COPD (early stage), US$5,037 for
patients in stage II (moderate stage) and US$10,812 for those in stage III (severe stage).30 A
majority of these costs are associated with exacerbations requiring hospitalizations. COPD
constitutes a larger proportion of respiratory inpatient exacerbations, as compared with asthma.31
Some studies have shown that the cost of hospital stay represents 40–57% of the total direct costs
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generated by patients with COPD, reaching up to 63% in severe patients.30-32 In the USA, the
mean cost of hospital admission by COPD in a cohort of patients with severe COPD was
estimated to be US$7,100.33

IPCC (Intergovernmental Panel on Climate Change) future climate projections
Temperature and precipitation extremes and their potential future changes are evaluated in an
ensemble of global coupled climate models participating in the Intergovernmental Panel on
Climate Change (IPCC) diagnostic exercise for the Fourth Assessment Report (AR4).34 Climate
extremes are expressed in terms of 20-year return values of annual extremes of near-surface
temperature and 24-hour precipitation amounts.35 The simulated changes in extremes are
documented in three 30-year time periods for years 2010-2039, 2040-2069 and 2070-2099 across
different emissions scenarios provided within the Special Report on Emissions Scenarios
(SRES).36 The tools most commonly adopted for projecting future climate are coupled
atmosphere-ocean general circulation models (AOGCMs). AOGCMs are numerical models that
provide a comprehensive three-dimensional representation of the climate system, and can
generate regional estimates of climate in response to given changes in greenhouse gas (which
tends to warm the earth) and aerosol concentrations (which tends to have a cooling effect).37

Our objective is to estimate the influence of temperature and precipitation scenarios modelled by
the IPCC on the future burden of COPD and Asthma hospitalizations accompanied by a burden
on healthcare systems as a whole. This study contributes to the literature on respiratory-related
hospitalizations by examining the association between predictive climatic variables provided by
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the IPCC and hospitalizations from COPD and asthma exacerbation, as influenced by
socioeconomic and sociodemographic factors.

Specific Aims
The aim of this study is to estimate the future burden of COPD and asthma-related hospital
discharges across the entire city of New York with IPCC predicted temperature and precipitation
measures, as well as predictive factors that are socio-demographic (age) and socio-economic
(race and poverty) in nature. The sub-aims entail looking at similar associations using the
following sub-outcomes: 1) Total charges and 2) Length of stay (LOS) (for inpatient settings
only). The aims will be carried out using Bayesian spatio-temporal modelling to adjust for
spatio-temporal autocorrelation.38

Hypotheses
We hypothesize the number of cases of respiratory-related hospitalizations (primary outcome),
number of total charges (secondary outcome), and length of stay [for inpatient settings only]
(secondary outcome) will increase into the year 2039 across New York City as a whole, given
the IPCC predicted temperature and precipitation values, as well as the socio-economic and
socio-demographic predictive covariates.

4.2 Methods
Data
This study combines health and spatial data from a variety of sources. The outcomes of interest –
hospital discharges related to COPD and asthma exacerbation episodes (primary), length of stay
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(inpatient medical setting) and total charges per visit – are provided by the New York State
(NYS) Statewide Planning and Research Cooperative System (SPARCS) as described in chapter
2.

COPD and/or Asthma Exacerbation
The primary outcome of interest was obtained from NYS SPARCS, which was measured by an
International Classification of Diseases 10th Revision Codes (ICD-10CM)39,40 pertaining to
either a COPD exacerbation:
J44.1 for “Chronic obstructive pulmonary disease with acute exacerbation, unspecified,”
Or an asthma exacerbation:
J45.21 for “Mild intermittent asthma with [acute] exacerbation,”
J45.31 for “Mild persistent asthma with [acute] exacerbation,”
J45.41 for “Moderate persistent asthma with [acute] exacerbation,”
J45.51 for “Severe persistent asthma with [acute] exacerbation,”
J45.901 for “Unspecified asthma with [acute] exacerbation.”
The secondary outcomes of interest were total charges in United States Dollars (USD) and length
of stay (LOS) (inpatient medical setting only) in days, for each respiratory exacerbation episode.
Data on the secondary outcomes were also made available by NYS SPARCS.

Type of Diagnosis Code
For this study, ‘Admitting Diagnosis (AD)’ was used for the inpatient dataset and ‘Reason for
Visit (RV)’ was used for the outpatient dataset.
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Socioeconomic and sociodemographic Variables
The American Community Survey (ACS) is a cross-sectional sample which provides single-year
poverty estimates for geographies with populations of 65,000 or greater and estimates for fiveyear periods at all geographies.41 For this study, the Census Bureau’s ‘American Community
Survey’ (ACS) 5-year estimates for 2014 through 2018 was used to obtain NYC-wide estimates
on the following community-level co-variates:
Age, measured as percentage of the population ‘under 20 years old’ for the asthma
diagnoses as asthma is more prevalent in the young42 or percentage of the
population ‘over 64 years old’ for the COPD diagnoses as COPD is more
prevalent among the elderly.43
Race, measured as percentage of the population being black (non-Hispanic Latino or
Hispanic Latino)
Poverty, measured as percentage of the population below poverty level (out of population
for whom poverty status is determined)

Climatic Variables
The IPCC provides projections for temperature and precipitation in three 30-year time periods
(2010-2039, 2040-2069, 2070-2099) relative to baseline levels from 1961 through 1990.37
Climate projections are based on special emissions scenarios that seek specifically to exclude the
effects of climate change and climate policies on society and the economy (“nonintervention”).36 The scenario with which our predictions are based upon include the second
scenario (B2), which defines emissions through economic, social and environmental
sustainability. In this emissions scenario, an emphasis is placed on community initiative and

124

social innovation to find local as opposed to global solutions. Furthermore, the IPCC employed
seven different coupled atmosphere-ocean general circulation models (AOGCMs) models to
provide future climate projections. For this study we chose the temperature and precipitation
predictions provided using the GFDL-R30 which employs flux adjustment and eliminates
background noise from unrealistic sea surface temperatures.37

Our research focused on climate projections modelled until the end of the first 30-year time
period 2039, as we expect the total population of NYC to increase substantially from now into
the future. IPCC projections were made available on a seasonal basis (December through
February, March through May, June through August, and September through November) with
climate predictions through the year 2039. IPCC projected temperature and precipitation
increases were measured in:
Temperature: maximum temperature in degrees Celsius
Precipitation: total precipitation in centimeters
IPCC temperature increase projections to 2039 ranged from 1.1 to 3.7 degrees Celsius; IPCC
precipitation increase projections to 2039 ranged from -17.4 to 5.9 cm.37

A table presenting all four primary outcomes, six secondary outcomes, and potential predictor
variables by type (Socio-demographic, socio-economic and Meteorological) is described in
Table 4.1.

Primary Response variables

Asthma exacerbation – inpatient cases*
Asthma exacerbation – outpatient cases*
COPD exacerbation – inpatient cases*

125

COPD exacerbation – outpatient cases*
Secondary Response variables

Asthma exacerbation – inpatient length of stay (LOS) (in days)*
Asthma exacerbation – inpatient total charges (in United States Dollars
[USD])*
Asthma exacerbation – outpatient total charges (in USD)*
COPD exacerbation – inpatient length of stay (LOS) (in days)*
COPD exacerbation – inpatient total charges (in USD)*
COPD exacerbation – outpatient total charges (in USD)*

Socio-demographic and socioeconomic predictor variables
Offset – primary outcomes

2014 5-year ACS** community estimates

% under 20 years old

Percent of the population age under 20 years (Asthma outcomes only)

% over 64 years old

Percent of the population age over 64 years (COPD outcomes only)

% black alone

Percent of total population that is Black or African American alone,
regardless of ethnicity

% poverty

Percent of total population who live in poverty

Climate predictor variables

2010 - 2039 IPCC projections***

Maximum temperature increase

Seasonal maximum temperature increase in degrees Celsius (°C)

Maximum precipitation increase

Seasonal maximum precipitation increase in centimeters (cm)

Total population**

Table 4.1: Table presenting all four primary outcomes, six secondary outcomes, and potential predictor variables by type (Sociodemographic, socio-economic and Meteorological).

*NYS DOH SPARCS, **American Community Survey, ***Intergovernmental Panel on Climate Change

Assessing the presence of Multicollinearity among the Covariates
Multicollinearity represents a high degree of linear intercorrelation between explanatory
variables in a multiple regression model and leads to incorrect results of regression analyses.44
We assessed for multicollinearity using the ‘ggscatter’ function within R to determine if any two
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potential predictor variables were highly correlated with one another, and if one of the two
should be removed from our final model.

Bayesian Spatio-Temporal Modelling using Poisson and Gaussian distributions
Poisson distributions were used to model our primary outcomes, whereas Gaussian distributions
were used to model our secondary outcomes. However, traditional regression models are unable
to model data that are spatio-temporally autocorrelated. Spatio-temporal autocorrelation can lead
to case observations from geographically close areal units and temporally close time periods to
have more similar values than units and time periods that are further apart.38 A few of the
covariates within our final datasets were spatially and temporally misaligned with the hospital
discharge data as hospital discharge information and ACS data were made available at the level
of the ZCTA from different time periods, 2016 – 2018 and 2014 – 2018, respectively. In
addition, IPCC climate projections were modelled for the years 2010 – 2039 and cover the
eastern North American region of the world. The IPCC projected estimates are further modelled
to occur randomly in nature.45

A Bayesian inferential approach is taken to model these data, where the spatio-temporal
autocorrelation is modelled via sets of autocorrelated random effects using the conditional
autoregressive (CAR) method proposed by Leroux et al.46 In this method38, each set of random
effects is mean-centered and can be written as either:
Ykt ~ Poisson(μkt 𝑛𝑘𝑡 )
T
ln(μkt 𝑛𝑘𝑡 ) = βxkt
+ ψkt + ln(𝑛𝑘𝑡 )

(1)

or
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Ykt ~ N(μkt , 𝑣 2 )
T
g(μkt ) = βxkt
+ ψkt

(2)

where in equation (1), μkt is the expected risk of an individual living in ZCTA k and discharge
month t, is multiplied by nkt, the offset population at-risk, of the observed respiratory case count
Ykt. Xkt are explanatory space–time covariates associated with the mean process with β
coefficients and ψkt is a set of spatio-temporally autocorrelated random effects for ZCTA k and
discharge month t. Equation (2) presents the gaussian likelihood model with an identity link
function. The additional scale parameter v2 is the observation variance. The scale parameter v2
for the Gaussian likelihood is assigned a conjugate inverse gamma prior distribution, where the
default specification is v2 ∼ Inverse-Gamma(0.001, 0.001).47 The expected values of the
responses are related to the linear predictor via an invertible link function, which in this software
is either the identity (g(.)) (Gaussian family) or the natural log (ln(.)) (Poisson family) function.47

The Bayesian paradigm naturally incorporates our prior belief about the unknown parameter φ,
and updates this belief based on observed data.48 This yields the posterior distribution of φ,
which represents our knowledge about the parameter φ after having observed the data X.48 The
proposed model represents the spatio-temporal structure with a multivariate first order
autoregressive process (which predicts future behavior from near-term past behavior) with a
spatially autocorrelated precision matrix.49 The models are summarized in chapter 3.

Assessing the presence of spatial autocorrelation across our primary and secondary outcomes
A Moran’s I statistic was computed for each discharge month to quantify the presence of spatial
autocorrelation in residuals from our Bayesian spatio-temporal model.50 The process explaining
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how this statistic was computed is described in chapter 3. The null hypothesis for the Moran’s I
test states there is no spatial autocorrelation and the alternative hypothesis states positive spatial
autocorrelation. Therefore, a significant result (p-value < 0.05) indicates spatial autocorrelation is
present within the model.

4.3 Results
Multicollinearity
We found none of the potential predictors were highly correlated, so we were able to include all
into our model.

Asthma Exacerbation Inpatient
Predicted Asthma exacerbation inpatient (AEi) outcomes across New York City, through 2039
The Markov chains appeared to have converged indicating posterior distributions of parameters
are essentially identical. This is the distribution representing our belief about
the parameter values after we have performed our calculations and have taken the observed data
into account.51 The trace-plots of the parameters, suggest convergence as they were stationary
and showed random fluctuations around a single mean level.47 In addition, CARBayesST
presents the convergence diagnostic proposed by Geweke52 for sample parameters, which uses
the geweke.diag() function. This statistic is in the form of a Z-score, and values between (-1.96,
1.96) are suggestive of convergence.52 All covariates had values between (-1.96, 1.96) and can
be seen in Table 4.2.
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Asthma
Inpatient
Cases

Asthma Inpatient
Length of Stay
(in days)

Asthma Inpatient
Total Charges (in
hundred thousands)

Percentage under 20 years old

- 1.4

-0.4

0.7

Percentage identifying as 'Black
(Hispanic and Non-Hispanic)'

0.1

0.3

-0.3

Percentage in Poverty

0.9

1.2

-0.9

Maximum temperature increase

-1.6

1.8

-1.3

Maximum precipitation increase

-0.6

1.4

-1.4

Socio-demographic/Socioeconomic Variables

IPCC Climate Variables

Table 4.2: Table showing statistics in the form of a Z-score for Geweke diagnostic function determining convergence of all
covariates across Asthma Inpatient outcomes.

Values between (-1.96, 1.96) are suggestive of convergence.

Effects of covariates on AEi primary and secondary outcomes across NYC
Tables 4.3 and 4.4 summarize the Bayesian models which evaluates the spatio-temporal random
effects on the case counts, length of stay (LOS) and total charges across NYC into the year 2039.
Case counts were modelled using Poisson regression, whereas Gaussian regression was used to
model LOS and total charges. The covariates exhibited substantial effects on LOS and total
charges except for age (across LOS and total charges), race (across LOS and total charges),
temperature (across total charges only) and precipitation (across total charges only) as their 95%
credible intervals did not include zero.(Table 4.4)

The estimated Moran’s I statistics and p-value obtained from the residuals of this model for AEi
cases, length of stay and total charges was 0.006 (0.38), 0.18 (7.999e-4) and 0.14 (4.3e-3),
respectively. The p-value for all Moran’s I statistics was only greater than 0.05 for AEi cases and
suggested no evidence of unexplained spatial autocorrelation after accounting for the covariate
effects.(Table 4.3) However, because the p-value for the Moran’s I statistic in the LOS and total
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charges models were both less than 0.05, this suggests these models were not properly
fitted.(Table 4.4) The spatial random effect was not enough to adjust for unidentified covariates;
therefore, the significance of any potential predictor covariates cannot be verified.

Asthma Inpatient Indicator
Fixed Effects
Intercept †
Socio-demographic/socioeconomic Variables
10% increase in population
under 20 years old
10% increase in population
identifying as 'Black
(Hispanic and NonHispanic)'
2% increase in population
under Poverty
IPCC Climate Variables
1-degree Celsius increase in
total temperature
2 cm total increase in
precipitation
Spatio-temporal random
effects variances †
Spatial and Temporal
Dependence †
Spatial dependence (ρS)
Temporal dependence (ρT)
Moran I test (statistic, pvalue)
DIC
MCMC Chain 1
MCMC Chain 2
MCMC Chain 3

Asthma Inpatient
Cases
(RR, 95% CI)
-12.4 (-12.78, -12)

1.55 (1.28, 1.84)

1.14 (1.1, 1.2)

1.17 (1.14, 1.2)

0.98 (0.97, 0.99)
1.01 (0.99, 1.04)
2.14 (1.95, 2.35)

0.1 (0.07, 0.13)
0.58 (0.55, 0.61)
0.006 (0.38)
24773
24736
24733

Table 4.3: Predicted asthma exacerbation inpatient discharges across New York City, modelled through 2039. A summary of the
parameter estimates from the Bayesian spatio-temporal model with Poisson regression.

The estimated covariate effects are relative risks (RR) and their 95% confidence interval associated with a
multiplier of 10, except for ‘population in poverty’ and ‘total increase in precipitation’ where a multiplier of 2 was
used and for ‘maximum temperature increase’ where a multiplier was not added. Note: †Coefficient on log scale,
DIC: deviation information criteria.
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Asthma Inpatient Indicator
Fixed Effects
Intercept
Socio-demographic/socioeconomic Variables†
10% increase in population
under 20 years old
10% increase in population
identifying as 'Black
(Hispanic and NonHispanic)'
2% increase in population
under Poverty
IPCC Climate Variables†
1-degree Celsius increase in
total temperature
2 cm total increase in
precipitation
Spatio-temporal random
effects variances
Spatial and Temporal
Dependence
Spatial dependence (ρS)
Temporal dependence (ρT)
Moran I test (statistic, pvalue)
DIC
MCMC Chain 1
MCMC Chain 2
MCMC Chain 3

Asthma Inpatient
Length of Stay
(in days)
(Coef, 95% CrI)

Asthma Inpatient
Total Charges (in
hundred thousands)
(Coef, 95% CrI)

-7.28 (-7.87, -6.65)

-0.52 (-1.67, 0.76)

3.57 (-1.12, 8.05)

0.3 (-0.3, 0.9)

0.54 (-0.44, 1.47)

0.01 (-0.1, 0.1)

1.85 (1.32, 2.4)

0.16 (0.09, 0.23)

-0.22 (-0.4, -0.04)

-0.01 (-0.04, 0.01)

0.27 (-0.47, 0.96)

0.02 (-0.1, 0.14)

1.36 (-2.36 4.82)

0.17 (0.11, 0.27)

0.11(0.008, 0.37)
0.998 (0.99, 1)

0.03 (0.001, 0.19)
0.998 (0.99, 1)

0.18 (7.999e-4)

0.14 (4.3e-3)

73191
73070
73085

47113
47057
47057

Table 4.4: Predicted asthma exacerbation outpatient length of hospital stay and total charges per hospital stay across New York
City, modelled through 2039. A summary of the parameter estimates from the Bayesian spatio-temporal model with Gaussian
regression.

The estimated covariate effects are posterior medians and 95% credible intervals associated with a multiplier of 10,
except for ‘population in poverty’ and ‘total precipitation increase’ where a multiplier of 2 was used, and for
‘maximum temperature increase’ where a multiplier was not added. Note: CrI: credible interval, DIC: deviation
information criteria, italicized values indicate covariates whose 95% CrI include zero and therefore do not exhibit
substantial effects on the response.

Effects of covariates on Predicted AEi cases
Regarding socio-demographic and socio-economic variables, the results (Table 4.3) showed that
the posterior median and 95% credible interval for the relative risk of a 10% increase in the
percentage of the NYC population under 20 years old into the year 2039 was 1.55 (1.28, 1.84)
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and a 10% increase in the percentage of the population that is Black (Hispanic and non-Hispanic)
was 1.14 (1.1, 1.2), indicating that an increase of this magnitude corresponds to an increase in
the episodes of AEi into the year 2039 by 55% and 14%, respectively. In addition, the posterior
median and 95% credible interval for the relative risk of only a 2% increase in the percentage of
the NYC population that is in poverty into the year 2039 was 1.17 (1.14, 1.2) indicating that an
increase of this magnitude corresponds to an increase in the episodes of AEi into 2039 by 17%.
Regarding IPCC predicted meteorological variables, the results showed that the posterior median
and 95% credible interval for the relative risk of a 1-degree Celsius increase in the maximum
temperature across NYC into the year 2039 was 0.98 (0.97, 0.99), indicating that an increase of
this magnitude corresponds to a decrease in the episodes of AEi into 2039 by 2%. However, the
posterior median and 95% credible interval for the relative risk of a 2 cm increase in total
precipitation across NYC into the year 2039 was 1.01 (0.99, 1.04), indicating that an increase of
this magnitude corresponds to an increase in the episodes of AEi into 2039 by 1%.

Asthma Exacerbation Outpatient
Predicted Asthma exacerbation inpatient (AEo) outcomes across New York City, through 2039
The Markov chains appeared to have converged indicating posterior distributions of parameters
are essentially identical. Despite the Geweke convergence diagnostic inadvertently suggesting
there was a lack of convergence for percentage in poverty, it did determine convergence for the
rest of the covariates with values inside (-1.96, 1.96).(Table 4.5) We were further able to
visualize the presence of convergence among the covariates through trace-plot visualization of
the parameters as they were stationary and showed random fluctuations around a single mean
level.47
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Asthma
Outpatient
Cases

Asthma Outpatient
Total Charges (in
hundred thousands)

Percentage under 20 years old

- 1.4

1.7

Percentage identifying as 'Black
(Hispanic and Non-Hispanic)'

-1.2

0.4

Percentage in Poverty

-1.7

-2.5

Maximum temperature increase

0.2

0.0

Maximum precipitation increase

-0.5

-0.7

Socio-demographic/Socioeconomic Variables

IPCC Climate Variables

Table 4.5: Table showing statistics in the form of a Z-score for Geweke diagnostic function determining convergence of all
covariates across Asthma Outpatient outcomes.

Values between (-1.96, 1.96) are suggestive of convergence.

Effects of covariates on AEo primary and secondary outcomes across NYC
Tables 4.6 and 4.7 summarize the Bayesian models which evaluates the spatio-temporal random
effects on the case counts, length of stay (LOS) and total charges across NYC into the year 2039.
Case counts were modelled using Poisson regression, whereas Gaussian regression was used to
model total charges. The covariates for total charges exhibited substantial effects on each
outcome variable except for age and total precipitation increase, as their 95% credible intervals
did not include zero.(Table 4.7)

The estimated Moran’s I statistics and p-value obtained from the residuals of this model for AEo
cases and total charges was -0.13 (0.996) and 0.16 (0.004), respectively. The p-value for Moran’s
I statistics within the AEo case counts outcome was greater than 0.05 and suggested no evidence
of unexplained spatial autocorrelation after accounting for the covariate effects. This indicates
this model was properly fitted and was able to adjust for spatial autocorrelation.(Table 4.6)
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However, the model for the AEo total charges outcome may not have been properly fitted.(Table
4.7) The spatial random effect was not enough to adjust for unidentified covariates.

Asthma Outpatient
Indicator
Fixed Effects
Intercept†
Socio-demographic/socioeconomic Variables
10% increase in population
under 20 years old
10% increase in population
identifying as 'Black
(Hispanic and NonHispanic)'
2% increase in population
under Poverty
IPCC Climate Variables
1-degree Celsius increase in
total temperature
2 cm total increase in
precipitation
Spatio-temporal random
effects variances†
Spatial and Temporal
Dependence†
Spatial dependence (ρS)
Temporal dependence (ρT)
Moran I test (statistic, pvalue)
DIC

Asthma
Outpatient Cases
(RR, 95% CI)
-9.32 (-9.65, -8.89)

0.94 (0.79, 1.09)

1.28 (1.24, 1.32)

1.17 (1.14, 1.19)

0.99 (0.98, 1)
1.01 (0.98, 1.03)
1.51 (1.39, 1.63)

0.39 (0.33, 0.45)
0.53 (0.5, 0.56)
-0.13 (0.996)
41348

Table 4.6: Predicted asthma exacerbation outpatient discharges across New York City, modelled through 2039. A summary of
the parameter estimates from the Bayesian spatio-temporal model with Poisson regression.

The estimated covariate effects are relative risks (RR) and their 95% confidence interval associated with a
multiplier of 10, except for ‘population in poverty’ and ‘total increase in precipitation’ where a multiplier of 2 was
used and for ‘maximum temperature increase’ where a multiplier was not added. Note: †Coefficient on log scale,
DIC: deviation information criteria.

Asthma Outpatient
Indicator
Fixed Effects
Intercept
Socio-demographic/socioeconomic Variables†

Asthma Outpatient
Total Charges (in
hundred thousands)
(Coef, 95% CrI)
-1.7 (-2.53, -0.88)
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10% increase in population
under 20 years old
10% increase in population
identifying as 'Black
(Hispanic and NonHispanic)'
2% increase in population
under Poverty
IPCC Climate Variables†
1-degree Celsius increase in
total temperature
2 cm total increase in
precipitation
Spatio-temporal random
effects variances
Spatial and Temporal
Dependence
Spatial dependence (ρS)
Temporal dependence (ρT)
Moran I test (statistic, pvalue)
DIC

0.29 (-0.11, 0.68)

0.39 (0.29, 0.48)

0.26 (0.21, 0.32)

-0.02 (-0.03, -0.001)
-0.003 (-0.6, 0.05)
1.39 (1.21, 1.59)

3.52 (3.36, 3.68)
0.84 (0.77, 0.89)
0.16 (0.004)
28333

Table 4.7: Predicted asthma exacerbation outpatient total charges per hospital stay across New York City, modelled through
2039. A summary of the parameter estimates from the Bayesian spatio-temporal model with Gaussian regression.

The estimated covariate effects are posterior medians and 95% credible intervals associated with a multiplier of 10,
except for ‘population in poverty’ and ‘total increase in precipitation’ where a multiplier of 2 was used, and for
‘maximum temperature increase’ where a multiplier was not added. Note: CrI: credible interval, DIC: deviation
information criteria, †Coefficient on antilog scale, italicized values indicate covariates whose 95% CrI include zero
and therefore do not exhibit substantial effects on the response.

Effects of covariates on Predicted AEo cases
Regarding socio-demographic and socio-economic variables, the results (Table 4.6) showed that
the posterior median and 95% credible interval for the relative risk of a 10% increase in the
percentage of the NYC population under 20 years old into the year 2039 was 0.94 (0.79, 1.09),
indicating that an increase of this magnitude corresponds to a decrease in the episodes of AEo
into 2039 by 6%. In addition, the posterior median and 95% credible interval for the relative risk
of a 10% increase in the percentage of the NYC population that is Black (Hispanic and nonHispanic) into the year 2039 was 1.28 (1.24, 1.32), indicating that an increase of this magnitude
corresponds to an increase in the episodes of AEo into 2039 by 28%. Furthermore, the posterior
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median and 95% credible interval for the relative risk of only a 2% increase in the percentage of
the NYC population that is in poverty into the year 2039 was 1.17 (1.14, 1.19) indicating that an
increase of this magnitude corresponds to an increase in the episodes of AEo into 2039 by 17%.
Regarding IPCC predicted meteorological variables, the results showed that the posterior median
and 95% credible interval for the relative risk of a 1-degree Celsius increase in the maximum
temperature across NYC into the year 2039 was 0.99 (0.98, 1.0), indicating that an increase of
this magnitude corresponds to a decrease in the episodes of AEo into 2039 by 1%. However, the
posterior median and 95% credible interval for the relative risk of a 2 cm increase in total
precipitation across NYC into the year 2039 was 1.01 (0.98, 1.03), indicating that an increase of
this magnitude corresponds to an increase the episodes of AEo into 2039 by 1%.

COPD Exacerbation Inpatient
Predicted COPD exacerbation inpatient (CEi) outcomes across New York City, through 2039
The Markov chains appeared to have converged indicating posterior distributions of parameters
are essentially identical. Despite the Geweke convergence diagnostic inadvertently suggesting
there was a lack of convergence for age in the LOS outcome, it did confirm convergence for the
rest of the covariates with a value inside (-1.96, 1.96).(Table 4.8) We were further able to
visualize the presence of convergence among the covariates through trace-plot visualization of
the parameters as they were stationary and showed random fluctuations around a single mean
level.47
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COPD
Inpatient
Cases

COPD Inpatient
Length of Stay
(in days)

COPD Inpatient
Total Charges (in
hundred thousands)

Percentage over 64 years old

-1.7

-0.6

1.3

Percentage identifying as 'Black
(Hispanic and Non-Hispanic)'

-1.3

-1.5

-1.2

Percentage in Poverty

-0.6

0.9

-0.1

Maximum temperature increase

0.0

0.2

-0.4

Maximum precipitation increase

-0.3

-0.2

0.2

Socio-demographic/Socioeconomic Variables

IPCC Climate Variables

Table 4.8: Table showing statistics in the form of a Z-score for Geweke diagnostic function determining convergence of all
covariates across COPD Inpatient outcomes.

Values between (-1.96, 1.96) are suggestive of convergence.

Effects of covariates on CEi primary and secondary outcomes across NYC
Tables 4.9 and 4.10 summarize the Bayesian models which evaluates the spatio-temporal random
effects on the case counts, length of stay (LOS) and total charges across NYC into the year 2039.
Case counts were modelled using Poisson regression, whereas Gaussian regression was used to
model LOS and total charges. The covariates for LOS and total charges exhibited substantial
effects on each outcome variable except for race (across LOS and total charges) and total
temperature increase (across total charges only), as their 95% credible intervals did not include
zero.(Table 4.10)

The estimated Moran’s I statistics and p-value obtained from the residuals of this model for AEi
cases, length of stay and total charges was 0.006 (0.38), -0.08 (0.99), and -0.04 (0.83),
respectively. The p-value for all Moran’s I statistics were greater than 0.05 and suggested no
evidence of unexplained spatial autocorrelation after accounting for the covariate effects. This
indicates the models were properly fitted and were able to adjust for spatial autocorrelation.
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COPD Inpatient Indicator

COPD Inpatient
Cases
(RR, 95% CI)

Fixed Effects
Intercept†
Socio-demographic/socioeconomic Variables
10% increase in population
over 64 years old
10% increase in population
identifying as 'Black
(Hispanic and NonHispanic)'
2% increase in population
under Poverty
IPCC Climate Variables
1-degree Celsius increase in
total temperature
2 cm total increase in
precipitation
Spatio-temporal random
effects variances†
Spatial and Temporal
Dependence†
Spatial dependence (ρS)
Temporal dependence (ρT)
Moran I test (statistic, pvalue)
DIC
MCMC Chain 1
MCMC Chain 2
MCMC Chain 3

-10.56 (-10.81,
-10.3)

1.41 (1.27, 1.55)

1.03 (1.0, 1.05)

1.06 (1.05, 1.08)

0.99 (0.98, 1.0)
1.01 (0.99, 1.03)
1.21 (1.11, 1.32)

0.37 (0.32, 0.43)
0.45 (0.41, 0.5)
-0.07 (0.9)
27458
27459
27466

Table 4.9: Predicted COPD exacerbation inpatient discharges across New York City, modelled through 2039. A summary of the
parameter estimates from the Bayesian spatio-temporal model with Poisson regression.

The estimated covariate effects are relative risks (RR) and their 95% confidence interval associated with a
multiplier of 10, except for ‘population in poverty’ and ‘total increase in precipitation’ where a multiplier of 2 was
used and for ‘maximum temperature increase’ where a multiplier was not added. Note: †Coefficient on log scale,
DIC: deviation information criteria.

COPD Inpatient Indicator
Fixed Effects
Intercept
Socio-demographic/socioeconomic Variables

COPD Inpatient
Length of Stay
(in days)
(Coef, 95% CrI)

COPD Inpatient
Total Charges (in hundred
thousands)
(Coef, 95% CrI)

-6.48 (-6.95, -5.97)

-1.81 (-3.99, 0.23)
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10% increase in population
over 64 years old
10% increase in population
identifying as 'Black
(Hispanic and NonHispanic)'
2% increase in population
under Poverty
IPCC Climate Variables
1-degree Celsius increase in
total temperature
2 cm total increase in
precipitation
Spatio-temporal random
effects variances
Spatial and Temporal
Dependence
Spatial dependence (ρS)
Temporal dependence (ρT)
Moran I test (statistic, pvalue)
DIC
MCMC Chain 1
MCMC Chain 2
MCMC Chain 3

19.64 (9.88, 28.19)

2.07 (1.13, 3.07)

0.55 (-1.58, 2.41)

-0.01 (-0.21, 0.2)

3.25 (2.1, 4.35)

0.23 (0.12, 0.34)

-0.38 (-0.67, -0.11)

-0.01 (-0.05, 0.03)

1.14 (0.02, 2.29)

0.2 (0.03, 0.35)

275.55 (177.05,
432.88)

0.57 (0.36, 0.97)

0.51 (0.29, 0.73)
0.96 (0.93, 0.98)

0.08 (0.003, 0.37)
0.996 (0.98, 1.0)

-0.08 (0.99)

-0.04 (0.83)

77794
77796
77793

53170
53168
53165

Table 4.10: Predicted COPD exacerbation inpatient length of hospital stay and total charges per hospital stay across New York
City, modelled through 2039. A summary of the parameter estimates from the Bayesian spatio-temporal model with Gaussian
regression.

The estimated covariate effects are posterior medians and 95% credible intervals associated with a multiplier of 10,
except for ‘population in poverty’ and ‘total increase in precipitation’ where a multiplier of 2 was used, and for
‘maximum temperature increase’ where a multiplier was not added. Note: CrI: credible interval, DIC: deviation
information criteria, italicized values indicate covariates whose 95% CrI include zero and therefore do not exhibit
substantial effects on the response.

Effects of covariates on Predicted CEi cases
Regarding socio-demographic and socio-economic variables, the results (Table 4.9) showed that
the posterior median and 95% credible interval for the relative risk of a 10% increase in the
percentage of the NYC population over 64 years old into the year 2039 was 1.41 (1.27, 1.55) and
a 10% increase in the percentage of the NYC population that is Black (Hispanic and nonHispanic) was 1.03 (1.0, 1.05), indicating that an increase of this magnitude corresponds to an
increase in the episodes of CEi into 2039 by 41% and 3%, respectively. In addition, the posterior
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median and 95% credible interval for the relative risk of only a 2% increase in the percentage of
the population that is in poverty within NYC into the year 2039 was 1.06 (1.05, 1.08) indicating
that an increase of this magnitude corresponds to an increase in the episodes of CEi into 2039 by
6%. Regarding IPCC predicted meteorological variables, the results showed that the posterior
median and 95% credible interval for the relative risk of a 1-degree Celsius increase in the
maximum temperature across NYC into the year 2039 was 0.99 (0.98, 1.0), indicating that an
increase of this magnitude corresponds to a decrease in the episodes of CEi into 2039 by 1%.
However, the posterior median and 95% credible interval for the relative risk of a 2 cm increase
in total precipitation across NYC into the year 2039 was 1.01 (0.99, 1.03), indicating that an
increase of this magnitude corresponds to an increase in the episodes of CEi into 2039 by 1%.

Effects of covariates on Predicted CEi hospital length of stay (LOS)
The results in Table 4.10 showed that the beta coefficient estimate and 95% credible interval for
a 10% increase in the percentage of the NYC population that is over 64 years old into the year
2039 was 19.64 (9.88, 28.19), indicating an increase of this magnitude corresponds to an
increase in the hospital LOS associated with CEi by 19.64 days. In addition, the beta coefficient
estimate and 95% credible interval for only a 2% increase in the NYC population that is in
poverty was 3.25 (2.1, 4.35), indicating that an increase of this magnitude corresponds to an
increase in the hospital LOS associated with CEi into 2039 by 3.25 days. Regarding IPCC
predicted meteorological variables, the results showed that the beta coefficient estimate and 95%
credible interval of a 1-degree Celsius increase in the maximum temperature across NYC into
2039 was -0.38 (-0.67, -0.11), indicating that an increase of this magnitude corresponds to a
decrease in the hospital LOS associated with CEi by 0.38 days. However, the beta coefficient
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estimate and 95% credible interval of a 2 cm increase in total precipitation across NYC into 2039
was 1.1 (0.02, 2.29), indicating that an increase of this magnitude corresponds to an increase in
the hospital LOS associated with CEi by 1.1 days.

Effects of covariates on Predicted CEi total hospital charges
The results in Table 4.10 also showed that the beta coefficient estimate and 95% credible interval
for a 10% increase in the percentage of the NYC population that is over 64 years old into 2039
was 2.07 (1.13, 3.07) per hundred thousand, indicating that an increase of this magnitude
corresponds to an increase in the total hospital charges associated with CEi by $207,000. In
addition, the beta coefficient estimate and 95% credible interval for only a 2% increase in the
percentage of the NYC population that is in poverty was 0.23 (0.12, 0.34) per hundred thousand,
indicating that an increase of this magnitude corresponded to an increase in total hospital charges
associated with CEi into 2039 by $23,000. Regarding IPCC predicted meteorological variables,
the results showed that the beta coefficient estimate and 95% credible interval for a 2 cm
increase in maximum precipitation across NYC into 2039 was 0.2 (0.03, 0.35) per hundred
thousand, indicating that an increase of this magnitude corresponded to an increase in total
hospital charges associated with CEi into 2039 by $20,000.

COPD Exacerbation Outpatient
Predicted COPD exacerbation outpatient (CEo) outcomes across New York City, through 2039
The Markov chains appeared to have converged indicating posterior distributions of parameters
are essentially identical. Despite the Geweke convergence diagnostic inadvertently suggesting
there was a lack of convergence for age, poverty and precipitation in CEo cases outcome, it did
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determine convergence for the rest of the covariates with a value inside (-1.96, 1.96).(Table 4.11)
We were further able to visualize the presence of convergence among all of the covariates
through trace-plot visualization of the parameters as they were stationary and showed random
fluctuations around a single mean level.47
COPD
Outpatient
Cases

COPD Outpatient
Total Charges (in
hundred thousands)

Percentage over 64 years old

-2.0

-1.2

Percentage identifying as 'Black
(Hispanic and Non-Hispanic)'

-1.5

0.3

Percentage in Poverty

-4.0

1.1

Maximum temperature increase

-1.9

0.6

Maximum precipitation increase

-3.1

-0.5

Socio-demographic/Socioeconomic Variables

IPCC Climate Variables

Table 4.11: Table showing statistics in the form of a Z-score for Geweke diagnostic function determining convergence of all
covariates across COPD outpatient outcomes.

Values between (-1.96, 1.96) are suggestive of convergence.

Effects of covariates on CEo primary and secondary outcomes across NYC
Tables 4.12 and 4.13 summarize the Bayesian models which evaluates the spatio-temporal
random effects on the case counts and total charges across NYC into the year 2039. Case counts
were modelled using Poisson regression, whereas Gaussian regression was used to model total
charges. The covariates exhibited substantial effects on the outcome of total charges except for
age, total temperature increase and total precipitation increase, as their 95% credible intervals did
not include zero.(Table 4.13)

The estimated Moran’s I statistics and p-value obtained from the residuals of this model for CEo
cases and total charges was 0.03 (0.2) and -0.02 (0.7), respectively. The p-value for all Moran’s I
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statistics were greater than 0.05 and suggested no evidence of unexplained spatial autocorrelation
after accounting for the covariate effects. This indicates these models were properly fitted and
were able to adjust for spatial autocorrelation.

COPD Outpatient Indicator
Fixed Effects
Intercept†
Socio-demographic/socioeconomic Variables
10% increase in population
over 64 years old
10% increase in population
identifying as 'Black
(Hispanic and NonHispanic)'
2% increase in population
under Poverty
IPCC Climate Variables
1-degree Celsius increase in
total temperature
2 cm total increase in
precipitation
Spatio-temporal random
effects variances†
Spatial and Temporal
Dependence†
Spatial dependence (ρS)
Temporal dependence (ρT)
Moran I test (statistic, pvalue)
DIC

COPD Outpatient Cases
(Coef, 95% CrI)

-11.34 (-11.91, -9.99)

1.77 (1.29, 2.47)

1.38 (1.21, 1.48)

1.01 (0.96, 1.04)

0.98 (0.975, 0.99)
1.01 (0.96, 1.04)
3.47 (3.2, 3.82)

0.16 (0.13, 0.21)
0.65 (0.62, 0.67)
0.03 (0.2)
40510

Table 4.12: Predicted COPD exacerbation outpatient discharges across New York City, modelled through 2039. A summary of
the parameter estimates from the Bayesian spatio-temporal model with Poisson regression.

The estimated covariate effects are relative risks (RR) and their 95% confidence interval associated with a
multiplier of 10, except for ‘population in poverty’ and ‘total increase in precipitation’ where a multiplier of 2 was
used and for ‘maximum temperature increase’ where a multiplier was not added. Note: †Coefficient on log scale,
DIC: deviation information criteria.

COPD Outpatient Indicator

COPD Outpatient
Total Charges (in hundred
thousands) (Coef, 95% CrI)

Fixed Effects
Intercept

-0.34 (-1.23, 0.48)
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Socio-demographic/socioeconomic Variables†
10% increase in population
over 64 years old
10% increase in population
identifying as 'Black
(Hispanic and NonHispanic)'
2% increase in population
under Poverty
IPCC Climate Variables†
1-degree Celsius increase in
total temperature
2 cm total increase in
precipitation
Spatio-temporal random
effects variances
Spatial and Temporal
Dependence
Spatial dependence (ρS)
Temporal dependence (ρT)
Moran I test (statistic, pvalue)
DIC

0.05 (-0.26, 0.36)

0.13 (0.05, 0.2)

0.09 (0.05, 0.12)

-0.002 (-0.03, 0.03)
0.01 (-0.07, 0.1)
0.33 (0.27, 0.4)

0.99 (0.985, 0.994)
0.997 (0.989, 1)
-0.02 (0.7)
30208

Table 4.13: Predicted COPD exacerbation outpatient total charges per hospital stay across New York City, modelled through
2039. A summary of the parameter estimates from the Bayesian spatio-temporal model with Gaussian regression.

The estimated covariate effects are posterior medians and 95% credible intervals associated with a multiplier of 10,
except for ‘population in poverty’ and ‘total increase in precipitation’ where a multiplier of 2 was used, and for
‘maximum temperature increase’ where a multiplier was not added. Note: CrI: credible interval, DIC: deviation
information criteria, italicized values indicate covariates whose 95% CrI include zero and therefore do not exhibit
substantial effects on the response.

Effects of covariates on Predicted CEo cases
Regarding socio-demographic and socio-economic variables, the results (Table 4.9) showed that
the posterior median and 95% credible interval for the relative risk of a 10% increase in the
percentage of the population over 64 years old within NYC was 1.77 (1.29, 2.47) and a 10%
increase in the percentage of the population that is Black (Hispanic and non-Hispanic) was 1.38
(1.21, 1.48), indicating that an increase of this magnitude corresponds to an increase in the
episodes of CEo by 77% and 38%, respectively. In addition, the posterior median and 95%
credible interval for the relative risk of only a 2% increase in the percentage of the population
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that is in poverty within NYC was 1.01(0.96, 1.04) indicating that an increase of this magnitude
corresponds to an increase in the episodes of CEo by 1%. Regarding IPCC predicted
meteorological variables, the results showed that the posterior median and 95% credible interval
for the relative risk of a 1-degree Celsius increase in the maximum temperature across NYC was
0.98 (0.975, 0.99), indicating that an increase of this magnitude corresponds to a decrease in the
episodes of CEo by 2%. However, the posterior median and 95% credible interval for the relative
risk of a 2 cm increase in the total precipitation across NYC was 1.01 (0.96, 1.04), indicating that
an increase of this magnitude corresponds to an increase in the episodes of CEo by 1%.

Effects of covariates on Predicted CEo total hospital charges
The results in Table 4.13 showed that the beta coefficient estimate and 95% credible interval for
a 10% increase in the percentage of the NYC population that is over 64 years old into 2039 was
0.13 (0.05, 0.2) per hundred thousand, indicating that an increase of this magnitude corresponds
to an increase in the total hospital charges associated with CEo into 2039 by $13,000. In
addition, the beta coefficient estimate and 95% credible interval for only a 2% increase in the
percentage of the NYC population that is in poverty was 0.09 (0.05, 0.12) per hundred thousand,
indicating that an increase of this magnitude corresponded to an increase in total hospital charges
associated with CEo into 2039 by $9,000. The 95% credible intervals for the beta coefficient
estimates of the IPCC predicted meteorological variables did not include zero and therefore do
not exhibit substantial effects on the response.
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4.4 Discussion
This study aimed to estimate the future burden of respiratory exacerbation on NYC residents and
the overall healthcare system into the year 2039. When assessing the risk of socioeconomic and
climatic predictive covariates, the estimates indicate an overall increased risk of respiratory
exacerbation from increased precipitation, race (regardless of ethnicity) and poverty status.
When assessing the relationship between hospital LOS within the inpatient setting and predictive
covariates, it was estimated the hospital LOS associated with CEi would increase if there was an
increase in precipitation as well as an increase in populations that were over the age of 64 years
old, black (regardless of ethnicity) and in poverty. When further assessing the relationship
between total hospital charges and predictive covariates, it was estimated the total hospital
charges associated with COPD exacerbation (regardless of medical setting) would increase if
there was an increase in populations that were over the age of 64 years old and in poverty. It was
also estimated there would be an increase in total charges associated with CEI specifically, if
there was an increase in precipitation.

Bayesian Spatio-temporal modelling presented the effects of the predictive socioeconomic and
climatic covariates on the outcome of predicted respiratory exacerbation episodes into the future.
Age (either under 20 years old for asthma exacerbation or over 64 years old for COPD
exacerbation), race (black, regardless of ethnicity) and poverty status were risk factors for
increased asthma and COPD exacerbation episodes within both medical settings into the year
2039.
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These results support the current understanding that asthma is more prevalent among individuals
who are younger and COPD is more prevalent among the elderly: the pathophysiology of these
diseases compromises the respiratory system among the young as their lungs are still
developing42, and among the elderly as they have decreased lung function from long-term
exposures to known irritants such as smoking 43. However, an increase in the population aged 20
years and under appeared to decrease the number of asthma exacerbation cases in the outpatient
setting into 2039. This finding may be explained by occupational exposures, smoking, and
obesity, variables that are all likely to be lower in this age group.53,54

Our findings also showed race and poverty status were increased risk factors for the future
burden of respiratory exacerbation on morbidity. The literature supports these results as studies
assessing respiratory-related hospitalizations within New York City found the highest rates were
predominantly located in neighborhoods with the highest percentage of NYC residents
identifying as non-Hispanic black.28 Racial disparities are an essential component in
understanding the relationship between the future burden of climate variability on respiratory
health outcomes. Not only does Medicare report black beneficiaries present with higher levels of
overall morbidity than their white counterparts, they also report lower levels of office visits and
more inpatient, emergency room, and nursing home visits.55 This may be due to black
beneficiaries having markedly fewer visits to their primary care physicians and specialists, such
as pulmonologists who typically diagnose and manage respiratory disease, as compared to their
white counterparts.55,56
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The IPCC predicted covariates presented risk factors for precipitation increase into the year
2039. Although periods of heavy rainfall have been occasionally found associated with
particulate matter “washout” in the atmosphere, our findings align with the notion suggesting
heavy rain is still an important trigger factor for COPD exacerbation and may be underrecognized.57 This indicates the projected rainfall into 2039 may increase exponentially at an
unsustainable rate tolerated by COPD patients. Several studies have also highlighted elevated
risk of asthma exacerbation following major thunderstorms.21,58-60 Thunderstorm events, or
periods of heavy rainfall and intense wind, are a novel phenomenon believed to trigger the
release of fungal spores and pollen (particularly grass pollen) that are carried by wind, thereby
resulting in increased exposure to these triggers.21,58,59,61 Heavy rainfall events could further alter
the humidity in the environment and contribute to changes in airflow in the respiratory system
that could further exacerbate asthma.60,62,63

IPCC projected temperature increase into 2039 consistently led to a decline in cases of
respiratory exacerbation across all four outcomes, however. Although it does not align with our
original hypotheses that temperature increase may be a risk factor for respiratory exacerbation, it
does support the literature citing colder air may be predictive of respiratory exacerbation instead.
Research has shown asthma exacerbation is largely precipitated by viral infections, especially
with rhinovirus, and it is likely that viruses are also important in increasing airway inflammation
in COPD during the winter.64 Furthermore, inflammatory changes in COPD could contribute to a
persistent decline in lung function without the presence of a symptomatic exacerbation.65 This
may be due to the role of mucous hypersecretion as a potential mediator of the COPD response
to cold temperature.66
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Our results estimate also estimated an increase in the populations over 64 years old, increase in
the population that is black regardless of ethnicity, and an increase in the population that is in
poverty, would all increase the hospital LOS associated with inpatient COPD exacerbation
hospitalizations into 2039. The finding with age may be explained by the nature of the disease
where an individual will not exhibit prominent signs and symptoms of COPD until years after
first exposure (e.g., smoking), despite loss of lung function more accelerated in the early stages
of COPD than in the later stages.67 The socioeconomic findings with race and poverty status
align with the results from our estimates on respiratory exacerbation morbidity. This further
indicates socioeconomic status may present with a heavy burden on the healthcare system within
the future. Climate variability may also present with additional implications as precipitation
increase led to an increase in hospital stay. These findings align with our results examining
respiratory exacerbation on risk of future morbidity, further indicating climate variability may
present with challenges on the healthcare system leading to longer duration of hospitalization.
However, because of residual spatial autocorrelation found within our asthma inpatient (AEi)
dataset, this research cannot conclude that climate variability coupled with socioeconomic status
will adversely affect hospital LOS associated with AEi

Total charges were not properly estimated in our models mostly due to residual spatial
autocorrelation, which is a systematic spatial similarity between nearby observations.68 This is
because the spatial random effect was not enough to adjust for unidentified covariates; therefore,
the significance of any covariates cannot be verified (although their point estimates are still
unbiased). In addition, our models may have been missing covariates that may either act as
confounders or effect modifiers that could also manifest in residual spatial autocorrelation. Our
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findings across COPD-associated total hospital charges showed, however, an increase in the
populations that were over the age of 64 years old and an increase in the populations that were in
poverty would lead to an increase in the total hospital charges. The prevalence of COPD climbs
appreciably higher with age, yet is under-recognized.69 Therefore, elderly patients with COPD
have high morbidity rates associated with hospitalizations leading to a subsequent increase in
cost of care.31 Hospital-associated costs may also be higher for socioeconomically disadvantaged
populations as they lack continuity of care with a primary care physician for prevention of an
exacerbation. Therefore, this population is more likely to receive care in nonoptimal
organizational settings (such as emergency rooms),70 where they may incur higher costs of care.
An increase in precipitation into the year 2039 was also found to increase estimates of total
hospital charges associated with CEi. These results align with our findings indicating
precipitation was a risk factor for morbidity associated with CEi. Increased hospitalizations from
CEi into 2039 are likely to increase total hospital charges as a result.

One of the primary strengths of our study is the application of the hierarchical Bayesian CAR
approach with data from several sources can address unknown sources of bias.71 This model
smooths the respiratory exacerbation case counts, considering the potential impact of model
instability caused by the small number of reported cases and the diversity of data source.72,73
Another strength is the ability to consider the driving impact of predictive sociodemographic and
socioeconomic covariates on the association between IPCC predictive climate variability and
future risk of respiratory exacerbation and subsequent burden unto the healthcare system.
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Findings from this study can be used in future applications estimating these relationships given
the context-specific conditions that are likely required to improve preparedness. Further research
can evaluate other predictive factors that can make an individual more susceptible to climate
extremes such as indoor air quality (IAQ) measures. Predictors of IAQ include house dust mites,
pets such as dogs and cats, pests such as cockroach and rodents, and molds.74 Crowding or the
number of people in the household and number of people per room can also be an indicator as
concentration could indicate greater generation sources over a smaller volume. The relative
importance of these different triggers varies based on different environmental factors depending
on geographic, climatic, socioeconomic, and housing conditions.74 We also suggest future
research investigate patterns involving day-to-day variation in local meteorological parameters
and hospital admissions in order to support relevant hospital planning at local scales.75
Nevertheless, understanding these context-specific relationships could be useful to improve
preparedness and could support shifting from reactive to anticipatory climate change adaptation
for the health sector.56 Opportunities for public health would benefit from providing intersectoral support for climate solutions with health co-benefits, and using a healthcare framework
to engage and mobilize communities, especially those presenting with highest risk.76

4.5 Conclusions
In summary this study used Bayesian spatio-temporal models to emphasize the importance of
long-term implications from climatic trends; but also, the implications of socio-economic
disparities on the associations between respiratory morbidity and subsequent impact on the
healthcare systems within the future. The overall findings from our study largely support the
original hypotheses regarding our primary and secondary outcomes of respiratory-related
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hospitalizations across New York City, given socioeconomic predictive covariates and the IPCC
predicted precipitation measures: it is estimated there will be increased respiratory exacerbation
hospitalizations, longer length of stay (LOS) (COPD exacerbations within the inpatient setting
only) and increased hospital charges (COPD exacerbations within the inpatient setting only).

Although temperature increase was estimated to increase respiratory exacerbation episodes and
hospital LOS, we can posit cooler temperatures may be indicative of future risk for respiratory
exacerbation hospitalizations and may increase hospital stays instead. Our contrasting results
suggest a very complex relationship between increasing temperature, precipitation and varying
sources of air pollution within the atmosphere. Future research should be done to further
investigate the relationship between temperature lows and varying sources of ambient air
pollution such as ozone and particulate matter, and the overall combined effect on respiratory
health outcomes.

Results also showed sociodemographic and socioeconomic factors such as age, race and/or
poverty status may increase risk of future asthma and COPD exacerbations as well as longer
length of hospital stay associated with these conditions. Causal linkages between our outcomes,
increased risk of respiratory exacerbation and an increase in associated hospital stays, and
predictive climatic and socioeconomic factors should be viewed with caution due to likely
unidentified confounding, but further research is merited to help safeguard the health of
individuals pre-diagnosed with respiratory conditions in extreme climate conditions.
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A major study limitation was the availability of the hospital discharge data, which also included
information on length of stay and total charges. This data was only made available for a 3-year
time period. Traditionally, scientists have defined a ‘Climate Normal’ as an average over a recent
30-year period simply because it is the accepted convention.77 However, the results of this study
can be used to inform future research with the capability of accessing respiratory exacerbation
for a longer period of time. In addition, future studies may benefit from assessing day-to-day
variation in climate to determine if there are any associations with respiratory exacerbation and
associated burden on the healthcare system.

Another limitation involves high uncertainty regarding projected changes in rainfall and
temperature variability into the future. At this time, the IPCC78 provides little to no assessment of
projected changes in extremes at spatial scales smaller than for large regions. Attempts to
estimate changes in precipitation extremes from observations are complicated by large natural
variability and spatial differences.79 Although these changes in precipitation extremes could lead
to changes in flood frequency, the linkage between precipitation changes and flooding can be
modulated by interactions between precipitation characteristics and river basin hydrology, the
nature of which are not yet well understood.80,81 The literature on temperature and precipitation
portray how an accurate scaling of extremes would not only have to involve average temperature
change under future scenarios, but also the skewness of its distribution. Additionally, attempts to
estimate changes in temperature extremes lack inclusion of key air pollution variables that may
be increased by rising temperatures such as ozone and other greenhouse gases, as well as the
effect of wind on dispersing air pollutants either throughout or away from a specified region.
Therefore, this study is limited in providing correlation between potentially dangerous levels of
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global temperature in the future contributing to the climate variability affecting respiratory
disease.

Further limitations include the ecological nature of the study making any findings from this study
only interpretable at the ecological level. Lastly, this study is based on secondary data and
observational information, which are both subject to selection and information bias, and may
present with residual confounding unable to be assessed within this study.82-84 For example, the
IPCC has stated that the ability of the models to simulate climate is best at large horizontal scales
and is severely restricted as the scale is decreased. The scale of analysis adopted by the IPCC
was at the sub-continental scale (106–108 km2) regions.37 Nevertheless, the IPCC mention
AOGCMs may still provide useful information on climate change at smaller spatial scales,
although they may be incapable of capturing many features of changes in local climate, such as
storms, orographic rainfall and heavy precipitation events.37 Uncertainties with the IPCC models
also lie in future emissions, which may impact the general climate system, and the natural
variability of climate. Part of this variability is unforced, due to internal perturbations in the
climate system, whereas another part is due to external forcing from natural phenomena such as
variations in solar activity or volcanic eruptions.37

The findings from this study can be generalizable to other individuals living within NYC that are
pre-diagnosed with asthma and COPD but were not included in this research, as well as to
individuals in other urban areas diagnosed with a chronic health condition (e.g., cardiac), that
may be also experience health inequities. The New York State SPARCS hospital discharge data
includes outcomes from a representative sample of an urban area (New York City) within the
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NYS population and includes individuals who were discharged from a NYS hospital or article 28
medical facility, regardless of age, sex, race/ethnicity and socioeconomic status. Therefore, this
study could also be transportable to other diverse urban populations within the U.S. with a
similar population structure, where there is a disproportionate burden of chronic health disease
(e.g., respiratory, cardiac) among disadvantaged populations. Given our findings in NYC,
research can focus on similar racial and socioeconomic disparities that are expected in other
large cities with a similar population makeup across the United States.

The results of this study underscore the importance of potential climate variability on the future
burden of respiratory disease morbidity and subsequent impact on the healthcare system. The
findings from this study further support the need for further research into assessing the varying
ways individuals of different socioeconomic classes experience adverse health effects from
climate variability. There are populations most vulnerable to environmental changes, and the
consequences of these changes are either attenuated or amplified by different human and
environmental conditions. Mediating influences and negative moderators to how a system can
withstand changes in climate include neighborhood-level (e.g., proximity to highways, toxic
waste sites) and individual-level (socioeconomic, pediatric, elderly, pre-existing medical
condition) variables. Collectively, these influences determine which societies or communities are
resilient and adaptive to climate variability. Potential outcomes include adverse health effects in
communities that are less resilient, whereas adaptive capacities can support a system’s
resiliency.85
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Adaptive methods can be implemented to reduce vulnerability to change and can include
increased annual primary care physician visits, increased access to specialty care within the
outpatient setting or population health informatics tools to easily connect patients to medical
resources. These capacities, either carried out individually or collectively, can support a system’s
resiliency and therefore need to be evaluated in future research. A clearer understanding of the
systems surrounding an individual’s risk for future respiratory morbidity can alleviate the impact
on the healthcare system, but interventions should and can be appropriately targeted to certain
sociodemographic and socioeconomic groups to include adaptive responses to variation in
climate such as coping, adjustments, and adaptations.
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Chapter 5. Summary of results, conclusions and future research
directions
The goal of this dissertation is to address the gaps in current understanding of respiratory
morbidity and associated hospitalizations and to contribute to our understanding of how climate
variability and sociodemographic factors impact respiratory disease among residents of NYC.
The research in Chapters 2 and 3 examined the associations between respiratory disease as a
function of space and time and the contextual factors surrounding an individual’s socioeconomic
circumstances and climate extremes. The research in Chapter 4 examined the future burden of
respiratory disease on morbidity and on the impact on the healthcare system, given predictive
climatic, socio-demographic and socio-economic factors.

5.1 Major findings from Chapter 2
Respiratory exacerbation risk increased temporally and across NYC ZIP code tabulated areas
(ZCTAs), with disproportionate increases in certain ZCTAs demonstrating geographic disparity.
•

Space-time permutation results showed a consistent amount of non-winter 2018 seasons
(Spring 2018 and Autumn 2018) appearing in statistically significant clusters across total
respiratory exacerbations (asthma and COPD). Seasonal allergies and meteorological
conditions may have played a role, but further research is required to confirm this
association.
o When looking at statistically significant clusters of asthma exacerbation episodes
across both medical facility settings, ‘Summer 2018’ appeared the most for a total
of 8 clusters. When looking at COPD exacerbation episodes across both medical
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facility settings, ‘Summer 2016’ appeared in the most statistically significant
clusters for a total of 5 clusters.
•

Space-time permutation showed the Melrose neighborhood part of the South Bronx
borough was persistent for the longest duration of the study period in both COPD
inpatient and outpatient exacerbation space-time permutation analyses. Melrose is near
facilities with air pollutant emissions, as well as within 400-480 m of a state or county
highway.1 This neighborhood is also located within the South Bronx, an area known to
have high poverty rates as well as the lowest percentage of insured people in the city.2
Furthermore, the highest percentage of the NYC population identifying as black reside in
the Bronx and Upper Manhattan (i.e. Harlem and East Harlem).2

•

Space-time permutation analyses revealed the Silver Lake neighborhood within the
borough of Staten Island was included among statistically significant clusters across total
respiratory (asthma and COPD) exacerbations for both inpatient and outpatient medical
facility settings. No other ZCTA was persistent and significant across all four ‘diagnosissettings’ (asthma inpatient, asthma outpatient, COPD inpatient and COPD outpatient) for
all three years of the study period. This finding may be attributed to high rates of obesity
in northern Staten Island, which is formally understood to be a risk factor for respiratory
disease.2; however, further research would be required to confirm this.

5.2 Major findings from Chapter 3
•

The crude inpatient case counts across Asthma and COPD exacerbation decreased
gradually over the course of the study period. However, the crude outpatient case counts
across Asthma and COPD exacerbation first increased from 2016 to 2017 and then
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decreased from 2017 to 2018. This may indicate possible fluctuation in the cases of
outpatient respiratory exacerbation cases per year, despite an overall decline in the trend.
o The annual asthma exacerbation inpatient crude case counts were estimated at
4755, 4070 and 3871 per year for 2016, 2017, and 2018, respectively. The annual
AEo crude case counts were estimated at 77 863, 74 137 and 69 016 per year for
2016, 2017, and 2018, respectively. The annual CEi crude case counts were
estimated at 11 752, 10 861 and 10 241 per year for 2016, 2017, and 2018,
respectively. The annual CEo crude case counts were estimated at 8 118, 8 354
and 8 075 per year for 2016, 2017, and 2018, respectively.
•

Crude case counts were higher for asthma exacerbation episodes occurring within the
outpatient (221 016) setting than the inpatient (12 696), as compared to crude case counts
being higher for COPD exacerbation episodes occurring within the inpatient (32 854)
setting than the outpatient (24 547). This suggests patients experiencing a COPD
exacerbation episode may primarily seek care within the inpatient setting, as opposed to
those experiencing an asthma exacerbation episode.

Results from our Bayesian model suggest spatial and temporal heterogeneity in the relationship
between asthma and COPD exacerbation and key socio-demographic and climatic characteristics
in NYC:
•

Through GIS mapping of posterior medians quantiles, we found high respiratory
exacerbation rates peaked between February through March 2016, October 2016 through
May 2017, Jan 2018 and October through December 2018. Meteorological conditions
may have influenced the temporal distribution of respiratory exacerbation rates,
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especially for October through December of 2018 as similarly found in Chapter 2, but
further research is required to support this relationship.
•

Bayesian spatio-temporal modelling showed neighborhoods with the highest risk of
respiratory exacerbation appeared closest to major highways and airports (JFK in
southern Queens and LGA in north-central Queens).3

Bayesian Spatio-temporal modelling further showed effects of the community-level
sociodemographic and city-wide climatic covariates on the outcome of respiratory exacerbation:
Socio-demographic predictive covariates
•

Increasing proportion of people under age 20 was protective of asthma inpatient
exacerbation (RR 0.819 [0.73, 0.92]) , which may be explained by occupational
exposures, smoking, and obesity, variables that are all likely to be lower in this age
group.4,5 However, increasing proportion of people over age 64 was a risk factor for
COPD exacerbation across both the inpatient (RR 1.4 [1.27, 1.54]) and outpatient (RR
1.2 [1.06, 1.35]) settings within a community. This finding may be explained by the
nature of the disease where an individual will not exhibit prominent signs and symptoms
of COPD until years after first exposure (e.g., smoking), despite loss of lung function
more accelerated in the early stages of COPD than in the later stages.6

•

An increasing proportion of blacks, regardless of ethnicity, (Asthma Inpatient RR 1.07
[1.05, 1.09], COPD Inpatient RR 1.004 [1.004, 1.049], and COPD Outpatient RR 1.09
[1.06, 1.12]) was a consistent risk factor across COPD and asthma within a community.
African American youth have greater odds of an asthma diagnosis even compared with
other minority groups, and the odds increase as socioeconomic status decreases.7
Differences in illness management may account for some of these disparities.8 Similarly,
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an increasing proportion of people living below the federal poverty level was also a
consistent risk factor (Asthma Inpatient RR 1.26 [1.18, 1.35], COPD Inpatient RR 1.22
[1.219, 1.36], and COPD Outpatient RR 1.51 [1.41, 1.61]). This indicates that those who
are of a lower socioeconomic status continue to seek emergency care for asthma
exacerbation as compared to those of higher SES. Lower SES has long been associated
with greater emergency health service use, worse asthma control and worse asthma selfefficacy.9 This may be due to the influence of SES on accessibility, affordability,
acceptability and actual utilization of various available health facilities.10
•

An increasing proportion of the adult population with at least a 4-year college degree was
protective against exacerbation in the inpatient setting for both asthma (RR 0.89 [0.886,
0.93]) and COPD (RR 0.892 [0.89, 0.96]) within a community. This observation agrees
with the literature suggesting educational attainment reduces the risk for health morbidity
and mortality due to increased accessibility to resources such as health insurance through
the employer, lack of occupational exposure, and lower smoking prevalence.4,5 Other
downstream benefits of educational attainment include the resources and knowledge to
adopt healthier behaviors and the resources to live in healthier neighborhoods, which can
inadvertently decrease air pollution exposure both indoors and outdoors.11

•

Our findings across homes heated with fuel oil, kerosene, etc. were inconsistent across
the outcomes. However, these heating methods are all sources of combustion products
and particulate matter, which can be directly emitted from the remaining residual oil
boilers in buildings or released when fuels are incompletely burned;12 nevertheless,
further research would be required to confirm this.
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Meteorological predictive covariates
•

Average monthly maximum temperature was consistently protective of respiratory
exacerbation across all four outcomes (Asthma Inpatient RR 0.91 [0.88, 0.94], Asthma
Outpatient RR 0.999 [0.996, 1.002], COPD Inpatient RR 0.94 [0.938, 0.97], and COPD
Outpatient RR 0.97 [0.94, 0.99]). However, the increase in respiratory exacerbation
episodes was only marginal for asthma patients within the outpatient setting. These
findings suggest less cases of both asthma and COPD exacerbation during the summer
and more in the winter, aligning with our spatial risk analyses where the Fall and Winter
seasons presented with higher case counts of respiratory exacerbation. A major trigger of
respiratory exacerbation during the fall and winter season is cold air and viral infections,
(e.g. rhinovirus), and it is likely that viruses are also important in increasing airway
inflammation in COPD in the winter.13

•

Total monthly precipitation was protective of COPD exacerbation episodes within the
inpatient setting (RR 0.95 [0.93, 0.98]). This may have occurred because the rainfall may
not have been as heavy to induce hydration and fragmentation of pollen grains, which
could release allergenic biological aerosols into the atmosphere making it more difficult
for those patients pre-diagnosed with respiratory conditions to breathe.14 It may also be
due to heavy rainfall that can “wash out” atmospheric particulate pollution leading to
respiratory exacerbation.15 Total monthly precipitation was not statistically associated
with COPD outpatient risk or either of the Asthma hospital settings.

Finally, annual average PM 2.5 in the 90th percentile was very marginally protective for Asthma
Inpatient (RR 0.87 [0.77, 1.01]), Asthma Outpatient (RR 0.998 [0.98, 1.01]), and COPD
Inpatient (RR 0.99 [0.92, 1.08]); while it was a risk factor for COPD exacerbation in the

167

outpatient setting (RR 1.15 [1.02, 1.29]). The highest levels of annual average PM 2.5 in the 90th
percentile was 10.1 mcg per cubic meter, observed in Williamsburg/Greenpoint in Brooklyn
(nearby major highways and a site of heavy industrialization), and 8.6 mcg per cubic meter
observed in the south Bronx (nearby major highways and housing higher populations of lower
income and minority groups).16 However, atmospheric “washout” from heavy rainfall is
recognized as one of the main mechanisms of reducing atmospheric particulate pollution, which
may explain the findings in the AEi, AEo and CEi outcomes.15

5.3 Major findings from Chapter 4
•

The overall findings from our study largely support the original hypotheses regarding our
primary outcome of respiratory-related hospitalizations across New York City, given
socioeconomic predictive covariates (a 10% increase in the percentage of the NYC
population under 20 years old into the year 2039 had a RR of 1.55 (1.28, 1.84) for AEi
and 0.94 (0.79, 1.09) for AEo; a 10% increase in the percentage of the NYC population
over 64 years old into the year 2039 had a RR of 1.41 (1.27, 1.55) for CEi and 1.77 (1.29,
2.47) for CEo; a 10% increase in the percentage of the population that is Black (Hispanic
and non-Hispanic) had a RR of 1.14 (1.1, 1.2) for AEi, 1.28 (1.24, 1.32) for AEo, 1.03
(1.0, 1.05) for CEi, and 1.38 (1.21, 1.48) for CEo; a 2% increase in the percentage of the
NYC population that is in poverty into the year 2039 had a RR of 1.17 (1.14, 1.2) for
AEi, 1.17 (1.14, 1.19) for AEo, 1.06 (1.05, 1.08) for CEi, and 1.01(0.96, 1.04) for CEo)
and the IPCC predicted precipitation measures (a 2 cm increase in total precipitation
across NYC into the year 2039 had a RR of 1.01 (0.99, 1.04) for AEi, 1.01 (0.98, 1.03)
for AEo, 1.01 (0.99, 1.03) for CEi, and 1.01 (0.96, 1.04) for CEo). Although increased
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temperature was found to decrease respiratory exacerbation into 2039 (RR of 1-degree
Celsius increase in the maximum temperature across NYC into the year 2039 is: 0.98
(0.97, 0.99) for AEi, 0.99 (0.98, 1.0) for AEo, 0.99 (0.98, 1.0) for CEi, and 0.98 (0.975,
0.99) for CEo), this finding indicates colder temperatures may increase the risk of an
exacerbation instead.
•

In addition, our findings for the secondary outcomes largely support the original
hypotheses within the inpatient setting for COPD exacerbations where length of hospital
stay was longer and total hospital charges were higher given socioeconomic predictive
covariates (a 10% increase in the percentage of the NYC population that is over 64 years
old into the year 2039 had a beta coefficient estimate of 19.64 (9.88, 28.19) days and 2.07
(1.13, 3.07) per hundred thousand dollars for CEi, and 0.13 (0.05, 0.2) per hundred
thousand dollars for CEo; a 2% increase in the NYC population that is in poverty had a
beta coefficient estimate of 3.25 (2.1, 4.35) days and 0.23 (0.12, 0.34) per hundred
thousand dollars for CEi, and 0.09 (0.05, 0.12) per hundred thousand dollars for CEo),
and the IPCC predicted precipitation measures (a 2 cm increase in total precipitation
across NYC into 2039 had a beta coefficient estimate of 1.1 (0.02, 2.29) days and 0.2
(0.03, 0.35) per hundred thousand dollars for CEi). Although increased temperature was
found to decrease hospital length of stay (a 1-degree Celsius increase in the maximum
temperature across NYC into 2039 had a beta coefficient estimate of -0.38 (-0.67, -0.11)
days for CEi), this finding indicates colder temperatures may potentially increase LOS
instead.
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5.4 Significance of findings and Key strengths
The findings of the studies in this dissertation contribute to our understanding of how climate
and sociodemographic covariates affect respiratory health. Although previous studies have
provided information on sociodemographic predictive variables and respiratory health, the
results are varied on specific climatic factors and the role of time and space. Within this
dissertation, space-time permutation analyses revealed clusters of increased risk of respiratory
exacerbation during varying time periods and spatial locations. Bayesian spatio-temporal Poisson
regression methods indicate the complexity of factors such as overall climate and socioeconomic
status. Overall, COPD and asthmatic events may be triggered by environmental factors such as
cooler air and can be augmented by certain socioeconomic conditions such as race and poverty
status. Respiratory health as a result of sociodemographic and climatic factors are conceptually
inherent and have been quantified with different methods and outcomes.

Moreover, this dissertation further quantifies the burden on our healthcare system of respiratory
exacerbation hospitalizations in an urban population. Bayesian spatio-temporal modelling was
applied to predict the expected cases, total hospital charges and length of stay (inpatient setting
only) based on Intergovernmental Panel on Climate Change (IPCC) predictive climatic factors
and other relevant predictive socio-demographic and socio-economic factors. By determining
populations most vulnerable to environmental changes and the consequent burden unto our
healthcare systems, we can have a clearer understanding of how the consequences of these
changes are either attenuated or amplified by different socio-economic and socio-demographic
conditions.
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The findings from this dissertation research support on-going respiratory management goals,
specifically New York City Department of Health and Mental Hygiene’s asthma management,
which aim to minimize symptoms and exacerbations so people with asthma can lead full, active
lives.17 Proper self-care and preventative guidance for asthmatic disease was incorporated into a
formalized ‘Asthma Action Plan’18 as part of asthma management policies implemented
throughout New York State and New York City. As COPD is an obstructive lung disease with a
similar pathophysiology to asthma, our findings can also support COPD management by
identifying predictive factors of COPD exacerbation. COPD prevalence is generally higher than
is recognized by health authorities.19,20 Few population-based prevalence surveys have been
carried out, and prevalence estimates have often relied on expert opinion or self-reported doctor
diagnosis, a notoriously unreliable source of information for COPD.21 For example, in the USA
National Health and Nutrition Examination Survey III, 70% of those with airflow obstruction
had never received the diagnosis of COPD.22

Incorporating COPD management into this formal action plan across NYC may help reduce
morbidity rates associated with COPD, especially given this dissertation’s findings suggesting
patients experiencing a COPD exacerbation episode primarily seek care within the inpatient
setting as opposed to those experiencing an asthma exacerbation episode. Another way of
placing the cost of COPD into perspective is to compare it with the cost of asthma. Asthma has
traditionally received greater investigator attention than COPD; however, the latter is more
prevalent in the aging adult population and its healthcare load may even be greater due to the
higher frequency of hospitalizations.21 Although there are a number of resources for patients with
pre-diagnosed COPD such as online and local support groups organized by organizations such as
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Freedom From Smoking® and a New York State Smokers’ Quitline organized by the NYS
Tobacco Control Program and the Roswell Park Cancer Institute, there is no available formal
‘action plan’ for COPD disease management and education at this time.23

The results from this dissertation also support adaptation measures for disadvantaged individuals
residing in specific geographical locations that may likely be unable to cope during adverse
climatic events. Such measures include development of preventative respiratory care measures in
the outpatient clinical setting within socioeconomically disadvantaged neighborhoods. This may
include proper medication reconciliation, follow-up on medication adherence, education on
diagnosis/prognosis including awareness of early warning symptoms, and access to resources to
better track environmental conditions (e.g., weather, pollutant levels). In addition, the results
from this study can support the work of environmental justice groups, such as WeACT24, to
provide awareness and garner community support in maintaining clean and healthy indoor living
environments, and the promotion of proper respiratory disease management.

5.5 Public Health Relevance
In Summary, this dissertation research address important problems in the fields of public health,
environmental health, climate science, health care, and sociology. It advances scientific
knowledge on refining the general understanding of the associations between climate variability
and COPD and Asthma as a function over space and time. In particular, this research addresses
the need for focused studies in major cities such as NYC, where there are diverse
sociodemographic classes who experience adverse health effects from extreme climate change in
varying ways. Despite progress in understanding spatial variation in population-based rates of
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COPD and asthma cases across NYC, there are only a few published studies assessing the
manner with which these rates change over both space and time and have adjusted for an array of
sociodemographic and climatic variables. Furthermore, very few studies assessed the future
burden respiratory disease can pose on human morbidity and the overall healthcare system,
specifically with regards to cost and length of stay, and the potential association of these
outcomes with projected temperature and precipitation variables in the context of socioeconomic
predictive factors.

This study was also able to determine populations most vulnerable to environmental changes.
The consequences of these changes are either attenuated or amplified by different human and
environmental conditions and methods that can be implemented to reduce vulnerability to change
include responses such as coping, adjustments, and adaptations.25 The exposures transcending
into a system’s sensitivity to climate variability is mitigated by factors such as resilient housing
and infrastructure as well as emission reduction. Mediating influences and negative moderators
to how a system can withstand variability in climate include neighborhood-level (e.g., proximity
to highways, toxic waste sites) and individual-level (socioeconomic, pediatric, elderly, preexisting medical condition) variables. Collectively, these influences determine which societies or
communities are resilient and adaptive to climate variability. Outcomes estimated in this
dissertation included increased risk of respiratory exacerbation hospitalizations in communities
that are less resilient. Adaptive capacities to further translate our findings into pragmatic and
practical measures to alleviate the variation observed in risk factors of respiratory exacerbation
include the promotion of increased annual primary care physician visits, increased access to
specialty care within the outpatient setting, and population health informatics tools to easily
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connect patients to medical resources. These measures can all support a system’s resiliency and
therefore need to be further assessed.

The findings from this study can be generalizable to other individuals living within NYC that are
pre-diagnosed with asthma and COPD but were not included in this research, as well as to
individuals in other urban areas diagnosed with a chronic health condition (e.g., cardiac), that
may be also experience health inequities. The New York State SPARCS hospital discharge data
includes outcomes from a representative sample of an urban area (New York City) within the
NYS population and includes individuals who were discharged from a NYS hospital or article 28
medical facility, regardless of age, sex, race/ethnicity and socioeconomic status. Therefore, this
study could also be transportable to other diverse urban populations within the U.S. with a
similar population structure, where there is a disproportionate burden of chronic health disease
(e.g., respiratory, cardiac) among disadvantaged populations. Given our findings in NYC,
research can focus on similar racial and socioeconomic disparities that are expected in other
large cities with a similar population makeup across the United States.

5.6 Limitations
The studies in this dissertation have several overlapping limitations. First, the studies in Chapters
2, 3 and 4 and 3 are based on secondary data. Thus, while they provide insight into various
associations, they do not imply causality. This limitation translates into the inability of this
dissertation to determine causal factors which can potentially guide on intervention. For
example, we were unable to assess underlying clinical components such as early warning
symptoms and proper adherence to medications, factors that can determine the effectiveness of
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early interventional measures. Secondly, the collected data about the number of COPD and
asthma exacerbation episodes were based on hospital discharge codes, so we cannot rule out
errors inherent in coding or data not collected with the etiology of the exacerbations. However,
the definition of discharge codes based on ICD-10 is used in all previous studies using this
methodology and their accuracy has been validated in several studies.26,27 This limitation is
partially compensated by the large sample size.28

Misclassification of case location could have also occurred, because addresses and geocoded
coordinates can be subject to errors.29 In addition, cases may spend a majority of their time
outside of their place of residence such as work and/or school, so the ZCTAs recorded for the
cases may not represent the locations where they may have highest exposure to predictive factors
for a respiratory exacerbation. However, respiratory exacerbation is usually an emergency so
patients are sent to the hospital or article 28 medical facility nearest their current location, which
may very likely be work or home.

Another limitation is the lack of primary care, pediatrician and pulmonary specialist visits
captured by SPARCS.30 Many patients go to their Primary Care Physician (PCP) once they
experience a symptom of COPD/Asthma, prior to heading to their nearest hospital or medical
facilities certified under Article 28 of the Public Health Law30 where they may fear experiencing
long waiting periods. Further, these limitations are hypothetical in nature and there is no
available evidence that these potential location errors are systematic. Therefore, they should be
minimized by the use of ZCTAs as the unit of analysis, as done in this study, rather than the
specific geocoded address points.31
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Additionally, limitations of the studies in Chapters 3 and 4 was the inability to analyze indoor air
quality (IAQ) co-variables due to unavailability of data, especially the main drivers of poor IAQ:
Crowding, second-hand smoke, pests (cockroaches, mice/rats) and pets.32

Further limitations across all three studies in Chapter 2, 3 and 4 include the 3-year time period.
Traditionally, scientists have defined a ‘Climate Normal’ as an average over a recent 30-year
period simply because it is the accepted convention.33 However, the results of this study can be
used to inform future research with the capability of accessing respiratory exacerbation for a
longer period of time, yielding more consistent findings and improved accuracy of future
predictions.

Additional limitations across all three studies involve the sociodemographic composition of the
Summer 2018’ and ‘Spring 2018’ appeared. For example, the population is aging over time
leading to age, period and cohort (APC) effects as different sources of health-related change:
change can occur as individuals age throughout their life course, over time due to differences
between cohort groups where the social and health composition of society as a whole can
change, and finally as a result of period effects where the passage through time results in a
change in health, regardless of the age of the individual.34 Prediction about the effects of climate
variability on health-related air pollution is further hampered by limits including population
growth, economic development, energy use and production. Current knowledge about weather
effects on air pollution is still unsatisfactory; there is still a need for better emission inventories
and observational datasets.35

176

5.7 Future Research Directions
Future research can begin at the level of the Primary Care Physician (PCP) providing acute
(outpatient) medical care, given this study’s inability to capture primary care or pediatrician
visits. Studies could estimate the effect of proximity to one’s PCP and/or a formal pulmonary
rehabilitation program on reducing respiratory exacerbation. A potential sample population can
be drawn from patients within specific socioeconomic classes or disadvantaged neighborhoods
frequenting primary care and/or pulmonology-focused medical practices for their prevention of
respiratory exacerbations. The study could also entail a longitudinal component spanning a
longer duration of time, as the three-year time period proved limiting within this dissertation.

Although we cannot use the findings of this dissertation to determine testable interventions, we
are still able to suggest testable predictive factors that may either increase or decrease the risk of
respiratory exacerbation. This includes: acknowledgement of early warning symptoms, access to
medication education using a formalized education tracking system within a medical dashboard,
adherence to medication, accessible environmental monitoring tracking applications that can be
easily downloaded unto patients’ cellphones, and availability of improved electronic medical
record documentation to include sociodemographic variables predictive of respiratory
exacerbation and/or location of work/school and/or residence.

The data sources and methodologies used in this dissertation are continuously growing and
improving. For example, there are many more climate datasets than even a few years ago and
geospatial software developers continue to add in new features.36 The SPARCS datasets are an
invaluable resource; however, with recognition of how socioeconomic status affects health, it
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would be beneficial if information on sociodemographic variables such as race, age group and
gender could be more adequately collected.

The findings from this dissertation, along with the abundance of literature available37,38, support
a need for further research on identifying additional predictive risk factors for respiratory
exacerbation in the context of ambient air pollution. There is a known relationship between
pulmonary ailments, individuals living within disadvantaged communities, and air emissions
from sources such as traffic, neighboring highways, factories and warehouse, yet the magnitude
and the direction of this association is still being extensively studied and analyzed. By
understanding the strength of this relationship and its contextual nuances, support can be
garnered towards policy-level provision.

The overall goal is to improve public health response and inform air emissions policies,
environmental monitoring tools and patient health education efforts. Conclusively, this
dissertation research will advance scientific knowledge towards reaching these objectives
through refining the general understanding of the associations between climate variability,
sociodemographic health disparities, and respiratory exacerbation (as defined by asthma and
COPD exacerbation) as a function over space and time.

5.8 References
1.
2.

Fund ED. All Choked Up. 2007.
Pala D, Pagán J, Parimbelli E, Rocca MT, Bellazzi R, Casella V. Spatial Enablement to
Support Environmental, Demographic, Socioeconomics, and Health Data Integration and
Analysis for Big Cities: A Case Study With Asthma Hospitalizations in New York City.
Front Med (Lausanne). 2019;6:84-84.

178

3.

4.

5.
6.
7.

8.
9.
10.
11.
12.
13.
14.

15.
16.
17.
18.

19.

20.
21.
22.

Akinbami L, Moorman J, Liu X. Asthma prevalence, health care use, and mortality:
United States, 2005-2009 (National Health Statistics Reports No. 32). Hyattsville, MD:
Centers for Disease Control and Prevention. 2011.
Assari S, Mistry R. Educational Attainment and Smoking Status in a National Sample of
American Adults; Evidence for the Blacks' Diminished Return. Int J Environ Res Public
Health. 2018;15(4).
Eagan TM, Gulsvik A, Eide GE, Bakke PS. The effect of educational level on the
incidence of asthma and respiratory symptoms. Respir Med. 2004;98(8):730-736.
Tantucci C, Modina D. Lung function decline in COPD. Int J Chron Obstruct Pulmon
Dis. 2012;7:95-99.
Thakur N, Oh SS, Nguyen EA, et al. Socioeconomic status and childhood asthma in
urban minority youths. The GALA II and SAGE II studies. Am J Respir Crit Care Med.
2013;188(10):1202-1209.
Naar S, Ellis D, Cunningham P, et al. Comprehensive Community-Based Intervention
and Asthma Outcomes in African American Adolescents. Pediatrics. 2018;142(4).
Kant S. Socio-economic dynamics of asthma. Indian J Med Res. 2013;138(4):446-448.
Agarwal A. Social classification: the need to update in the present scenario. Indian J
Community Med. 2008;33(1):50-51.
Sciences NAo. Why Educational Attainment Is Crucial to Improving Population Health.
Washington, DC: ;2015.
Hygiene NYCDoHaM, Queens College CUoNY. Neighborhood Air Quality 2008 - 2015.
April 2017 2017.
Nicholson KG, Kent J, Ireland DC. Respiratory viruses and exacerbations of asthma in
adults. BMJ. 1993;307(6910):982-986.
Amato GD, Cecchi L, Amato MD, Licardi G. Urban Air Pollution and Climate Change as
Environmental Risk Factor of Respiratory Allergy. J Investig Clin Immunol.
2010;20(2):95-102.
Guo LC, Zhang Y, Lin H, et al. The washout effects of rainfall on atmospheric particulate
pollution in two Chinese cities. (1873-6424 (Electronic)).
NYCDOHMH, Environment QCBCCfHat. The New York City Community Air Survey:
Neighborhood air quality 2008-2016. NYC Health. 2018.
Hygiene NYCDoHaM. Managing Asthma. 2018.
Health NYSDo, Hospitals NHa. Asthma Action Plan.
https://www.nychealthandhospitals.org/healthtips_tags/asthma-action-plan/. Accessed
04/09, 2020.
Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS, Committee GS. Global
strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary
disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD)
Workshop summary. Am J Respir Crit Care Med. 2001;163(5):1256-1276.
GOLD Guidelines. 2003; www.goldcopd.com. Accessed 04/15, 2020.
Chapman KR, Mannino DM, Soriano JB, et al. Epidemiology and costs of chronic
obstructive pulmonary disease. Eur Respir J. 2006;27(1):188-207.
Stang P, Lydick E, Silberman C, Kempel A, Keating ET. The prevalence of COPD: using
smoking rates to estimate disease frequency in the general population. Chest.
2000;117:354S–359S.

179

23.

24.
25.
26.
27.
28.

29.
30.
31.

32.

33.

34.

35.
36.

37.

38.

Health NYSDo. Chronic Obstructive Pulmonary Disease (COPD). Chronic Diseases and
Conditions https://www.health.ny.gov/diseases/chronic/copd/fact_sheet.htm. Accessed
04/09, 2020.
WeACT. WeACT for Environmental Justice. 2020; https://www.weact.org/whoweare/.
Accessed 12/10, 2019.
Turner BL, 2nd, Kasperson RE, Matson PA, et al. A framework for vulnerability analysis
in sustainability science. Proc Natl Acad Sci U S A. 2003;100(14):8074-8079.
Brock A, Griffiths C, Rooney C. The impact of introducing ICD-10 on analysis of
respiratory mortality trends in England and Wales. Health Stat Q. 2006(29):9-17.
Beckman KD. Coding Common Respiratory Problems in ICD-10. Fam Pract Manag.
2014;21(6):17-22.
Almagro P, Hernandez C, Martinez-Cambor P, Tresserras R, Escarrabill J. Seasonality,
ambient temperatures and hospitalizations for acute exacerbation of COPD: a populationbased study in a metropolitan area. Int J Chron Obstruct Pulmon Dis. 2015;10:899-908.
Cayo MR, Talbot TO. Positional error in automated geocoding of residential addresses.
International journal of health geographics. 2003;2(1):10-10.
SPARCS. NYS SPARCS Data Dictionary. In: Safety OoQaP, ed. Bureau of All Payer
Database. New York: New York State Department of Health; 2019.
Recuenco S, Eidson M, Kulldorff M, Johnson GD, Cherry B. Spatial and temporal
patterns of enzootic raccoon rabies adjusted for multiple covariates. International Journal
of Health Geographics. 2007;6(14).
Morawska L, Ayoko GA, Bae GN, et al. Airborne particles in indoor environment of
homes, schools, offices and aged care facilities: The main routes of exposure.
Environment International. 2017;108:75-83.
Administration NOaA. Defining Climate Normals in New Ways.
https://www.ncdc.noaa.gov/news/defining-climate-normals-new-ways. Accessed 02/27,
2020.
Bell A, Jones K. Age, Period and Cohort Processes in Longitudinal and Life Course
Analysis: A Multilevel Perspective. In: Burton-Jeangros C, Cullati S, Sacker A, al. e, eds.
A Life Course Perspective on Health Trajectories and Transitions [Internet]. Cham,
Switzerland: Springer; 2015.
D'Amato G, Vitale C, De Martino A, et al. Effects on asthma and respiratory allergy of
Climate change and air pollution. Multidiscip Respir Med. 2015;10:39.
Dunn G, Johnson GD. The geo-spatial distribution of childhood diarrheal disease in West
Africa, 2008-2013: A covariate-adjusted cluster analysis. Spat Spatiotemporal Epidemiol.
2018;26:127-141.
Patel MM, Quinn JW, Jung KH, et al. Traffic density and stationary sources of air
pollution associated with wheeze, asthma, and immunoglobulin E from birth to age 5
years among New York City children. Environ Res. 2011;111(8):1222-1229.
Maantay J. Asthma and air pollution in the Bronx: methodological and data
considerations in using GIS for environmental justice and health research. Health Place.
2007;13(1):32-56.

180

